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Environmental exposures are experienced throughout the human lifespan and may have a vast 
influence on human health. Certain subgroups of the population might be more susceptible to adverse 
effects. The developmental origins of health and disease (DOHaD) hypothesis suggests that adverse 
exposures in early life might induce permanent developmental adaptations leading to increased risks 
of cardiometabolic disease in later life.1,2 For women, pregnancy itself is also considered a period of 
increased susceptibility to potentially long-term physiological changes due to exposure to endocrine 
disrupting chemicals.3
Studies presented in this thesis were designed to investigate potential associations of environmental 
exposures during pregnancy with maternal and child health. The studies are particularly focused on 
exposures of the endocrine disrupting chemicals bisphenols and phthalates and parental smoking. 
Bisphenols and phthalates
Bisphenols are used to produce polycarbonate plastics and epoxy resins which are used in various 
consumer products, including the lining of metal cans, toys and water pipes.4 Phthalates are synthetic 
chemical esters of phthalic acid that are widely used to impart flexibility, pliability and elasticity to 
plastics.5 Phthalates can be divided in low molecular weight (LMW) phthalates, which are frequently 
added to personal care products to impart flexibility or retain scent, and high molecular weight (HMW) 
phthalates, that are used as plasticizers to impart flexibility in vinyl plastics for diverse applications 
including flooring, medical devices and food packaging. 6,7 Both bisphenols and phthalates are at risk for 
leaching into the human environment.4,6 Bisphenols and phthalates are lipophilic chemicals (phthalates 
> bisphenols), have short biological half-lives (<24h, bisphenols < phthalates) and undergo a first-pass 
effect when ingested orally before excretion in urine. 8-10 Bisphenols and phthalates have several potential 
mechanisms of effect, including endocrine disruption through estrogen and androgen receptor binding, 
activation of nuclear transcription factors leading to epigenetic changes, and induction of oxidative or 
nitrosative stress.10-15  
As pregnancy and early life are periods with increased vulnerability to environmental exposures, 
exposure to bisphenols and phthalates during pregnancy may pose a risk for maternal and fetal health 
in the short and long term. As example, estimated health care costs of obesity and diabetes attributable 
to adult bisphenol and phthalate exposure in Europe is in the order of €17 billion annually.16 Thus 
far, only few studies have been performed assessing the impact of bisphenols and phthalates on the 
course of pregnancy and maternal health. Recently, the European Union expanded its regulations 
concerning bisphenol A and several phthalates. 17,18 In the meantime, these embargoes stimulated the 
industries to progressively switch to synthetic bisphenol analogues and di-2-ethylhexylphthalate (DEHP) 
replacements.19 Effects of these replacements have been studied scarcely. Further studies are needed 
to investigate effects of these substitute chemicals. Assessing the associations of bisphenols and 
phthalates with maternal and pregnancy related outcomes may give an insight in potential pathways in 




Since the first Surgeon General’s report in 1964 more than 20 million premature adult deaths can be 
attributed to cigarette smoking and a wide range of studies have causally linked smoking to numerous 
diseases.20 Although strategies to prevent smoking are globally implemented, Europe has the highest 
prevalence of adult tobacco smoking among the World Health Organization (WHO) regions. Total costs 
attributable to smoking were estimated in the order of €544 billion annually, about 4.6% of the EU27 
combined gross domestic product.21 
While tobacco smoking used to be mainly a male phenomenon, the gap in prevalence between male 
and female adults is now very small (<5%) in several European countries, including The Netherlands.22 
It has been estimated that one in five women of reproductive age worldwide are expected to be 
tobacco users by 2025.23 Many studies have been conducted on the impact of maternal smoking during 
pregnancy on adverse birth outcomes showing causal pathways leading to congenital abnormalities, 
stillbirth, preterm birth and low birth weight and sudden infant death syndrome.24-28 Maternal smoking 
during pregnancy has also been associated to increased risks of overweight in childhood.29-31 The effects 
of changing maternal smoking habits during pregnancy and the share of paternal smoking in these 
associations remain inconclusive.32-37 Further examination of these associations are needed to develop 
preventive strategies.   
General aim
The general aims of this thesis was to investigate the associations of well-known adverse exposures, 
namely endocrine disruptors and parental smoking during pregnancy with maternal, fetal and childhood 
outcomes. 
General design
The studies described in this thesis were embedded in the Generation R Study, a population-based 
prospective cohort study, and in an international consortium of collaborating pregnancy and birth 
cohort studies. 
Generation R Study
The Generation R Study is a population-based prospective cohort study from fetal life until young 
adulthood in Rotterdam, the Netherlands.38 The Generation R Study was designed to identify early 
environmental and genetic determinants of growth, development and health in fetal life and childhood. 
All pregnant women living in the study area with a delivery date between April 2002 and January 2006 
were eligible for enrolment in this study. Enrolment was aimed at early pregnancy, but was allowed 
until the birth of the child. At baseline 9,778 mothers were enrolled in the study, of whom 8,880 
(91%) were included during pregnancy. The Generation R study is a multi-ethnic cohort. Participants 




(7%) and Moroccan (6%). Measurements were planned in early pregnancy (<18 weeks of gestation), 
mid-pregnancy (18-25 weeks of gestation) and late pregnancy (≥25 weeks of gestation) and included 
parental physical examinations, biological samples (i.e. blood and urine), fetal ultrasound examinations, 
self-administered questionnaires and medical records completed by midwives and obstetricians. From 
child age 6 years onward, all children and mothers were invited to a dedicated research center in the 
Erasmus MC – Sophia’s Children Hospital to participate in detailed body composition and cardiovascular 
follow-up measurements. Data collection at age 13 is currently ongoing.
Bisphenol and phthalate metabolite concentrations were measured among a subgroup of 1,405 women 
who delivered singletons, had at least one urine sample available for analysis and whose children also 
participated in postnatal studies at 6 years of age.
The LifeCycle Project – EU Child Cohort Network
As part of this thesis, we conducted an individual participant data meta-analysis on the associations 
of parental smoking with risks of adverse birth outcomes and childhood overweight. We used data 
of more than 220,000 parents and children from different cohorts that started during pregnancy or 
childhood working together in the EU Child Cohort Network established by the LifeCycle Project.39
Outline of this thesis
The general aim of this thesis is addressed in the several studies presented in this thesis. Chapter 1.2 
gives an introduction on bisphenols and phthalates, their potential routes of exposure, metabolism, 
mechanisms of effect and a narrative review of the literature. Chapter 2 presents multiple studies 
that examine the associations of bisphenols and phthalates with maternal outcomes. In Chapter 2.1 
we studied the determinants of maternal bisphenol and phthalate concentrations among pregnant 
women. In Chapter 2.2 we examined whether maternal bisphenol and phthalate concentrations in 
early pregnancy were associated with time to pregnancy. Chapter 2.3 presents the associations of 
maternal bisphenol and phthalate concentrations in early pregnancy with maternal hemodynamics and 
the risks of gestational hypertensive complications. We assessed associations of maternal bisphenol and 
phthalate concentrations in early and mid-pregnancy with maternal gestational weight gain in Chapter 
2.4 and with maternal postpartum weight gain in Chapter 2.5. In Chapter 3, we examined whether 
changes in parental smoking during pregnancy affect the risks of adverse birth outcomes and childhood 
overweight. All findings are discussed in Chapter 4 where we will place our results in a broader context. 
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Effects of early exposure to 
phthalates and bisphenols on 
cardiometabolic outcomes in 
pregnancy and childhood
1.2




Pregnant women are exposed to various chemicals, including endocrine-disrupting chemicals 
(EDCs) such as phthalates and bisphenols. Increasing evidence suggests that early life exposures to 
phthalates and bisphenols may contribute to cardiometabolic risks. The aim of this narrative review 
was to summarize current knowledge of the effects of fetal and childhood exposure to phthalates and 
bisphenols on child growth and child cardiometabolic outcomes and the effects on maternal outcomes. 
In total, 54 studies were identified and included. The majority of studies found effects of phthalates 
and bisphenols on maternal, child growth, and cardiometabolic outcomes. Currently results suggest 
that early life exposure to phthalates and bisphenols may have a substantial influence on perinatal and 
postnatal cardiometabolic programming. In a large part of the investigated outcomes studies show 
contradictory results. However, the majority of the existing evidence is based on non-cohort studies 
with single samples neglecting time-variant effects and complicating conclusions regarding causal 
inference. More studies are needed investigating the mechanisms and its potential interactions. 




Pregnant women are exposed to a variety of chemicals,1,2 including endocrine-disrupting chemicals 
(EDCs) such as phthalates and bisphenols.3-6 Increasing evidence suggests that early life exposures 
to phthalates and bisphenols may contribute to the burden of cardiovascular and metabolic disease 
in western countries. Recent work suggests that these exposures may be costly. Health care costs of 
obesity and diabetes attributable to adult phthalate and bisphenol exposure in Europe is in the order 
of €17 billion annually.7 Insofar as prenatal and childhood exposures may even be more impactful, the 
costs of cardiometabolic conditions due to these exposures may be higher.
In this narrative review, we summarize current knowledge of the effects of fetal and childhood exposure 
to phthalates and bisphenols on child growth and child cardiometabolic outcomes. Additionally, we 
summarize the effects of phthalate and bisphenol exposure on maternal outcomes.
Phthalates and bisphenols
Phthalates are synthetic chemical esters of phthalic acid that are widely used in a variety of consumer 
products to impart flexibility, pliability and elasticity to plastics and therefore known as “plasticizers”.8 
Phthalates can be classified in two groups. Low molecular weight (LMW) phthalates (e.g. di-methyl 
phthalate (DMP), di-ethyl phthalate (DEP), di-n-butyl phthalate (DBP)) are frequently added to 
personal care products as aerosol delivery agents, emollients, to impart flexibility in nail polishes, 
and to retain scent.9 High molecular weight (HMW) phthalates (e.g. di-2-ethylhexylphthalate (DEHP), 
di-isononylphthalate (DiNP), di-isodecylphthalate (DiDP), di-n-octylphthalate (DnOP), butylbenzyl 
phthalate (BBzP)) are used as plasticizers to impart flexibility in vinyl plastics (e.g. polyvinyl chloride 
plastics (PVC)) for diverse applications including flooring, medical devices and food packaging.10 In the 
category of HMW phthalates, di-2-ethylhexylphthalate (DEHP) is of particular interest, considering 
many food packaging methods include the use of plastics containing DEHP.11 However, the last few 
years DiNP and DiDP have replaced DEHP to a great extent, mainly due to governmental embargoes.12 
Bisphenol A (BPA) is used to produce polycarbonate plastics and epoxy resins used in various consumer 
products, including the lining of metal cans, toys and water pipes.13 The last few years, bisphenol A has 
been substituted by synthetic bisphenol analogues like bisphenol F (BPF) and bisphenol S (BPS), which 
has been determined in various food items14. BPS has been found as well in paper and paper products, 
including currency bills.15 
Routes of exposure and metabolism
Phthalates are non-covalently bound to many plastics, creating a large risk for release into the 
environment over time.9 Phthalates are generally lipophilic16 and have short biological half-lives (less 
than 24h), undergoing hydrolysis and sometimes oxidation before glucuronidation or sulfation before 
excretion into urine of feces, but it can be measured as well in blood and breast milk.9 A portion of 
the unconjugated (free) monoester and/or its secondary metabolites may also be directly excreted 
in urine.17 The primary routes of exposure to phthalates are ingestion, salivary absorption, inhalation, 
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intravenous, and transdermal. Depending on the route of exposure, the chemical is distributed into 
various body parts based on vascular blood supply and affinity, which in turn may lead to a difference 
in bioavailability. Ingested chemicals often undergo a first-pass effect, entering the liver through the 
hepatic portal system for metabolization, which reduces bioavailability. Following inhalation, salivary 
absorption, intravenous, and transdermal exposure this first-pass effect is initially bypassed, provoking 
a higher bioavailability.18 
Population based studies often use urine as a measurement for exposure to phthalates because it is 
noninvasive and notwithstanding the short biological half-life it may reasonably reflect the exposure 
in the last several weeks or even months.18,19 The majority of the population based studies using 
urinary phthalate concentrations measured the concentration of the free plus glucuronidated species 
of phthalate metabolites, together being the total concentration. However, the free metabolite 
concentrations are less stable over time than the total metabolite concentration, suggesting free 
metabolite concentrations are not a useful indicator of metabolic susceptibility. Time of collection is an 
important factor that must be taken into account, since concentrations of metabolites vary during the 
day as a result of timing of exposure.17  
Various products containing polycarbonate plastics and epoxy resins have been studied to obtain 
more knowledge on bisphenol leaching. Regarding polycarbonate plastics, different results have been 
obtained on the effects of washing and heating on BPA leaching, although all studies found leaching. 
Several studies have been performed that found that heating temperature had a significant effect on 
BPA leaching from metallic coated food cans.13 
Studies investigating the metabolism of BPS and BPF are lacking. Concerning BPA it is known that after 
ingestion BPA undergoes a first-pass metabolism in the gastrointestinal tract and liver consisting of 
glucuronidation and, to a lesser extent, sulfation metabolizing BPA to bisphenol A monoglucuronide 
(BPAG) and bisphenol A sulphate (BPAS) for approximately 98%. In plasma, more than 90% of BPA is 
bound, depending on the route of exposure. Exposure through inhalation and skin absorption have 
been reported as important routes of exposure, as unconjugated bisphenols might circulate longer 
in the plasma, while ingested bisphenols undergo the first-pass metabolism.20,21 However, it has 
been reported that UDP-glucuronosyltransferase (UGT) enzymes found in the airways exhibit a high 
activity towards bisphenols.21 Both BPAG and BPAS are excreted in urine within 5-7 hours after oral 
administration.20,22 BPA penetrates and accumulates in the human placenta, with higher levels of BPA in 
the placenta compared to maternal and fetal plasma.23 In a rat-study, BPF residues have been detected 
in the uterus, placenta, amniotic fluid, and fetuses, with comparable higher levels of BPF in the (intra)
uterine compartment compared to maternal blood.24 
Biomonitoring studies have observed high plasma concentrations not consistent with the observation of 
an extensive first-pass metabolism of oral BPA. However, concentrations of urinary BPA tend to be much 
higher than serum concentrations. It has been hypothesized that these relatively high concentrations 
both in plasma and urine could be explained by sublingual absorption, bypassing the first-pass 
metabolism.25 While another study has suggested that this hypothesis does not hold, the contradictory 
study is beset by critical differences in site of blood collection and volume of urinary output that actually 
support sublingual absorption as a substantial contributor to exposure.22,25
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A potentially important role in metabolism with a large effect on bioavailability is reserved for the 
human microbiome. The microbiome comprises the residential microbes humans are colonized by 
and there is a broad interindividual variation. Several bacterial species possess β-glucuronidases and 
β-glucuronides, enzymes involved in deconjugation and conjugation. Depending on the composition of 
the microbiome, phthalates and bisphenols could be conjugated or deconjugated after enterohepatic 
circulation, resulting in a smaller or larger exposure to unconjugated chemicals, respectively.26,27
Potential mechanisms of effect
Hydrolysed phthalate metabolites have been shown to penetrate the human placenta.28 In vitro studies 
demonstrated that several commercially used phthalates may bind to estrogen receptor alpha (ERα), 
having a weak estrogenic activity,29,30 and to androgen receptors (ARs), having a strong anti-androgen 
activity.31,32 
Another potential mechanism is by activation of nuclear transcription factor peroxisome proliferator-
activated receptors (PPARs). PPAR-gamma (PPARγ), expressed predominantly in adipose tissue and 
to a lesser extent the macrophage and liver, acts as regulator for adipocyte differentiation, lipid 
metabolism and reduces inflammation resulting in improved insulin sensitization.33,34  However, despite 
potential benefits, PPARγ agonists have been shown to cause adverse effects regarding increased lipid 
accumulation and release of adipocyte-related hormones leading to an increased susceptibility for 
the development of obesity.35 Several phthalates have been shown to be PPARγ activators, causing 
obesogenic effects.34-37 PPARs form heterodimers with the retinoid X receptors (RXRs), binding together 
on the target DNA and thereby activating the expression of downstream genes. Therefore, RXRs have 
the same targets as PPARs. Many common phthalates have been shown to bind to RXRs.37 Likewise, 
oxidative stress is a potential mechanism for phthalate effects. In a prospective cohort study of pregnant 
women all urinary phthalates were associated with increased oxidative stress markers.38
The potential mechanisms of action from bisphenols resemble those from phthalates to a great 
extent. Studies regarding the mechanism of action from BPF and BPS are scarce. Bisphenols are weak 
xenoestrogens binding to estrogen receptors (ER) and the G-protein-coupled receptor 30 (GPR30) in 
its unconjugated form, with greater binding affinity to ERβ compared to ERα, considering a 100 to 
10.000-fold lower relative binding affinity of bisphenols to ERs compared to estradiol (E2).20,39,40 
However, findings suggest that BPA is equally potent as E2 and it is suggested that this results from 
actions through non-genomic pathways and disruption of steroidogenesis.13,20,41 BPF and BPA have been 
reported to increase the level of 17β-estradiol. BPF appears to be even more potent than BPA, given 
the higher concentrations of 17β-estradiol after exposure of H295R human adrenocortical carcinoma 
cell line to BPF. 
Like phthalates, bisphenols have anti-androgen capacities, binding to ARs.31,39 A decrease in free 
testosterone level is reported when exposed to bisphenols, in the order BPF > BPS > BPA. Since the 
binding affinity of BPS to the AR is low, the testosterone effect of BPS seems to be androgen receptor 
independent.39,42 Both BPS and BPF increased progesterone levels, BPA and BPS decreased cortisol 
levels, and BPF increased cortisol levels.42 
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Similar to phthalates, BPA appears to induce an acti vati on of PPARα and possibly to a smaller extent 
a weak acti vati on of PPARγ, causing obesogenic eff ects.34,35,37 Besides the binding to PPARs, also BPA 
binds to RXRs with more affi  nity to RXRs.37 Likewise, oxidati ve stress is a potenti al mechanism for BPA 
eff ects. The same Puerto Rican prospecti ve cohort study describing the associati on between phthalates 
during pregnancy and oxidati ve stress markers found a signifi cant associati on between urinary BPA and 
oxidati ve stress markers in pregnant women.43 An in vitro study showed oxidati ve stress eff ects from 
BPS and BPF.42 Furthermore, BPA has been reported to have nitrosati ve stressor eff ects and eff ects on 
free fatt y acids (FFAs). Oxidati ve stress and imbalances in FFAs are known mediators of ti ssue specifi c 
insulin resistance and infl ammati on.44
Adverse metabolic outcomes could also be hypothesized by interacti on of phthalates and bisphenols 
with the adipocytokines lepti n and adiponecti n. Adiponecti n and lepti n are adipocyte-produced 
hormones having a role in metabolic regulati on and functi on. In adults, lepti n inhibits appeti te, 
sti mulates thermogenesis, enhances fatt y acid oxidati on, decreases glucose, and reduces body weight 
and fat. Paradoxically, lepti n levels increase in obesity.45 Meanwhile, in adults low adiponecti n levels have 
been associated with insulin resistance, dyslipidemia, atherosclerosis, and metabolic syndrome.45,46  An 
overview of the potenti al mechanisms of eff ect is shown in Figure 1. 
Figure 1. Potenti al mechanisms of eff ect
ERα: estrogen receptor alpha ; ERβ: estrogen receptor beta ; E2: estradiol ; AR : androgen receptor ; T/DHT: 
testosterone / dihydrotestosterone ; PPAR: peroxisome proliferator-acti vated receptors ; RXR: reti noid X receptors ; 
FFA: free fatt y acids.




Two studies investigated the effect of phthalates and BPA on the time to pregnancy. A Canadian 
pregnancy cohort found no association between first trimester phthalates or BPA and recalled time 
to pregnancy.47 Meanwhile, a preconceptional cohort study exploring the effects of phthalates and 
BPA on fertility in the both men and women in the United States found several phthalates to be 
associated with longer time to pregnancy in males, while other phthalates were associated with shorter 
time to pregnancy in females. Neither male nor female BPA concentration was associated with time 
to pregnancy.48 Two human studies have pointed out that a higher level of BPA was associated with 
(recurrent) aneuploidy and euploid miscarriages.49,50 
During pregnancy maternal glucose levels increase to provide adequate nutrition for fetal growth and 
development. Two studies investigated the effect of phthalates and BPA on maternal glucose levels 
and gestational diabetes mellitus (GMD).51,52 Neither phthalates nor BPA was associated with increased 
maternal glucose levels or GMD. However, a small cohort study of pregnant women found that women 
in the highest tertile of urinary MiBP and MBzP had lower blood glucose levels at time of the routine 
GMD screening compared to women in the lowest concentration tertile.52 A Japanese study investigated 
the effect of DEHP on maternal triglycerides and fatty acid levels, detecting an inverse association 
between maternal serum MEHP concentrations and triglyceride and fatty acid levels during pregnancy. 
These findings could have implications for fetal health. The growth and development of the fetus and its 
organs depend on a sufficient supply of nutrients including fatty acids and lipids crossing the placenta, 
determining birth outcomes. However, in this particular study no effect on fetal growth was observed.53 
Only one study explored the association with preeclampsia, investigating differences in the distribution 
of BPA between maternal, placental and fetal compartments. This small case-control study reported 
that preeclamptic women have significantly higher concentrations of BPA in placental tissue compared 
to normotensive pregnant women, while concentrations of BPA in maternal serum and cord blood did 
not differ significantly. Accordingly, BPA was equally distributed between maternal, placental and fetal 
compartments in the normotensive group, while preeclamptic women showed an unequal distribution 
with a high level of BPA in the placental compartment.54 
Overall, the amount of studies for the separate outcome measures is limited. However, the presented 
outcomes suggest potential adverse effects of phthalates and bisphenols on fecundity, miscarriages, and 
preeclampsia. There are no studies reporting on pregnancy induced hypertension or HELLP syndrome. 
An overview of the included studies including outcomes, strengths and weaknesses is given in Table 1. 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In addition, the same mechanisms that affect maternal outcomes may also affect fetal outcomes. 
Phthalates have been investigated more thoroughly for their effects on prematurity compared 
to bisphenols. Nine studies explored the relationship between prenatal phthalate exposure and 
prematurity. In contrast to our hypothesis, two of these studies found a positive association between 
phthalate exposure and gestational age at delivery, reporting an increase of only one or two days to the 
gestational age at birth due to higher levels of phthalates. Both studies measured phthalates in urinary 
samples in the beginning of the third trimester.55,56 A French small prospective cohort study found no 
association of dibutylphthalate and its main metabolite monobutylphthalate in cord blood and breast 
milk with length of gestation.57 The remaining six studies found a significant association between a 
higher exposure to phthalates and reduced gestational age at time of birth.58-63 Two of these studies 
performed the measurements of exposure in cord blood samples.58,61 Of the remaining four studies with 
phthalate measurements performed in urinary samples, one found a significant reduction in gestational 
age which only remained in male infants after analysis was stratified for gender. Unfortunately, the 
timing of urinary sample collection was not specified.63 Two included studies consist of the same birth 
cohort with up to four urinary samples during pregnancy investigating the overall relationship with 
prematurity and windows of vulnerability for spontaneous and placental preterm birth, respectively. 
Both studies report that the odds of preterm birth compared to term birth are 1.3-1.5 times higher for 
children prenatally exposed to high levels of phthalates compared to children exposed to lower levels of 
phthalates.59,60 One of these studies revealed that spontaneous and placental preterm birth, defined as 
delivery with presentation of preeclampsia or intrauterine growth restriction, had different sensitivity 
windows of exposure to phthalates during pregnancy. Spontaneous preterm birth, defined as delivery 
with presentation of spontaneous labor of preterm premature rupture of membranes, showed to be 
significantly associated with higher phthalate metabolite concentrations measured at the beginning 
of the third trimester, while placental preterm birth was associated with higher phthalate metabolite 
concentrations measured during the first trimester.60 
Regarding bisphenols, all four studies presented in this review examined only BPA and its relationship 
with prematurity.56,63-65 Three of these studies associated higher urinary BPA levels, mainly measured 
during third trimester, with a significant reduction in gestational age at time of birth of one to four 
days.63-65 As for phthalates the gestational age reduction remained only significant in male infants in one 
of these pregnancy cohorts.63 The remaining study on bisphenols found no relationship between BPA 
with gestational age at time of birth.56
The association of phthalates and bisphenols with fetal growth is explored with 7 studies reporting 
on phthalates and 7 studies on bisphenols, including the already presented results from the Japanese 
study investigating also fetal nutrients during pregnancy displaying no association between DEHP and 
fetal growth.53 With respect to phthalates, of the remaining 6 studies, 4 all Chinese studies found that a 
higher exposure to phthalates was significantly related with reduced body size measures at birth.58,66-68 
A cohort study among 207 women reported a reduction in birth weight of 15-139 grams per natural 
log increase in phthalate concentrations.58 One of these studies also displayed a negative association 
between phthalates and DNA methylation in the human placenta, suggesting placental methylation 
as a possible mediator of the relationship between phthalates and birth measurements.67 Contrasting 
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with our hypothesis, two studies found positive associations between phthalates and fetal head 
circumference at time of birth.56,57 
Of the studies on BPA, 4 studies found no association between BPA and body size measures at 
birth.56,64,69,70 Two studies found higher BPA levels to be associated with decreased body size measures 
at birth.71,72 In a subset of the Dutch Generation R study fetal weight and head circumference were 
significantly decreased per unit increase in creatinine corrected BPA among women with three urinary 
BPA measurements during pregnancy. Children born to women in second highest exposure group had 
an average decrease of 683 grams birth weight. This relationship progressively attenuated among 
women with fewer BPA measurements.72 On the contrary, a Korean multi-center birth cohort study 
found a higher creatinine corrected urinary BPA levels during third trimester to be associated with and 
increased birth weight in male neonates and increased ponderal index in female neonates.73 
Hence, the majority of studies show mostly negative effects of phthalates and negative or no effects of 
BPA on gestational age and body size measures at birth. No studies have explored the other bisphenols 
besides BPA. An overview of the included studies is given in Table 1. Details of all described studies are 
represented in Supplementary Table 1.  
Childhood outcomes
Phthalates and bisphenols have been reported to have an influence on childhood growth. All three 
studies exploring the relationship between prenatal phthalates and childhood growth discovered 
different results in males and females, predominantly resulting in negative associations with growth in 
males.74-76 An extensive Spanish birth cohort reported that the molar sum of first and third trimester 
urinary HMW phthalates was significantly associated with reduced weight gain z-score in the first 6 
months in boys and nonsignificantly with lower BMI z-scores in boys at any age (measured until 
7 years of age). Meanwhile, in girls the molar sum of first and third trimester HMW phthalates was 
nonsignificantly associated with higher BMI z-scores.76 
Two out of 4 studies reported that a higher level of prenatal BPA exposure was associated with an 
increase in several childhood growth parameters in preschoolers, including BMI z-score, weight and 
waist circumference.69,77 The remaining two studies showed prenatal BPA exposure to be related 
to a lower postnatal BMI in preschool till mid-childhood aged girls, not boys.6,78 After subdivision in 
prepubertal and pubertal girls, only in prepubertal girls prenatal BPA exposure remained negatively 
associated with BMI z-score and waist circumference.6
In total, 18 studies investigated the influence of exposure to phthalates and bisphenols during 
childhood on childhood growth. Five out of nine studies found childhood exposure to phthalates to 
be associated with increased growth parameters in mid-childhood till adolescence, including obesity 
indices consisting of subscapular skinfold thickness, BMI, hip- and waist circumference.79-83 Four of these 
studies reported different effects in males and females, suggesting sex to be an effect modifier.79-82 
Also ethnicity is a potential modifier of effects. A cross-sectional analysis of the 2003-2008 NHANES 
data showed an increase in overweight and obesity among non-Hispanic blacks related to childhood 
phthalate exposure, while among other ethnic groups no significant associations have been found.83 
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Two studies found childhood phthalate exposure to be associated with reduced mid-childhood growth 
measures, including BMI, fat mass, waist circumference, BSA, weight and height.75,84 The two remaining 
studies found no relationship between childhood phthalate exposure and preschool till adolescent 
growth, defined as a BMI >85th and >95th percentile, respectively.85,86 
Eleven studies examined the relationship between levels of BPA in childhood and growth, of which 2 
studies did not find any relationship between BPA and preschool till mid-childhood growth measures, 
including weight, height, waist circumference and BMI.87,88 The earlier mentioned HOME study found 
two-sided outcomes: exposure early in childhood to higher levels of BPA was associated with a lower 
BMI at the age of two. However, their BMI slopes increased more rapidly between 2 and 5 years of 
age.78 Six studies showed that higher BPA levels in childhood were associated with increased growth 
parameters, including BMI, waist circumference, waist-to-height ratio, hip circumference and body 
fat.6,89-93 Measurements are obtained over the whole age spectrum of childhood and adolescence. 
Three of these studies were based on subsamples from the National Health and Nutrition Examination 
Survey (NHANES) in the United States. Samples were not identical as a result of heterogeneous inclusion 
criteria and outcome measures differed to a certain extent. However, all examined the relationship with 
BMI.90-92 Both sex and ethnicity were shown to be potential effect modifiers of the relation between 
childhood exposure to BPA and childhood growth parameters. In the NHANES data, childhood urinary 
BPA concentrations were significantly associated with increased risks for obesity and increased waist-to-
height ratios among non-Hispanic white boys.90-92 Contrastingly, a study of Chinese schoolchildren  found 
a significant association between childhood BPA exposure and increased BMI and hip circumference in 
girls, but not in boys. However, it must be noted that BPA concentrations were not adjusted for urinary 
dilution.93 Two earlier mentioned studies found childhood BPA exposure to be associated with reduced 
overweight and obesity, respectively.85,86 One of these studies is the only study included in this review 
investigating not only BPA but also BPS. However, no associations have been found with BPS regarding 
growth measures.86
The aforementioned Spanish study showed that in girls the molar sum of prenatal exposure to both 
HMW and LMW phthalates was significantly associated with lower systolic blood pressure z-scores at 
4 and 7 years of age. For both sexes there was a negative association with diastolic blood pressure, but 
none of the associations reached the level of significance.76
Four studies have examined childhood exposure to phthalates and bisphenols with respect to 
cardiovascular outcomes. All studies, including 2 studies published on phthalates and 2 studies on BPA, 
confirmed the hypothesis that childhood exposure to phthalates and bisphenols is associated with 
adverse cardiovascular outcomes in terms of increased blood pressure and low-grade albuminuria in 
preschool till adolescent age.87,94-96 Details are shown in Supplementary Table 1.
The relationship between childhood exposure to phthalates and bisphenols and childhood metabolic 
outcomes has been explored in six studies. The majority of studies used the homeostatic model 
assessment of insulin resistance (HOMA-IR) to assess insulin resistance in which a HOMA-IR ≥ 4.39 
was defined as insulin resistance.87,88,91,97,98 The analysis of the 2003-2008 NHANES data showed HMW 
phthalate metabolites to be related to a higher HOMA-IR in adolescents, which was mainly DEHP 
dependent. Adding BPA to the model did not change the association.97 A recent follow-up analysis 
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of the 2009-2012 NHANES data confirmed this association and explored whether the newer DINP, a 
replacement for DEHP, was also associated with increased insulin resistance. Also DINP showed to be 
associated with an increased insulin resistance.98 Further evidence on the association with phthalates 
is lacking. 
Three studies of BPA failed to find an association with childhood metabolic outcomes in mid-childhood 
till adolescent age, including adipokines, insulin resistance, blood lipids, insulin and glucose.88,91,99 The 
earlier mentioned case study of obese children found a significant mainly negative non-monotonic 
exposure-response relationship between BPA and fasting insulin and HOMA-IR in a case study of obese 
or overweight children aged 3-8 years. Unfortunately, BPA was not adjusted for urinary dilution in this 
analysis, which made it difficult to estimate its adjusted effect.87  
To conclude, the greater part of studies examined the association of phthalates and bisphenols with 
growth, giving contradictory results. Sex, stage of puberty and ethnicity are proposed as potential effect 
modifiers. An overview of the included studies is given in Table 1. Details of all described studies are 
represented in Supplementary Table 1.  
Discussion
We identified many studies investigating potential effects of prenatal and childhood phthalate and 
bisphenol exposure on growth and cardiometabolic risks. As presented throughout the paragraphs, 
exposure to phthalates and bisphenols is believed to induce pathways towards several adverse health 
effects. This conceptual model of mechanisms is shown in Figure 2. In vitro studies showed that 
exposure to phthalates and bisphenols causes hormonal disruption, epigenetic changes, oxidative and 
nitrosative stress. The effects could be affected by the time of exposure, both during fetal life and 
childhood. Exposure during fetal life may induce prematurity and low birth weight. Aside from the 
many disadvantageous outcomes from premature birth, both premature birth and low birth weight 
have been associated with cardiometabolic dysfunction, including overweight in adolescence and 
adulthood, dyslipidemia, insulin resistance, endothelial and glomerular dysfunction.100-103 As shown 
before, exposure during childhood is associated with aberrant growth patterns inducing overweight 
and obesity and early signs of cardiovascular and metabolic dysfunction, including glomerular and 
endothelial dysfunction, increased blood pressure and increased insulin resistance. Together with the 
earlier mentioned cellular changes both fetal and childhood exposure to phthalates and bisphenols 
may give rise to an increased risk for cardiovascular and metabolic disease in adulthood. As shown 
in the earlier paragraphs, effects could be affected by the time of exposure, both during fetal life and 
childhood, as well as by the sex and race of the child. 
Little is known about the epigenetic changes phthalates and bisphenols can cause and what mechanism 
lies behind it. The epigenetic effects of fetal BPA exposure were explored in mouse models. This study 
showed that BPA induces DNA hypomethylation, while maternal nutritional supplementation of methyl 
donors like folate negated the BPA-induced DNA hypomethylation in the offspring.104 This could be 
a major point of engagement, yet has not been examined in humans. An in vitro study of human 
adipocytes from prepubertal non-obese children investigated the effect of BPA on gene expression in 
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adipocytes, disclosing an increase in pro-inflammatory cytokines involved in the lipid metabolism and 
a decrease in a gene involved in insulin production.105 As mentioned in the mechanisms paragraph 
phthalates and bisphenols are reported to interfere with PPARs and RXRs, potentially causing epigenetic 
changes. RXRs form heterodimers using its nuclear receptor with all members of the class 1 nuclear 
receptors, including PPARs, but also the vitamin D3 receptor and the thyroid hormone receptor. Several 
drugs and mechanisms are claimed to interfere with the nuclear receptor from RXRs.106,107 However, 
little is known about the interaction mechanisms. Overall, very few studies have been investigating the 
mechanisms of phthalates and bisphenols combined with clinical outcomes in humans. More studies 
are needed investigating mechanisms and potential.
This review shows several limitations in the present literature, especially regarding time of exposure. 
One of the main limitations is the inconsistent exposure-response relationship in almost all studies 
performed so far, causing non-differential misclassification of exposure leading to underestimation of 
the effect. Only one study controlled for puberty, while the degree of puberty could be an important 
modifier of effects. Only one study described in this review investigated the effects of exposure to BPS, 
while all other studies only examined BPA. Exposure to BPF has not been studied at all. As shown in 
the paragraph on maternal pregnancy outcomes, studies on maternal pregnancy outcomes are scarce, 
in particular studies investigating the effect of phthalates. Studies investigating prenatal exposure to 
phthalates and bisphenols and metabolic outcomes are lacking, just as studies investigating prenatal 
exposure to bisphenols and childhood cardiovascular outcomes. The cardiovascular effects of prenatal 
phthalates have only been examined in one study; therefore it is difficult to draw conclusions. Adult 
studies on delayed effects of prenatal and childhood exposure to phthalates and bisphenols are lacking. 
Due to the long effect latency this might be harder to investigate. 
In total, 54 studies are included in this review, of which the majority uses urinary samples to estimate 
phthalate or bisphenol exposure. Eight cohort studies collected more than one urine sample during 
pregnancy,6,59,60,72,76-78,99 of which 3 studies collected additionally childhood urine samples.6,78,99 Only three 
of these multi-sample studies during pregnancy did not take the average of measured concentrations, 
but analyzed the samples separately, trying to find windows of vulnerability.6,60,99 An overview of the 
included studies and their strengths and weaknesses is presented in Table 1.
Concluding, the human evidence for effects of these chemicals is suggested but limited by 
methodological difficulties that complicate interpretation. However, an underestimation of effect is 
most likely. Future studies should focus on also the newer phthalates and bisphenols investigated in 
a distinct range of time with preferably multiple urine samples to reveal windows of sensitivity for 
the various biomarkers of effect. When windows of sensitivity during pregnancy would be uncovered, 
future parents could be informed through preconceptional consults or in early pregnancy. Moreover, to 
gain a better understanding in the effects, more studies are needed investigating the mechanisms and 
its potential interactions preferably combined with clinical outcomes. Furthermore, to provide more 
evidence on prolonged health effects epigenetics should be included in future studies in order to guide 
evidence-based prevention of harmful exposures.




Exposure to phthalates and bisphenols is believed to induce pathways towards several adverse health effects, 
including epigenetic changes, hormonal disruption, oxidative and nitrosative stress. Effects could be affected by the 
time of exposure, both during fetal life and childhood. Fetal exposure has been linked with prematurity and low birth 
weight. Childhood exposure has been associated with early signs of cardiovascular and metabolic dysfunction. Both 
prematurity and low birth weight have also been associated with cardiometabolic dysfunction. Therefore, both fetal 
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Bisphenol and phthalate 








Background: Exposure to bisphenols and phthalates in pregnancy may lead to adverse health effects in 
women themselves and their offspring. 
Objective: To describe first trimester bisphenol and phthalate urine concentrations, including bisphenol 
and phthalate replacements, and determine nutritional, socio-demographic and lifestyle related 
determinants.
Methods: In a population-based prospective cohort of 1,396 mothers, we measured first trimester 
bisphenol, phthalate and creatinine urine concentrations (samples collected in 2004-2005, median 
gestational age 12.9 weeks [inter-quartile range (IQR) 12.1-14.4]). We examined associations of 
potential determinants with log-transformed bisphenol and phthalate concentrations. Outcomes were 
back-transformed. Nutritional analyses were performed in a subgroup of 642 Dutch participants only, 
as the Food Frequency Questionnaire was aimed at Dutch food patterns.
Results: Bisphenol A, bisphenol S, and bisphenol F were detected in 79.2%, 67.8% and 40.2% of 
the population, respectively. Mono-n-butylphthalate, mono-(2-ethyl-5-hydroxyhexyl)phthalate  and 
monobenzylphthalate  were detected in >90% of the population. Nutritional intake was not associated 
with bisphenol and phthalate concentrations after correction for multiple testing was applied. Obesity 
was associated with higher high-molecular-weight phthalate concentrations and the lack of folic acid 
supplement use with higher di-n-octylphthalate concentrations (respective mean differences were 
46.73 nmol/l [95% CI 14.56-93.72] and 1.03 nmol/l [0.31-2.06]).
Conclusion: Bisphenol S and F exposure was highly prevalent in pregnant women in the Netherlands 
as early as 2004-5. Although associations of dietary and other key factors with bisphenol and phthalate 
concentrations were limited, adverse lifestyle factors including obesity and the lack of folic acid 
supplement use seem to be associated with higher phthalate concentrations in pregnant women. The 
major limitation was the availability of only one urine sample per participant. However, since phthalates 
are reported to be quite stable over time, results concerning determinants of phthalate concentrations 
are expected to be robust.




Bisphenols are used to produce polycarbonate plastics and epoxy resins used in various consumer 
products, including the lining of metal cans, toys, water pipes and paper products.1-3 Phthalates 
are frequently added to personal care products and vinyl plastics to impart flexibility, pliability and 
elasticity.4-6 When ingested, both bisphenols and phthalates undergo a first-pass metabolism consisting 
of glucuronidation or sulfation and these chemicals have been shown to cross the placenta-blood 
barrier.5,7-9 
During the last few decades, concerns over human exposure and potential health effects from bisphenol 
A (BPA) and several phthalates including di-2-ethylhexylphthalate (DEHP) have led to regulations on 
its production and usage in North America and the European Union. However, these governmental 
embargoes apply mainly to toys and childcare products for oral exposure. In the meantime, this stimulated 
the use of synthetic bisphenol analogues and DEHP replacements. A shift in phthalate metabolite 
concentrations has been observed in the first decade of this century.10 The European Chemicals Agency 
(ECHA) reported that the share of phthalate replacements, such as di-isononylphthalate (DINP) and 
di-isodecylphthalate (DIDP), in total phthalate sales in Europe has increased with over 40% in the years 
between 2001 and 2010 with concurrently a decline in the share of DEHP.11 DEHP replacements have 
been introduced in the mid-20th century and have first been identified in human urinary samples from 
1988 .12 Several studies reported the presence of bisphenol analogues in environmental compartments, 
foods and consumer products in the last decade.13 However, bisphenol S (BPS) has not been reported 
in a human biomonitoring study before 2010.14 Quantification of bisphenol analogues in those 
specimens that were collected before the governmental regulations were effective is lacking. Human 
biomonitoring and association studies have rarely focused on bisphenol analogues and were performed 
in non-pregnant subjects. 
An increasing body of evidence suggests that early life exposure to bisphenols and phthalates may 
lead to several adverse short and long term health effects.15 Diet is considered an important source 
of bisphenol and phthalate exposure.16-18 Certain food groups such as canned food, fish, meat and 
poultry have been associated with bisphenol and phthalate levels.19-22 Previous studies among pregnant 
women generally reported higher levels of bisphenols and phthalates to be associated with lower socio-
economic status, younger maternal age and smoking,23-26 but results are inconsistent.24,27 Overweight 
has also been suggested as a determinant of bisphenol and phthalate levels.23 Detailed information 
on nutritional, socio-demographic and lifestyle related determinants of bisphenol and phthalate 
concentrations in pregnant women might improve identification of women at risk for higher exposure 
to these chemicals. 
We performed a population-based prospective cohort study among 1,396 pregnant women in 2004-
2005 to describe first trimester bisphenol and phthalate urinary concentrations and determine 




Study design and population for analysis
The present study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards.28 In total, 8,879 women were enrolled in pregnancy, of which 76% 
before a gestational age of 18 weeks. The study has been approved by the Medical Ethical Committee of 
the Erasmus Medical Centre in Rotterdam. Written consent was obtained from all participating women.29 
Bisphenol and phthalate concentrations were measured in a subgroup study among 1,431 mothers 
whose children also participated in postnatal studies. This subgroup included singleton pregnancies 
only. Thirty-five women without a first trimester urinary sample were excluded, which led to 1,396 
women included in the analysis. Dietary intake assessment in the Generation R study was aimed at 
Dutch dietary intake patterns. Therefore, information on maternal dietary intake was only included for 
Dutch participants, leading to 642 women included in the analysis for nutrition related factors (Flow 
chart is given in Figure 1).
Figure 1. Flowchart
Bisphenol and phthalate measurements in urine 
Bisphenol and phthalate concentrations were measured in a spot urine sample obtained from each 
subject during the first trimester measurement (median gestational age 12.9 weeks, inter-quartile 
range 12.1-14.4 weeks). All urine samples were collected between February 2004 and July 2005. Urine 
samples were collected between 8 am and 8 pm in 100-mL polypropylene urine collection containers, 
stored at 4 °C and transported within 24 h of receipt to the STAR-MDC laboratory before being 
distributed manually in 25 mL polypropylene vials to be frozen at -20 °C. The urine specimens were 
shipped on dry ice in 4 mL polypropylene vials to the Wadsworth Center, New York State Department of 
Health, Albany, New York for analysis of bisphenol and phthalate concentrations. 
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Quantitative detection of phthalate metabolites was achieved utilizing a solid-phase extraction (SPE) 
method followed by enzymatic deconjugation of the glucuronidated phthalate monoesters coupled 
with high performance liquid chromatography electrospray ionization-tandem mass spectrometry 
(HPLC-ESI-MS/MS), as previously used.30 Assay precision is improved by incorporating 13C4- or 
2D4-
 
isotopically-labeled internal standards for each of the phthalate metabolites. This selective method 
allows for rapid detection of eighteen metabolites of phthalates with the majority of limits of detection 
(LOD) in the range of 0.008-0.3 ng/ml. 
Quantitative detection of bisphenols was achieved utilizing a liquid-liquid extraction (LLE) method 
followed by enzymatic deconjugation of the glucuronidated bisphenols coupled with high performance 
liquid chromatography electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS). With 
the use of 13C12-BPA and 
13C12-BPS isotopically labeled internal standards, eight bisphenols were 
quantified with limits of detection in the range of 0.03 and 0.18 ng/ml, except for bisphenol AF with 
an LOD of 0.79 ng/ml. 
Contamination that arises from laboratory materials and solvents was monitored by the analysis of 
procedural blanks. All values remained below the LOD and were subtracted. The regression coefficients 
of the calibration curves were >98%. For each batch of 25 samples, one procedural blank was analyzed. 
Throughout the analysis, 1 pre-extraction matrix spike sample was prepared for every 25 samples 
analyzed by spiking known concentrations (40 ng mL−1) of target analytes and passing them through the 
entire analytical procedure. In addition, the Standard Reference Materials 3672 (Organic Contaminants 
in Smokers’ Urine) and 3673 (Organic Contaminants in Non-Smokers’ Urine) from the National Institute 
of Standards & Technology (NIST), which contain certified values for 11 phthalate metabolites and BPA, 
were analyzed with every 50 samples.31 Our results for NIST SRMs were within ±15% of the certified 
values. A calibration check standard was performed, and methanol was injected after every 25 samples 
as a check for drift in instrumental sensitivity and carry-over between samples, respectively.
Recoveries of target chemicals passed through the entire analytical procedure ranged between 84.4 and 
112.0%, except for mono-(8-methyl-1-nonyl)phthalate (mIDP), phthalic acid (PA), monooctylphthalate 
(mOP) and monoisononylphthalate (mINP). Relative recoveries for mINP, PA and mIDP were 77-125% 
after correction with isotope labeled analogues. Samples were analyzed for creatinine using HPLC-
ESI-MS/MS, improved by incorporating 2D3-creatinine. Quantification of calibration check standards 
resulted in an LOD of 0.30 ng/ml.  All identified bisphenol and phthalate urinary biomarkers, their values, 
detection rates, limits of detection and quantification, and recoveries are shown in Supplementary 
Table S1. Detailed description of the analytical procedure is shown in Supplementary Material S2. 
We grouped urinary biomarkers for exposure to phthalates according to their origin and use in product 
categories. Metabolites were included in the metabolite groups if >20% of metabolites were above the 
limit of detection (LOD). We calculated the weighted molar sums for total bisphenols, low molecular 
weight (LMW) phthalate, high molecular weight (HMW) phthalate, di-2-ethylhexylphthalate (DEHP), 
and di-n-octylphthalate (DNOP) metabolites by using the formula: ((concentration in ng/ml) * (1 / 
molecular weight) * (1 / 10^-3)) + ((concentration in ng/ml) * (1 / molecular weight) * (1 / 10^-3)) + etc. By 
using this formula, weighted molar sums are presented in nmol/L. Phthalate groups were constructed 
based on molecular weight and parent phthalates. LMW phthalate concentration was calculated as the 
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weighted sum of molar concentrations of mono-methyl phthalate (mMP), mono-ethyl phthalate (mEP), 
mono-n-butyl phthalate (mBP), and mono-isobutyl phthalate (mIBP); HMW phthalate concentration 
as the sum of mono-(2-ethyl-5-carboxypentyl) phthalate (mECPP), mono-(2-ethyl-5-hydroxyhexyl)
phthalate (mEHHP), mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), mono-[(2-carboxymethyl)hexyl]
phthalate (mCMHP), mono(3-carboxypropyl) phthalate (mCPP), monobenzyl phthalate (mBzP), mono-
hexylphthalate (mHxP), and mono-2-heptylphthalate (mHpP). DEHP concentration was calculated by 
adding the molarities of mECPP, mEHHP, mEOHP, and mCMHP. DNOP concentrations was calculated as 
the molarity of mono(3-carboxypropyl)phthalate (mCPP). Phthalic acid (PA) was analyzed separately 
as a proxy for total phthalate exposure. Bisphenols with >50% of the samples above the LOD were 
analyzed separately. For bisphenol and phthalate concentrations below the LOD we substituted values 
with a LOD value divided by the square root of 2 (LOD/√2), as performed earlier.32 
Maternal nutrition, socio-demographic, and lifestyle related factors
Nutrition related factors: Dietary determinants included maternal daily caloric intake and 23 food 
groups. Maternal daily dietary intake was assessed at enrollment using a modified version of the 
validated semi-quantitative food-frequency questionnaire (FFQ) of Klipstein-Grobusch et al.33 The FFQ 
covered the average dietary intake over the previous three months, covering the dietary intake in the 
first trimester of pregnancy.34 The Dutch food composition table 2006 was used for calculating daily 
intake of nutritional values.35 Maternal daily caloric intake was categorized in four groups (<1600 kcal, 
1600-1999 kcal, 2000-2399 kcal, and ≥2400 kcal). 
Socio-demographic related factors: Information on maternal age at enrollment (<25 years, 25-29.9 
years, 30-34.9 years, and ≥35 years), parity (nulliparity/multiparity), educational level (low/high) and 
maternal ethnicity (Dutch or European/Non-European) was obtained from the first questionnaire 
at enrollment. Low educational level was defined as no education, or finished primary or secondary 
education. High educational level was defined as higher education finished. 
Lifestyle related factors: Information on pre-pregnancy weight (kg) and use of folic acid supplementation 
(yes/no) was obtained from the first questionnaire at enrollment. Maternal height (cm) was measured 
at enrollment and used to calculate pre-pregnancy body mass index (BMI) (<20 kg/m2, 20-24.9 kg/m2, 
25-29.9 kg/m2, and ≥30 kg/m2). Information on smoking (yes/no) was assessed by questionnaires in 
each trimester. 
Statistical analysis
First, we performed descriptive statistics to examine all identified bisphenol and phthalate urinary 
biomarkers, including their values and detection rates, and general subject characteristics. 
Second, we examined correlations between first trimester bisphenol and phthalate urine concentrations 
using Spearman’s correlation coefficients, taking the skewed distribution of bisphenols and phthalates 
into account. 
Third, we investigated the associations of maternal nutrition, socio-demographic and lifestyle related 
determinants with differences in maternal first trimester bisphenol and phthalate urine concentrations 
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using basic and multivariable linear regression models. For all regression models, all bisphenol and 
phthalate urinary metabolite concentrations were log-transformed to account for right skewness in 
the distribution and to prevent for negative numbers. Outcomes were back-transformed by using the 
formula: (econstant + ecoef) – (econstant). 
We examined the associations of dietary food groups and daily dietary caloric intake in Dutch women 
with differences in bisphenol and phthalate urinary concentrations. Non-Dutch women were excluded 
from nutritional analyses, since dietary intake assessment was aimed at Dutch dietary intake patterns. 
Food groups were dichotomized for the amount of consumption by using the 90th percentile as a cutoff. 
Daily dietary caloric intake was categorized to account for potential non-linear effects, with the largest 
group as the reference group. 
We examined socio-demographic and lifestyle related factors in the larger, entire study population 
with differences in bisphenol and phthalate urinary concentrations. To account for non-linear effects of 
potential determinants and confounders, all were included as categorical variables. The largest group 
was used as the reference.
Sub-analyses of individual bisphenols or phthalate metabolites were performed for all significant 
models to determine which metabolites were driving the association. All basic models were adjusted for 
urinary creatinine to adjust for dilution. Multivariable models were additionally adjusted for maternal 
age, parity, educational level, maternal ethnicity, pre-pregnancy BMI, smoking and use of folic acid 
supplementation. Multivariable models investigating nutrition related determinants were additionally 
adjusted for daily dietary caloric intake. Owing to the fact that nutrition related determinants were 
derived from a food frequency questionnaire (FFQ) aimed at Dutch food consumption patterns, nutrition 
related determinants were not imputed. Missing data of the potential socio-demographic and lifestyle 
related determinants and covariates were imputed using multiple imputation. Five imputed data sets 
were created and pooled for analyses. Imputed socio-demographic and lifestyle related determinants 
were used for both the univariate and multivariable models to prevent exclusion of incomplete cases. 
The percentage of missing values within the population for analysis was ≤15%, except for folic acid 
supplement use (20.1%). We used the Bonferroni correction to account for multiple testing at P<0.05/k 
(k: the number of hypotheses by means of the number of potential determinants tested summed by 
the two main metabolite groups of bisphenols and phthalates). All analyses were performed using the 
Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc, Chicago, IL, USA). 
Results
Participant characteristics and correlations
Table 1 shows the subject characteristics of included women. Table 2 shows all the metabolites that 
were included in all separate groups as abovementioned, their values and detection rates in urine. 
Supplementary Table S1 shows all identified bisphenol and phthalate urinary biomarkers.
 Chapter 2.1
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Table 1. Subject characteristics (n=1,396)1
Value
Maternal age (years) 30.6 (4.8)
Pre-pregnancy body mass index (kg/m²)2 22.7 (18.5, 35.0)
Parity (% nulliparous) 61.0




Highest completed education (%)
Low education 49.6
High education 50.4
Daily dietary caloric intake (kcal) 2077 (509)
Maternal smoking during pregnancy (%)
No 75.2
Yes 24.8
Folic acid supplement use (%)
No 19.4
Yes 80.6
Creatinine (µg/mL)2 1011 (153, 3435)
1Values represent means (standard deviation) or valid percentages  
2Median (95% range)
Measurable urinary concentrations of BPA, bisphenol S (BPS), and bisphenol F (BPF) were found in 
79.2%, 67.8% and 40.2% of the samples, respectively. Bisphenol Z (BPZ), bisphenol B (BPB), bisphenol 
AP (BPAP) and bisphenol P (BPP) were detected in <15% of samples. We did not detect BPAF in any 
sample. In the detected samples, median concentrations of BPA, BPS and BPF were 1.66 ng/mL (IQR 
0.72-3.56), 0.36 ng/mL (IQR 0.17-1.08), and 0.57 (IQR 0.30, 1.29), respectively. LMW phthalate, and 
DEHP metabolites were detected in >98% of the population. Mono-hexylphthalate (mHxP) and mono-2-
heptylphthalate (mHpP) were detected in a considerable number of samples; however a significant part 
of values was detected in the range between the limit of detection (LOD) and the limit of quantification 
(LOQ). DEHP replacements including di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP) had 
detection rates below 15%. 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3 shows Spearman’s correlation coefficients of bisphenol and phthalate concentrations, 
including separately BPA, BPS and PA. Bisphenol and phthalate concentrations were strongly correlated 
(Spearman’s correlation coefficient for the correlation between total bisphenols and PA metabolites 
0.37, P value <0.001). Phthalate groups were strongly correlated, ranging from 0.46 for the correlation 
between LMW phthalate and DNOP metabolites to 0.98 for the correlation between HMW phthalate and 
DEHP metabolites (all have a P value <0.001). Among the separate bisphenols, except for correlations of 
BPA with BPS , BPF and BPAP, bisphenols are not correlated (Supplementary Table S3). For the separate 
phthalate metabolites, PA is strongly correlated with all other phthalates with >20% of samples above 
LOD (Spearman’s correlation coefficient ranging from  0.34 to 0.69 (P value <0.001) (Supplementary 
Table S4). All in the analyses included phthalate metabolites with >20% of samples above LOD are 
strongly correlated (P value <0.001). Among the DEHP metabolites correlation is very high, ranging from 
0.77 to 0.98 (P value <0.001). 
Maternal dietary determinants
Urinary bisphenol and phthalate concentrations did not vary by intake frequencies of examined food 
groups or daily dietary caloric intake after correction for multiple testing, both in basic and multivariable 
models. Basic models showed high consumption of grains, cakes, coffee, soft drinks, alcoholic drinks, 
soups and bouillon and daily dietary caloric intake to be associated with differences in bisphenol or 
phthalate urine concentrations (Supplementary Table S5). 
Table 4 shows multivariable models for nutritional related factors with a nominal p-value <0.05. At 
nominal level, pregnant women in the upper 10% of consumption of vegetables had higher HMW 
phthalate, DEHP and DNOP metabolite concentrations (respective mean differences 38.17 nmol/l (95% 
CI 7.18, 90.7), 31.4 nmol/l (95% CI 5.16, 77.3) and 1.14 nmol/l (95% CI 0.12, 2.98). In a subanalysis of 
individual phthalate metabolites, the association between vegetable intake and HMW phthalates was 
mainly driven by DEHP metabolites, however associations did not remain after correction for multiple 
testing (Supplementary Table S6). We observed lower concentrations of bisphenol S (BPS) and PA in 
pregnant women who had eaten a large quantity of grains in the past three months, while for women 
with a high consumption of fish and shellfish higher total bisphenol or bisphenol A (BPA) concentrations 
were found. Women who consumed a large amount of soft drinks had higher LMW phthalate 
concentrations, while women with a frequent intake of soups and bouillon had lower LMW phthalate 
concentrations. Both associations were mainly driven by mono-ethylphthalate (mEP) metabolites, but 
attenuated to non-significance after Bonferroni correction (Supplementary Table S6). As compared to 
pregnant women who consumed 2000-2399 kcal per day, women who consumed somewhat less or 
more kcal per day had lower BPS concentrations. 
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Maternal socio-demographic and lifestyle determinants
After correction for multiple testing was applied, all investigated determinants were associated with 
differences in bisphenol or phthalate urine concentrations in basic models (Supplementary Table S7). 
Table 5 shows multivariable associations of socio-demographic and lifestyle related factors with urinary 
bisphenol and phthalate concentrations. After Bonferroni correction, pre-pregnancy obesity was 
associated with higher HMW phthalate concentrations (mean difference 46.73 nmol/l (95% CI 14.56, 
93.72) and the lack of folic acid supplement use with higher DNOP concentrations (mean difference 
1.03 nmol/l (95% CI 0.31, 2.06). In a subanalysis of individual HMW phthalate metabolites, the 
association of pre-pregnancy BMI was driven by mono-(2-ethyl-5-carboxypentyl)phthalate (mECPP), 
monobenzylphthalate (mBzP) and mono-2-heptylphthalate (mHpP) metabolites (Supplementary Table 
S8).
Maternal age was not associated with bisphenol or phthalate concentrations. At nominal level, 
multiparous women had higher DNOP concentrations (mean difference 0.58 ng/ml [95% CI 0.11, 
1.24]). Pregnant women with a low educational level had higher PA and LMW phthalate concentrations. 
Among pregnant women with non-European descent, we observed lower urinary BPS concentrations, 
but higher HMW phthalate concentrations which was driven by mBzP metabolites. The association with 
mBzP metabolites remained significant after correction for multiple testing. Pregnant women with a 
higher pre-pregnancy BMI, who smoked during pregnancy and did not use folic acid supplementation 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































One of the major findings of this study is that bisphenol exposures other than BPA were widely prevalent 
in pregnant women in a population-based cohort in the Netherlands between 2004 and 2005. The 
second major finding was that first trimester bisphenol and phthalate urine concentrations were 
mainly influenced by lifestyle related factors such as high pre-pregnancy BMI and the lack of folic acid 
supplement use. Nutritional factors were not associated with bisphenol and phthalate concentrations 
when correction for multiple testing was applied.
Interpretation of findings
To our knowledge, this is the first study to describe BPS and BPF in samples collected as early as 
2004-2005. Generally, comparisons of values need to be restricted to the time and place of sampling, 
because bisphenol and phthalate use changes over the years due to governmental embargoes.10 
Urinary concentrations of BPA and phthalate metabolites found in our study population were generally 
somewhat lower than concentrations in other Western studies performed in the same time period. 
Detection rates were comparable or slightly lower.26,36-39 
Except substitution of BPA by BPS and BPF in man-made consumer products as an explanation for 
our findings, we cannot exclude BPS and BPF exposure through natural sources. A recent study found 
BPF in mustard made from seeds of Sinapis alba.40 Contamination was ruled out. The authors explain 
this finding as reaction product of a breakdown pathway. This finding suggest potential other natural 
sources that could explain BPF and also BPS exposure. 
Since the year 1999 certain phthalates, including DEHP, dibutylphthalate (DBP), butylbenzylphthalate 
(BBP), DINP, DIDP and DNOP, have been banned from toys and childcare products in the European 
Union.41 We observed high detection rates for DEHP metabolites, metabolites of DBP and BBP 
(respectively mBP and mBzP) and mCPP, which is a DNOP metabolite. DINP and DIDP metabolites were 
scarcely detected in our study population. A recent re-evaluation concluded that there was no evidence 
for further exposure bans on DINP and DIDP. However, the other banned phthalates have not been 
included in this assessment.11 Although, since February 2015 (REACH sunset date), several phthalates, 
including DEHP, BBP, DBP and diisobutylphthalate (DIBP), have been listed on the Authorisation List of 
the ECHA.42 Our findings suggest that DEHP, DBP, BBP and DNOP were widely used in the early 2000s. 
Due to recent regulations DEHP, DBP and BBP exposure should be limited nowadays. DNOP has not 
been included in these regulations and is therefore a cause for concern.
In the general population, diet has been considered the major source of phthalate exposure.16,17 DEHP 
seems to be of major concern, which is widespread in food packaging.6 Also bisphenols are potentially 
transferred into food items from food packaging, including the lining of metal cans.15,43 In previous 
studies, high consumption of canned vegetables and canned fish was associated with higher BPA 
concentrations in pregnant women.22,26 For phthalates, frequent consumption of poultry, meat and fish 
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were associated with higher DEHP and HMW phthalate concentrations, while soy consumption was 
inversely associated with DEHP concentrations.20,21 
In contrast to our hypothesis and previous findings, none of the nutrition related factors was associated 
with bisphenol and phthalate urine concentrations when corrections for multiple testing were applied. 
The absence of multiple testing correction and the use of short-term diet recall data (24/48h) in 
previous studies might be responsible for this discrepancy. In contrast to previous studies, we have 
used a FFQ for the average intake in the past three months. Both bisphenols and phthalates have 
short biological half-lives (less than 24h).5,7 The trends we have observed for high consumption of 
certain food groups, though not significant, may therefore rather be a proxy for healthy or unhealthy 
food consumption patterns of lifestyle than that those food groups actually contain these compounds. 
However, we cannot explain why women with a high intake of vegetables have higher concentrations 
of HMW phthalate metabolites.
Several studies have examined potential determinants of BPA and phthalate concentrations during 
pregnancy using various methodologies, which complicates comparisons. In general, previous studies 
identified maternal younger age, lower education, overweight and smoking as determinants of higher 
BPA and LMW phthalate concentrations during pregnancy.20,23-26 However, for HMW phthalates maternal 
older age, higher education and nonsmoking have been associated with higher concentrations.20,24 In 
our study, maternal age was not associated with bisphenol or phthalate concentrations. Correction 
for multiple testing has not been applied in previous studies. In agreement with previous studies, we 
found an association at nominal level of lower education with higher LMW phthalate concentrations. 
In contrast to our finding that multiparity was associated with higher DNOP metabolite concentrations 
at nominal level, previous studies did not find consistent associations between parity and phthalate 
concentrations.20,24 Nulliparity, however, has been identified as a determinant of higher BPA 
concentrations in a Spanish birth cohort study.26
To some extent in line with our findings, a cohort study in 350 pregnant women reported that non-
Hispanic black and Hispanic women had higher concentrations of LMW phthalate metabolites, mBzP 
and mono-(2-ethylhexyl)phthalate (mEHP) metabolites in early pregnancy than other ethnic groups.44 
Although, the role of ethnicity as a determinant of bisphenol and phthalate concentrations has been 
scarcely studied, several association studies have identified race/ethnicity-specific associations of 
bisphenols and phthalates with childhood BMI and diabetes risks.45-47 Consequently, determinants 
underlying these ethnic differences need to be further studied. 
Previous studies have shown associations of higher maternal BMI and smoking during pregnancy with 
higher BPA and LMW phthalate concentrations, whereas inversed associations or no associations were 
found for HMW phthalate concentrations.20,23,24,48 Conversely, in our study we found strong associations 
between pre-pregnancy BMI in the obesity range and higher HMW phthalate concentrations. 
Phthalates, and bisphenols to some extent, are lipophilic chemicals.15,49 Even though we cannot rule 
out that obese women are more exposed to HMW phthalates, it seems metabolically feasible that 
obese women have greater adipose stores of lipophilic chemicals. In line with previous studies we 
found higher total bisphenol, PA and LMW phthalate concentrations in smokers than in non-smokers, 
driven by BPA and mEP.23,24 Although the associations with smoking might reflect lifestyle habits, in- and 
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exhaled tobacco smoke may contain BPA and PA because BPA and di-2-methoxyethyl phthalate are used 
in some cigarette filters.50 
To our knowledge, this is the first study to examine folic acid supplement use as a determinant of 
bisphenol and phthalate concentrations. In our study, we found the lack of folic acid supplement use to 
be associated with higher DNOP metabolite concentrations. Although epigenetic effects of bisphenols 
and phthalates are not yet clear, methyl donors like folate have been proposed as a potential point of 
engagement to prevent potential epigenetic effects.51 Effects of folic acid supplement use on epigenetic 
changes due to bisphenol and phthalate exposure need to be further investigated. 
In line with our hypothesis, in this population-based sample in the Netherlands adverse lifestyle related 
factors seem to be associated with higher bisphenol and phthalate urine concentrations rather than 
socio-demographic factors. Many research groups have raised their concerns about confounding effects 
on bisphenol and phthalate concentrations from nutrition related factors. As a sensitivity analysis, we 
included maternal daily dietary caloric intake as a covariate in models for potential socio-demographic 
and lifestyle related determinants. In these analysis, maternal daily dietary caloric intake has been 
included as a categorical variable with a separate missing group to prevent exclusion of incomplete 
cases. Since maternal daily dietary caloric intake was only included for Dutch mothers and the missing 
category was highly correlated with non-European descent, effects on ethnicity estimates could not 
be compared. Conclusions for all other socio-demographic and lifestyle related determinants did not 
change. 
All adverse lifestyle related factors assessed in this study were associated with higher bisphenol and 
phthalate urine concentrations at nominal level. However, despite of the scarce associations found 
with certain food groups in Dutch mothers, we cannot rule out that lifestyle related factors are a proxy 
for unmeasured food consumption patterns. Several studies have found associations of phthalate 
concentrations with the use of personal care products, household products and materials used for 
flooring and walls.23,52 The adverse lifestyle related factors identified in this study might therefore be 
a proxy for harmful product exposure. Altogether, we cannot exclude that the associations we have 
observed are rather a proxy for unhealthy lifestyle habits in general with consequently higher exposure 
levels than that these factors actually increase exposure or urinary excretion. 
Strengths and limitations
Strengths of this study were the prospective data collection from early pregnancy onwards in a multi-
ethnic population, the relatively large sample size, and large amount of bisphenols and phthalate 
metabolites analyzed. Analyses for the current study are performed in a subgroup from the Generation 
R Study. Non-response analyses showed similar distributions and values of potential socio-demographic 
and lifestyle determinants (Supplementary Table S9). The response rate at baseline was 61%.28 It seems 
unlikely that this level of non-response would lead to biased effect estimates, since selection bias in 
large cohort studies arises mainly from loss to follow up rather than from a non-response at baseline.53 
For this study, a large amount of bisphenols and phthalate metabolites have been analyzed. The analytical 
techniques as used for this study allowed for detection of both unconjugated (free) compounds, as well 
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as glucuronidated and sulfated bisphenol and phthalate conjugates. Assay precision has been improved 
by incorporating isotopically-labeled internal standards and confirmed with regularly proficiency testing 
and reference maternal analysis. 
Urinary concentrations of bisphenols and phthalates were based on a single spot urine in the first 
trimester of pregnancy. Both bisphenols and phthalates have short biological half-lives (less than 24h).5,7 
Despite of the reported short biological half-lives, it has been suggested that one single urine sample 
for phthalate concentrations reasonably reflects exposure for up to three months or even longer.54,55 
Within-person variability of BPA urinary concentrations is reported to be high, constraining the value 
of one single urine sample for bisphenol measurement.56 We can therefore not exclude that the results 
of our study with regards to the bisphenols would be different when multiple samples were included. 
However, for the phthalates, we expect the results to be robust.   
Samples have been stored at -20 °C for approximately 10 years. Therefore, we cannot exclude that there 
has been some biological activity during the storage period. It has been suggested that -80 °C would 
be a more optimal storage temperature. A study investigating effects of storage time and temperature 
on bisphenol and phthalate levels found that samples stored at room temperature (20 °C) had lower 
concentrations of phthalate metabolites and BPA than samples stored at -80 °C after a time period of 8 
weeks.57 Studies investigating effects of storage temperature over a longer period are lacking.
Some studies measure mEHP concentrations as a metabolite of DEHP. Based on literature, we decided not 
to measure mEHP concentrations. MEHP only represents a small percentage (<1%) of DEHP metabolites 
and is not considered a reliable biomarker for human DEHP exposure.58 MEHP occurs naturally from the 
hydrolysis of DEHP and is ubiquitous in the environment, explaining the high background that tempers 
our analysis. The other DEHP metabolites, such as mECPP, mEHHP, mCMHP and mEOHP are oxidative 
metabolites that are produced only in vivo and therefore reliable biomarkers.59 
The FFQ as used in this study was aimed at Dutch dietary intake patterns, making this assessment less 
reliable for non-Dutch participants. We therefore excluded non-Dutch participants from this analysis. 
As mentioned before, ethnicity might play a key factor in bisphenol and phthalate metabolism and 
effects. Therefore, the lack of ethnic variance results in non-generalizable effect estimates of dietary 
determinants. As abovementioned, we have used a FFQ for the average intake in the past three months 
instead of the last 24 hours while both bisphenols and phthalates have short biological half-lives, making 
it difficult to draw firm conclusions about food groups as sources of exposure. 
In our study, information on nutritional and several lifestyle related determinants was self-reported, 
in which underreport may have led to misclassification and consequently underestimation of effects. 
However, the prevalence of lifestyle related factors corresponds with national figures for that time 
period.60,61 Previous studies reported time of sampling, fasting time and seasonality as potential 
determinants for bisphenol and phthalate urine concentrations.62,63 As mentioned above, personal care 
products and household products have been identified as determinants of phthalate concentrations.23,52 




BPS and BPF exposure was highly prevalent in pregnant women in the Netherlands as early as 2004-
2005. This finding questions the assumption that BPS and BPF exposure was limited in the early 2000s. 
Associations attributed to BPA in this time-period may be therefore confounded. DEHP replacements 
were scarcely detected in our population. However, high detection rates were found of DEHP itself 
and other phthalates that already were banned from toys childcare products, suggesting continued 
exposure through consumer products. We identified limited associations of dietary and other key 
determinants with bisphenol and phthalate concentrations. Adverse lifestyle factors including obesity 
and the lack of folic acid supplement use seem to be associated with higher phthalate concentrations in 
pregnant women. Notwithstanding the associations found between obesity and higher HMW phthalate 
concentrations, associations were limited suggesting a lower likelihood of confounding of phthalate 
body mass contaminant relationships which we plan to examine in forthcoming work.  
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Supplementary Table S9. Nonresponse analysis1
Sample n = 1396 Generation R n = 4847  
(inclusion <18w + visit F@5)
Maternal age 30.6 (4.8) 30.4 (4.9)
Nulliparous (%) 61.0 58.8
Low educational level (%) 49.6 51.8
Dutch/European (%) 61.9 63.7
Maternal pre-pregnancy BMI2 22.7 (20.8, 25.3) 22.6 (20.8, 25.3)
Maternal non-smoking (%) 75.2 73.1
Folic acid supplement use (%) 90.6 88.0
1Values represent means (standard deviation) or valid percentages  
2Median (IQR)





First trimester urinary bisphenol 
and phthalate concentrations 
and time to pregnancy
2.2





Background: Increasing evidence suggests that exposure to synthetic chemicals such as bisphenols 
and phthalates can influence fecundability. The current study describes associations of first trimester 
urinary concentrations of bisphenol A (BPA), BPA analogues and phthalate metabolites with time to 
pregnancy (TTP).
Methods: Among 877 participants in the population-based Generation R pregnancy cohort, we 
measured first trimester urinary concentrations of bisphenols and phthalates (median gestational age 
12.9 weeks [inter-quartile range 12.1-14.4 weeks]). We used fitted covariate-adjusted Cox proportional 
hazard models to examine associations of bisphenol and phthalate concentrations with TTP. Participants 
who conceived using infertility treatment were censored at 12 months. Biologically plausible effect 
measure modification by folic acid supplement use was tested.
Results: In the main models, bisphenol and phthalate compounds were not associated with fecundability. 
In stratified models, total bisphenols and phthalic acid were associated with longer TTP among women 
who did not use folic acid supplements preconceptionally (respective fecundability ratios per each 
natural log increase were 0.90 [95% Confidence Interval (CI) 0.81, 1.00] and 0.88 [95% CI 0.79, 0.99]). 
Using an interaction term for the exposure and folic acid supplement use showed additional effect 
measure modification by folic acid supplement use for high molecular weight phthalate metabolites.  
Conclusions: We found no associations of bisphenols and phthalates with fecundability. Preconception 
folic acid supplementation seems to modify effects of bisphenols and phthalates on fecundability. 
Folic acid supplements may protect against reduced fecundability among women exposed to these 
chemicals. Further studies are needed to replicate these findings and investigate potential mechanisms.




Increasing evidence suggests that synthetic chemicals can influence both male and female health and 
fecundability, the biological ability to conceive a pregnancy. Persistent organic pollutants have been 
linked to a host of reproductive disorders in both men and women,1,2 including prolonged time to 
pregnancy (TTP), a marker of couple fecundability. The literature on nonpersistent chemicals is more 
limited. Prior studies of female urinary bisphenols and TTP have not found an association, but have 
relied exclusively on linear models.3-5 Results of studies investigating female phthalate metabolites and 
TTP have been inconsistent.3-8 Differences among these studies’ conclusions may stem from variations 
in study size and population, as well as design, as they did not all measure the same metabolites and 
some measured TTP prospectively while others relied on retrospective recall of TTP from the first 
trimester of pregnancy. 
DNA methylation is a potential mechanism through which bisphenols and phthalates may be related to 
female reproductive disorders.9 Bisphenol A (BPA), in particular, has been shown to target reproductive 
tissues and affect reproductive outcomes in numerous animal studies.10 In a now classic experiment, 
mice exposed to BPA during pregnancy were more likely to give birth to offspring with yellow coats as 
a result of decreased methylation upstream of the Agouti gene. The effect was negated when BPA-
exposed dams were supplemented with folic acid, a methyl donor.11 Folate depletion has been associated 
with global hypomethylation, but also with targeted hypermethylation (reviewed in 12). A recent study 
among women undergoing infertility treatment reported that high urinary BPA concentrations were 
associated with lower probabilities of implantation, clinical pregnancy, and live birth, but only among 
women who consumed <400 μg/day of dietary folate; there were no associations among women who 
consumed ≥400 μg/day.13 
Phthalates also affect reproductive outcomes in animals and humans 10 and, depending on the 
metabolite, have been shown to be associated with either DNA hypermethylation or hypomethylation. 
Among 336 Mexican-American newborns, phthalate metabolites—in particular, metabolites of di-2-
ethylhexylphthalate (DEHP)--in maternal urine samples collected during pregnancy were associated 
with increased DNA methylation in cord blood.14 By contrast, among 181 mother-newborn pairs in 
China, maternal third trimester urinary mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP) and mono-
(2-ethyl-5-oxohexyl)phthalate (MEOHP) were associated with decreased DNA methylation in placental 
tissue.15 
In the current study, we evaluate associations of urinary bisphenols and phthalate metabolites with 
TTP among 877 women participating in a large population-based pregnancy cohort. Because both 
bisphenols and phthalates affect DNA methylation, we assess potential effect measure modification 
by preconception folic acid supplementation, which prior studies have not explored. Our analysis 
expands upon earlier studies in three additional ways. 1) Where prior studies focused exclusively on 
BPA, we also investigate eight BPA analogues, chemical replacements that are commonly found in “BPA-
free” products and have yet to be reported on in human fertility research. 2) In addition to measuring 
associations between molecular weight groupings of urinary phthalate metabolites and TTP, we also 
examine TTP in relation to phthalic acid (PA). As the final common metabolic form of all phthalates, 
PA represents a proxy for total phthalate exposure and captures exposure to phthalates for which we 
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do not have individual metabolite measures. 3) As contrasted to prior studies, which are restricted to 
women who have conceived naturally, we include women who conceived using some form of infertility 
treatment, permitting the investigation of potential associations of bisphenol and phthalate exposure 
with longer TTP. 
Methods
Study design and population for analysis
The present study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onward that was approved by the Medical Ethical Committee of the 
Erasmus Medical Centre in Rotterdam.16 In total, 8879 women were enrolled, 76% before gestational 
age of 18 weeks. Written consent was obtained from all participants.17 
Bisphenol and phthalate concentrations were measured in first trimester urine samples among a 
subgroup of 1396 women with singleton pregnancies whose children also participated in postnatal 
studies at child age 5 years. Of these, 519 participants were excluded due to missing data on TTP and 
whether they had used infertility treatment, yielding an analytic sample of 877 women. 
Urinary bisphenol and phthalate measurements 
Bisphenol and phthalate concentrations were measured in a spot urine sample obtained from each 
participant during the first trimester visit (median gestational age 12.9 weeks, inter-quartile range 
12.1-14.4 weeks). All urine samples were collected between February 2004 and July 2005. Details on 
collection, transportation, and analysis methodology are provided elsewhere.18  
For analysis, we grouped bisphenols together and grouped phthalate metabolites according to their 
molecular weight categories and parent compounds. Phthalate metabolites and bisphenols were only 
included in groupings if <80% of the sample concentrations were below the limit of detection (LOD). 
Additionally, individual bisphenols were analyzed separately if <50% of the sample concentrations were 
below the LOD. We calculated the weighted molar sums for groups representing total bisphenols, low 
molecular weight (LMW) phthalates, high molecular weight (HMW) phthalates, and two subgroups of 
HMW phthalates, total di-2-ethylhexyl phthalate (DEHP) and di-n-octylphthalate (DNOP) metabolites, 
using the formula: ((concentration in ng/mL) * (1 / molecular weight) * (1 / 10^-3)) + ((concentration 
in ng/mL) * (1 / molecular weight) * (1 / 10^-3)) + etc. PA was analyzed separately as a proxy for total 
phthalate exposure. For bisphenol and phthalate concentrations <LOD, we substituted LOD/√2.19 Table 
1 shows the concentrations and detection rates of all of the bisphenols and phthalate metabolites we 
analyzed, both individually and in groups.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Bisphenols, phthalates and time to pregnancy
131 
2.2
TTP and infertility treatment 
Information on TTP (months) and whether pregnancy was the result of any kind of infertility treatment 
(ovulation induction, surgery, artificial insemination, or in vitro fertilization) was obtained from the first 
questionnaire at enrollment. When we modeled TTP as a continuous outcome, we assigned 12 months 
as the TTP for all participants who received infertility treatment, reflecting the clinical definition of 
infertility,20 regardless of when they commenced intervention, to avoid bias. 
Covariates
Potential covariates were identified via causal diagram and a review of the literature. Information on 
maternal and paternal age (years), parity (nulliparous/multiparous), maternal educational level (low/
high), ethnicity (Dutch or European/Non-European), pre-pregnancy weight (kg), and preconception 
folic acid supplementation (Y/N) was obtained from the first questionnaire at enrollment. Maternal 
height (cm) was measured at enrollment without shoes or heavy clothing. Paternal weight and height 
were measured once during pregnancy. Maternal pre-pregnancy and paternal body mass index (BMI) 
were calculated according to the standard formula (kg/m2). Information on maternal smoking and 
alcohol consumption (Y/N) was assessed by questionnaires in each trimester.
Statistical analysis
Descriptive statistics were performed to assess participant characteristics. Depending on the distribution 
of the variables, Pearson or Spearman correlations were used to test for collinearity among potential 
covariates. Missing data for covariates were imputed using multiple imputation. Five imputed datasets 
were created and pooled for analyses. The percentage of missing values for any given covariate within 
the analytic sample was ≤10% except for folic acid supplementation (13.3%).  For the main regression 
analyses, all bisphenol and phthalate urinary metabolite concentrations were natural log-transformed 
to reduce variability and all models were adjusted for urinary creatinine concentration.
To examine associations of first trimester urinary bisphenol and phthalate concentrations with TTP 
modeled continuously, we used discrete Cox proportional hazard models. Participants who conceived 
by use of infertility treatment were censored at 12 months. Proportional hazards assumptions for 
covariates were checked using plots of Schoenfeld residuals for continuous variables and log-minus-
log plots for categorical variables. The resulting fecundability ratios (FR) represent the probability 
of becoming pregnant in a single menstrual cycle per log unit increase in bisphenol or phthalate 
metabolite/group (note: FR>1 indicates shorter TTP, while FR<1 indicates longer TTP). To select potential 
covariates for inclusion in the regression models, Cox proportional hazards models were manually fitted 
using log-likelihood ratio test based backward selection. Non-linearity of exposure variables in the Cox 
proportional hazards model was tested using quintiles.
Sensitivity analysis was performed excluding participants who used infertility treatment. Given the 
biological plausibility that folic acid may influence the mechanism by which bisphenol and phthalate 
compounds affect female reproductive function, we stratified on preconception folic acid supplement 
use and performed a test for interaction among participants with non-missing values of folic acid 
supplementation. Interaction on the multiplicative scale was considered significant for p-value <0.1. 
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For all models with statistically significant results, subanalyses of individual bisphenols or phthalate 
metabolites were performed to determine which compounds were driving the association. 
Cox proportional hazard models were performed using R statistical software version 3.3.2 for Windows 
(package survival and msm). All other analyses were performed using the Statistical Package of Social 
Sciences version 21.0 for Windows (SPSS Inc., Chicago, IL, USA). 
Results
Participant characteristics
Table 1 shows first trimester urinary bisphenol and phthalate concentrations of participating women. 
Due to low detection rates, not all bisphenols and phthalates were included in subsequent analyses. 
Maternal participants were mean age 31.2 years (standard deviation (SD) 4.4) and had a median BMI 
of 22.7 kg/m2 (inter-quartile range (IQR) 20.9, 25.2). The majority were Dutch or European (68.9%), 
nulliparous (62.7%), and non-smokers (73.9%). The median TTP was 3 months (range 1-85), and 52 
pregnancies (5.9%) resulted from any form of infertility treatment (Table 2). 
We noted strong correlations between maternal and paternal age (Pearson correlation coefficient 0.6) 
and weak correlations between maternal and paternal BMI (Spearman’s rho 0.2) (data not shown). To 
avoid multicollinearity, only maternal covariates were used in regression analyses. 
Generation R participants who met the eligibility criteria for our study (enrollment <18 weeks gestation, 
information on TTP and infertility treatment use, singleton live born children, 5-year postpartum visit, 
n=2835) had generally similar population characteristics to those who additionally had first trimester 
urine samples and were included in our analysis (n=877) (Supplementary Table S1). 
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Maternal age (years) 31.2 (4.4)
Paternal age (years) 33.7 (5.2)
Maternal pre-pregnancy BMI (kg/m²)* 22.7 (20.9, 25.2)

























Time to pregnancy (months) † 3 (1, 85)
Use of infertility treatment
Conceived naturally 825 (94.1)
Conceived using infertility treatment 52 (5.9)
¹Values for continuous variables reported as mean (standard deviation); values for categorical variables reported as 
number of participants (percent) 




Associations with time to pregnancy
Schoenfeld residuals of all continuous covariates were evenly distributed using the Kaplan Meier 
time scale, indicating that the proportional hazards assumption was met (Supplementary Table S2a). 
In log-minus-log plots, lines for parity crossed and had a p-value of 0.055 for non-proportionality 
(Supplementary Table S2b). Therefore, all Cox proportional hazards models were stratified for parity. 
Although the p-value for non-proportionality for folic acid supplement use was 0.058, proportionality 
was assumed because the lines did not cross.
None of the first trimester urinary bisphenol or phthalate groups or compounds was associated with 
fecundability (Table 3). Modeling quintiles of exposures did not reveal any non-linear associations 
(data not shown). Sensitivity analysis, using only participants who conceived naturally, yielded similar 
fecundability ratios (Supplementary Table S3).  
Table 3. Covariate-adjusted fecundability ratios (FR) for maternal first trimester urinary bisphenol and phthalate 
concentrations (n=877)
FR (95% CI)
Total bisphenols 0.98 (0.92, 1.04)
Bisphenol A 0.99 (0.95, 1.04)
Bisphenol S 0.98 (0.94, 1.02)
Phthalic acid 0.96 (0.90, 1.02)
LMW phthalate metabolites 0.96 (0.92, 1.02)
HMW phthalate metabolites 0.98 (0.91, 1.05)
DEHP metabolites 0.99 (0.92, 1.06)
DNOP metabolites 0.96 (0.90, 1.03)
Data analyzed using a Cox proportional hazards model (R v3.3.2).   
Increases are per natural log increase in first trimester urinary total bisphenols/BPA/BPS/Phthalic acid/LMW/
HMW/DEHP/DNOP metabolite concentrations. Models are fitted. All models are adjusted for maternal age, 
education, parity, folic acid supplement use, and urinary creatinine concentration.    
*p-value <0.05.
Effect measure modification by preconception folic acid supplement use 
Among women who did not use folic acid supplements preconceptionally, each log unit increase in total 
bisphenols and PA decreased fecundability (FR=0.90 [95% Confidence Interval (CI) 0.81, 1.00] and 0.88 
[95% CI 0.79, 0.99], respectively). Slightly weaker associations were detected for BPA and bisphenol 
S (BPS) (FR=0.93 [95% CI 0.86, 1.01] and 0.94 [95% CI 0.87, 1.01], respectively). Correlations of first 
trimester BPA and BPS are weak.18 BPA and BPS were assessed in a simplified multipollutant model by 
adding both in the same model. This yielded exactly the same estimates. Among preconception folic 
acid supplement users, bisphenol and phthalate compounds were not associated with fecundability. 
Tests for interaction indicated effect measure modification by folic acid supplement use for associations 
of total bisphenols, BPA, BPS, PA, HMW phthalates, and DNOP metabolites with fecundability (p-values 
<0.1). In all cases, fecundability was lower in women without preconception folic acid supplement use, 
indicating longer TTP (Table 4).
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Table 4. Covariate-adjusted fecundability ratios (FR) for maternal first trimester urinary bisphenol and phthalate 




   Inadequate folic acid 
   supplement use
0.90 (0.81, 1.00)*
   Folic acid supplement use 1.00 (0.92, 1.09)
Bisphenol A†
   Inadequate folic acid 
   supplement use
0.93 (0.86, 1.01)**
   Folic acid supplement use 1.00 (0.94, 1.07)
Bisphenol S†
   Inadequate folic acid 
   supplement use
0.94 (0.87, 1.01)**
   Folic acid supplement use 1.02 (0.96, 1.09)
Phthalic acid†
   Inadequate folic acid 
   supplement use
0.88 (0.79, 0.99)*
   Folic acid supplement use 0.99 (0.91, 1.08)
LMW phthalate metabolites
   Inadequate folic acid 
   supplement use
0.94 (0.85, 1.03)
   Folic acid supplement use 0.98 (0.91, 1.05)
HMW phthalate metabolites†
   Inadequate folic acid 
   supplement use
0.93 (0.82, 1.04)
   Folic acid supplement use 1.03 (0.93, 1.14)
DEHP metabolites
   Inadequate folic acid 
   supplement use
0.94 (0.83, 1.05)
   Folic acid supplement use 1.03 (0.93, 1.13)
DNOP metabolites†
   Inadequate folic acid  
   supplement use
0.90 (0.80, 1.02)
   Folic acid supplement use 1.02 (0.93, 1.11)
Data analyzed using a Cox proportional hazards model (R v3.3.2).   
Increases are per natural log increase in first trimester urinary total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/
DEHP/DNOP metabolite concentrations. All models are adjusted for maternal age, education, parity, and urinary 
creatinine concentration.          
*p-value <0.05 **p-value 0.05-0.1 †interaction term p-value <0.1. 
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Subanalysis of bisphenol F (BPF) did not reveal further associations (Supplementary Table S4). Subanalysis 
of individual HMW phthalate metabolites showed effect measure modification by folic acid supplement 
use for mono-(2-ethyl-5-carboxypentyl)phthalate (mECPP), mono-[(2-carboxymethyl)hexyl]phthalate 
(mCMHP), mono(3-carboxypropyl)phthalate (mCPP) and monobenzylphthalate (mBzP) in models that 
included interaction terms (p-values <0.1). Modeling quintiles of bisphenol and phthalate compounds 
did not show any non-linear associations (data not shown). 
Discussion
In this population-based birth cohort study with recalled information on TTP, we found total bisphenols 
and PA in the first trimester of pregnancy to be associated with decreased fecundability among women 
without preconception folic acid supplementation. We found no associations of first trimester urinary 
concentrations of bisphenols and phthalates with fecundability in unstratified models. The addition of 
an interaction term suggested effect measure modification by folic acid use of the association of total 
bisphenols, BPA, BPS, PA, HMW phthalate metabolites and DNOP metabolites with TTP. Among those 
with preconception folic acid supplementation, bisphenols and phthalates were not associated with 
TTP. 
We did not find maternal BPA to be associated with TTP, in line with previous studies.3-5 Both animal and 
human studies, however, have suggested a role for BPA in the pathogenesis of several known causes 
of female infecundability, including endometriosis and polycystic ovarian syndrome (reviewed in 21,22). 
Results from previous studies examining associations between phthalates and TTP have been 
inconsistent.3-5,7,8 Among prospective cohorts of couples discontinuing contraception, the North 
Carolina Early Pregnancy Study reported no associations between female urinary phthalates and TTP,4 
the Danish First Pregnancy Planner Study reported female urinary monoethylphthalate (mEP) to be 
associated with a longer TTP,7,while the Longitudinal Investigation of Fertility and the Environment study 
observed an association between female urinary mCPP and shorter TTP.3 Among pregnancy studies that 
used recalled TTP, as we did, the Canadian Maternal-Infant Research on Environmental Chemicals study 
reported no associations between first trimester urinary phthalate concentrations and TTP,5 while the 
multi-site European INUENDO study reported a shorter TTP per log unit increase in maternal serum 
DEHP concentrations during pregnancy.8 
Our findings of effect measure modification by folic acid supplementation of the associations of total 
bisphenols, BPA, BPS, PA, HMW phthalates and DNOP metabolites with TTP, and of reduced FRs for 
those without preconception folic acid supplementation support our hypothesis that bisphenols and 
phthalates may influence fecundability by inducing changes in DNA methylation. This is the first study 
to report this for phthalates and is in line with a recent study among women undergoing infertility 
treatment that reported that high urinary BPA concentrations were associated with lower probabilities 
of implantation, clinical pregnancy, and live birth, among women who consumed <400 μg/day of 
dietary folate.13 Diet interactions might explain the null findings reported in previous studies. DNA 
methylation has been identified as a potential mechanism in the association of persistent organic 
pollutants and reduced fecundability. A recent study in European adult males observed a weak 
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association between exposure to persistent organic pollutants and global DNA methylation in sperm.23 
In rodents, polychlorinated biphenyls have been identified to impair endometrial receptivity and cause 
failure of embryo implantation by disturbing the methylation level of the implantation-associated gene 
Homeobox A10 (HOXA10).24 However, no studies have investigated the role of preconception folic acid 
supplementation in this association. Further studies, ideally with maternal preconception serum folate 
concentrations rather than retrospective self-reported supplement use, are needed to confirm these 
results. 
Strengths and limitations
Strengths of this study include the relatively large sample size of 877 participants with information on 
the use of infertility treatment and TTP. Participants were recruited in early pregnancy and asked to 
recall TTP in the first questionnaire at enrollment. Although prospectively measured TTP would have 
been preferable, the only published validation study comparing prospectively measured TTP to TTP 
recalled during the first trimester of pregnancy reported perfect agreement between measures among 
53% of their sample. Recall error was on average small (only 12% had a discrepancy of  ≥2 months), with 
a median of 0 and a mean of -0.11 months, indicating reasonable validity.25 
Detailed information on a large number of potential confounding factors was available, although we 
lacked information on several potential covariates predicting TTP such as timing/frequency of sexual 
intercourse and medical history, which may have introduced residual confounding. Most covariates 
used for this analysis were self-reported, which may have led to misclassification and consequently 
underestimation of effects. In the stratified and interaction models, we adjusted for maternal 
age, education, and parity, which are all associated with self-reported preconception folic acid 
supplementation in this cohort,26 but the possibility of residual confounding by other sociodemographic 
factors remains.
This is the first study to assess associations of BPA analogues such as BPS, which recent studies have 
shown to have adverse effects on the reproductive neuroendocrine system,27-30 and of PA, a proxy for 
total phthalate exposure, with TTP. Unfortunately, our exposure measures were based on a single spot 
urine in the first trimester of pregnancy and may not accurately reflect preconception levels. Both 
bisphenols and phthalates are reported to have short biological half-lives (<24 h),31,32 although it has 
been suggested that a single urine sample for phthalate concentrations reasonably reflects exposure 
for up to three months.33 Studies investigating variability of bisphenols and phthalates before and 
during pregnancy are scarce. Variability has been reported to be biomarker specific, with reasonable 
correlations for BPA and DEHP metabolites and stronger correlations for LWM phthalate metabolites 
and mBzP.34,35 Cross-sectional studies are at risk for reversed causation. In the current study, the 
observed interaction with folic acid supplementation use negates potential reversed causation induced 
by preconception behavioral changes in women taking longer to conceive. The absence of paternal 
exposure measurements may have introduced residual confounding, as several recent epidemiologic 
studies suggest that BPA and phthalates may diminish semen quality.36-40 
Our main analyses violated the assumption of non-informative censoring for Cox proportional hazards 
models, as those who were censored because they used infertility treatment likely had a lower probability 
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of natural conception.41 To overcome this limitation, we performed a sensitivity analysis including only 
participants who conceived naturally and found comparable results (Supplementary Table S3) despite 
differences among those with TTP <12 months vs. TTP ≥12 months in maternal age, daily dietary caloric 
intake, ethnicity, education and folic acid supplementation (Supplementary Table S5). 
Finally, while there was reasonable similarity between the subgroup of the Generation R cohort in 
which we performed these analyses and the entire sample (Supplementary Table S1), the response 
rate at baseline for the Generation R study was 61%.16 We therefore cannot rule out selection toward 
a relatively healthy population that may limit the generalizability of our results. As a population-
based pregnancy cohort, all women in this study successfully conceived, with or without infertility 
treatment. Therefore, this study is less generalizable for the general population of couples discontinuing 
contraception, were 15-30% of couples are estimated to suffer from unexplained subfertility.42 
Conclusion
Although we found no associations of first trimester bisphenol and phthalate urinary concentrations 
with fecundability in full-sample analyses, we detected evidence of effect measure modification by 
folic acid supplement use. Among women without preconception folic acid supplementation, increased 
bisphenol and phthalate concentrations were associated with reduced fecundability, suggesting that 
the mechanism by which these chemicals impair reproductive potential may involve changes in DNA 
methylation. Our findings add to the already substantial evidence of the benefits of preconception folic 
acid supplementation to reproductive health. Further studies are needed to replicate these findings 
and investigate potential mechanisms. 
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Supplementary Table S1. Nonresponse analysisa
Sample n = 877† Eligible Generation R n = 2835†† 
Time to pregnancy (months)b 3.0 (1.0, 85.0) 3.0 (1.0, 120.0)
Maternal age (years)c 31.2 (4.4) 31.0 (4.5)
Infertility treatment use (yes) 52 (5.9) 148 (5.2)
Education (high education) 482 (56.2) 1482 (53.3)
Parity (nulliparous) 550 (62.7) 1746 (61.6)
Folic acid supplement use  
(yes, periconceptional)
458 (60.3) 1403 (57.0)
aExcept where noted, values are reported as number of participants (valid percentages)  
bMedian (min, max)  
cMean (standard deviation)  
† Singleton live born children + inclusion <18w + visit 5 years postpartum + information on time to pregnancy and 
the use of infertility treatment + first trimester urine sample     
†† Singleton live born children + inclusion <18w + visit 5 years postpartum + information on time to pregnancy and 
the use of infertility treatment  





































































































































































































































































































Kaplan-Meier and –log(-log(Survival) plots are shown for all categorical covariates. If lines cross or the p-value 
<0.05, the proportional hazards assumption is not met. The proportional hazards assumption holds for all the above 
covariates except for parity. Therefore, stratification for parity was used to overcome this issue.
P>0.058
P>0.05
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Supplementary Table S3. Sensitivity analysis; without participants who conceived through infertility treatment 
(n=825)
FR (95% CI)a
Total bisphenols 1.00 (0.94, 1.06)
Bisphenol A 1.00 (0.95, 1.05)
Bisphenol S 0.99 (0.95, 1.04)
Phthalic acid 0.98 (0.92, 1.05)
LMW phthalate metabolites 0.97 (0.92, 1.03)
HMW phthalate metabolites 1.01 (0.94, 1.09)
DEHP metabolites 1.02 (0.96, 1.10)
DNOP metabolites 0.99 (0.93, 1.06)
Data analyzed using a Cox proportional hazards model (R v3.3.2).   
Increases are per natural log increase in first trimester urinary total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/
DEHP/DNOP metabolite concentrations. Models are fitted.       
aAll models are adjusted for maternal age, education, parity, folic acid supplement use, and urinary creatinine 




Supplementary Table S4. Covariate-adjusteda fecundability ratios (FR) for maternal first trimester urinary bisphenol 
and phthalate metabolite concentrations, stratified by folic acid supplement use (n=760; none or postconception 
(inadequate) n=302, preconception (adequate) n=458)
FR (95% CI)
Total bisphenols†
   Inadequate folic acid supplement use 0.90 (0.81, 1.00)*
   Folic acid supplement use 1.00 (0.92, 1.09)
Bisphenol A†
   Inadequate folic acid supplement use 0.93 (0.86, 1.01)**
   Folic acid supplement use 1.00 (0.94, 1.07)
Bisphenol S†
   Inadequate folic acid supplement use 0.94 (0.87, 1.01)**
   Folic acid supplement use 1.02 (0.96, 1.09)
Bisphenol F
   Inadequate folic acid supplement use 1.02 (0.91, 1.15)
   Folic acid supplement use 1.00 (0.91, 1.10)
HMW phthalate metabolites†
   Inadequate folic acid supplement use 0.93 (0.82, 1.04)
   Folic acid supplement use 1.02 (0.93, 1.14)
mECPP metabolites†
   Inadequate folic acid supplement use 0.94 (0.84, 1.04)
   Folic acid supplement use 1.04 (0.95, 1.14)
mEHHP metabolites
   Inadequate folic acid supplement use 0.98 (0.89, 1.09)
   Folic acid supplement use 1.01 (0.93, 1.10)
mEOHP metabolites
   Inadequate folic acid supplement use 0.98 (0.89, 1.09)
   Folic acid supplement use 1.01 (0.93, 1.10)
mCMHP metabolites†
   Inadequate folic acid supplement use 0.91 (0.81, 1.03)
   Folic acid supplement use 1.03 (0.93, 1.14)
mCPP metabolites†
   Inadequate folic acid supplement use 0.90 (0.80, 1.02)
   Folic acid supplement use 1.02 (0.93, 1.11)
mBzP metabolites†
   Inadequate folic acid supplement use 0.95 (0.88, 1.03)
   Folic acid supplement use 1.02 (0.96, 1.09)
mHxP metabolites
   Inadequate folic acid supplement use 0.99 (0.90, 1.08)
   Folic acid supplement use 0.98 (0.90, 1.06)
mHpP metabolites
   Inadequate folic acid supplement use 1.01 (0.92, 1.11)
   Folic acid supplement use 0.94 (0.85, 1.04)
Data analyzed using a Cox proportional hazards model (R v3.3.2).   
Increases are per natural log increase in first trimester urinary bisphenol or phthalate metabolite concentrations. 
aAll models are adjusted for maternal age, education, parity, and urinary creatinine concentration.  
*p-value <0.05 **p-value 0.05-0.1 †interaction term p-value <0.1.
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Supplementary Table S5. Distributions of covariates in participants with TTP < 12 months and TTP ≥ 12 months 






Maternal age (y) 31.0 (4.2) 32.1 (5.0) 0.017*
Maternal BMI (kg/m2)* 22.7 (21.0, 25.1) 23.0 (20.8, 25.5) 0.418
Daily dietary caloric intake (kcal) 2100 (492) 1985 (511) 0.030*
Creatinine (ug/ml)* 976 (479, 1565) 912 (476, 1573) 0.908
Nulliparous (%) 61.6 69.2 0.094
Dutch/European (%) 70.9 58.3 0.004*
Low educated (%) 42.3 52.8 0.028*
Smokers (%) 20.1 26.0 0.136
Alcohol users (%) 58.6 53.7 0.316
Adequate folic acid supplement use (%) 62.0 50.9 0.025*
Values are presented as means (SD) or valid percentage.   
*median (IQR)  
aDifferences between groups of TTP < 12 months and TTP ≥ 12 months were assessed using independent t-tests for 
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STUDY QUESTION: Are early-pregnancy urinary bisphenol and phthalate metabolite concentrations 
associated with placental function markers, blood pressure (BP) trajectories during pregnancy, and risk 
of gestational hypertensive disorders?
SUMMARY ANSWER: Early-pregnancy bisphenols and phthalate metabolites were not consistently 
associated with maternal BP changes or gestational hypertensive disorders, but subclinical but significant 
associations with placental angiogenic markers and placental hemodynamics were identified. 
WHAT IS KNOWN ALREADY: In vitro studies suggest that bisphenols and phthalate metabolites may 
disrupt early placental development and affect the risk of gestational hypertensive disorders. Previous 
studies investigating effects of bisphenols and phthalate metabolites on gestational hypertensive 
disorders reported inconsistent results and did not examine placental function or BP throughout 
pregnancy.
STUDY DESIGN, SIZE, DURATION: In a population-based prospective cohort study, bisphenol and 
phthalate metabolite concentrations were measured in a spot urine sample in early pregnancy among 
1,396 women whose children participated in postnatal follow-up measurements.  
PARTICIPANTS/MATERIALS, SETTING, METHODS: After exclusion of women without any BP 
measurement or with pre-existing hypertension, 1,233 women were included in the analysis. Urinary 
bisphenol and phthalate metabolite concentrations were measured in early-pregnancy [median 
gestational age 13.1 weeks, inter-quartile range 12.1–14.5]. Molar sums of total bisphenols and of low 
molecular weight phthalate, high molecular weight (HMW) phthalate, di-2-ethylhexylphthalate, and 
di-n-octylphthalate metabolites were calculated. Placental angiogenic markers (placental growth factor 
(PlGF), soluble fms-like tyrosine kinase (sFlt)-1), placental hemodynamic function measures (umbilical 
artery pulsatility index (PI), uterine artery resistance index (RI), notching, and placental weight), and 
maternal BP were measured in different trimesters. Information on gestational hypertensive disorders 
was obtained from medical records. 
MAIN RESULTS AND THE ROLE OF CHANCE: Each log unit increase in HMW phthalate metabolites 
was associated with a 141.72 (95% CI 29.13, 373.21) higher early pregnancy sFlt-1/PlGF ratio (range 
in total sample 9-900). This association was driven by mono-[(2-carboxymethyl)hexyl]phthalate. In the 
repeated measurements regression models, each log unit increase in bisphenol A was associated with 
a 0.15 SD (95% CI 0.03, 0.26) higher intercept and -0.01 SD (95% CI -0.01, -0.00) decreasing slope of 
the umbilical artery PI Z-score and a -1.28 SD (95% CI -2.24, -0.33) lower intercept and 0.06 SD (95% CI 
0.02, 0.11) increasing slope of the uterine artery RI Z-score. These associations remained significant 
after Bonferroni correction. Early-pregnancy bisphenols or phthalate metabolites showed no consistent 
associations with any other outcome.
LIMITATIONS, REASONS FOR CAUTION: Information on a large number of potential confounders was 
available but was partly self-reported. Bisphenols and phthalate metabolites, which typically have a 
half-life of 24-48 hours, were measured via single spot urine samples in early-pregnancy. In addition, 
at the current sample size, the study was powered to detect an odds ratio of 1.57 for gestational 
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hypertension and 1.78 for pre-eclampsia, but was underpowered to perform multivariable analyses for 
these outcomes. Further studies combining data from different cohorts may be necessary to increase 
power. These limitations are possible sources of non-differential misclassification leading to bias toward 
the null.
WIDER IMPLICATIONS OF THE FINDINGS: Bisphenols and phthalate metabolites were not associated 
with longitudinal changes in BP in pregnancy in our low-risk population. The observed subclinical 
associations of phthalates with the sFlt-1/PlGF ratio and of bisphenol A with placental hemodynamics 
may contribute to adverse pregnancy outcomes. Our results are therefore more supportive of an 
association of early pregnancy bisphenols and phthalate metabolites with risk for pre-eclampsia than 




Gestational hypertension and pre-eclampsia complicate 4-10% of all pregnancies and are major causes 
of morbidity and mortality.1 They appear to originate in early-pregnancy.2 In normal pregnancy, a balance 
of pro-angiogenic and anti-angiogenic factors, such as placental growth factor (PlGF) and soluble fms-
tyrosine kinase (sFlt)-1, respectively, is established in the developing placenta.3 An imbalance in these 
factors is associated with impaired vascular proliferation, which may result in placental dysfunction 
and increased risk of gestational hypertensive disorders.4 Pregnant women are exposed to numerous 
chemicals, including bisphenols and phthalates.5-7 Phthalates can be classified as low molecular weight 
(LMW) or high molecular weight (HMW). LMW phthalates are frequently added to personal care 
products, while HMW phthalates are used to impart flexibility to vinyl and plastic products.8 Among 
HMW phthalates, di-2-ethylhexylphthalate (DEHP) is of particular interest because of its widespread 
use in food packaging.9 Di-n-octylphthalate (DNOP) is also of concern because, although banned 
from use in the European Union since 2005, its primary metabolite, mono(3-carboxypropyl)phthalate 
(mCPP), is still detectable in biosamples.10,11 Bisphenols and phthalate metabolites may disrupt early 
placental development.12-15 Urinary bisphenol A (BPA) and DEHP concentrations have been associated 
with altered placental angiogenic markers.14 Three previous studies on the associations of bisphenols 
and phthalate metabolites with gestational hypertensive disorders 16-18 showed inconsistent results. 
Among 1,233 women participating in a population-based prospective cohort study, we examined 
associations of early-pregnancy urinary bisphenol and phthalate metabolite concentrations with 
placental angiogenic and hemodynamic function measures, blood pressure (BP) trajectories, and risk of 
gestational hypertensive disorders.
Materials and Methods
Study design and population for analysis
This study was embedded in a population-based prospective cohort study that enrolled 8,879 women 
from early-pregnancy onwards 19 and was approved by the Medical Ethical Committee of the Erasmus 
MC, Rotterdam. Written informed consent was obtained from all participants. Bisphenol and phthalate 
metabolite concentrations were measured in 1,396 participants with singleton pregnancies, an available 
early-pregnancy urine sample, and whose children participated in postnatal studies. After excluding 
women without any BP measurement or with pre-existing hypertension, 1,233 women remained in the 
analysis (Supplementary Fig. S1). 
Early-pregnancy urinary bisphenol and phthalate metabolite concentrations 
Bisphenol, phthalate metabolite, and creatinine concentrations were measured in a spot urine sample 
obtained from participants in early-pregnancy (median gestational age 13.1 weeks, inter-quartile range 
(IQR) 12.1-14.5) between February 2004 and July 2005. Samples were collected between 8am and 
8pm in 100-mL polypropylene urine collection containers, refrigerated, aliquoted, and frozen at -20 
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°C within 24 hr. Frozen samples were shipped to the Wadsworth Center, New York State Department 
of Health (Albany, NY, USA) for high-performance liquid chromatography-tandem mass spectroscopy 
analysis. Eight bisphenols and 18 phthalate metabolites were measured, including phthalic acid (PA), a 
common endpoint of phthalate metabolism, which was used as a proxy of total phthalate exposure 20. 
Details have been described previously.10,21 
We grouped phthalate metabolites according to molecular weight, reflecting their use in product 
categories. The inclusion criteria for chemicals and the formulae by which we calculated the weighted 
molar sums for total bisphenols and phthalate metabolite groupings are shown in Supplementary 
Data.22 Supplementary Table S1 shows the bisphenols and phthalate metabolites in each group, with 
their concentrations and detection rates.
Placental angiogenic markers, hemodynamic function, and weight  
sFlt-1 and PlGF concentrations were measured in early and mid-pregnancy blood samples using an 
immune-electrochemoluminence assay.23 The sFlt1/PlGF ratio was calculated. Mid- and late-pregnancy 
placental vascular resistance was evaluated with flow velocity waveforms from the uterine and umbilical 
arteries.24 Umbilical artery pulsatility index (PI) was measured in a free-floating loop of the umbilical 
cord. Uterine artery resistance index (RI) was measured in the uterine arteries near the crossover with 
the external iliac artery. Increased uterine artery RI and umbilical artery PI indicate elevated placental 
vascular resistance and are linked with gestational hypertensive disorders. We assessed the presence 
of uterine artery notching, which reflects increased resistance to blood flowing into the placenta and 
is used to identify high-risk pregnancies.25 Placental weight was obtained from medical records and 
measured according to standard protocols. 
Blood pressure and gestational hypertensive disorders
BP was measured at each visit (median gestational age 13.1 weeks, IQR 12.1-14.5; 20.4 weeks, 
IQR 19.9-20.9; and 30.2 weeks, IQR 29.9-30.6) using an Omron 907 automated digital oscillometer 
sphyghmanometer (OMRON Healthcare Europe, Hoofddorp, the Netherlands).26 The mean value of 
two BP readings over a 60-s interval was documented for each participant.25 Information on gestational 
hypertensive disorders was obtained from medical records.27,28 
Covariates
Potential covariates were selected via causal diagram, literature review, and results from our previous 
study.10 Maternal age at enrollment, education level, ethnicity, parity, pre-pregnancy weight, and 
folic acid supplementation were obtained from the enrollment questionnaire. Gestational age was 
established during the first ultrasound visit. Height (cm) was measured at enrollment without shoes 
and pre-pregnancy BMI (kg/m²) was calculated. Information on smoking and alcohol consumption was 




Descriptive statistics were performed to assess participant characteristics. Missing covariate data were 
imputed using multiple imputation and p-values were adjusted for multiple testing using the Bonferroni 
correction. Bisphenol and phthalate metabolite concentrations were natural log-transformed to reduce 
variability and account for right skewness in the distribution. To adjust for dilution, urinary creatinine 
was included as a covariate.29
First, to explore the associations of early-pregnancy urinary bisphenol and phthalate metabolite 
concentrations with angiogenic markers, mid- and late pregnancy placental hemodynamic function, 
notching, and placental weight at delivery, we used multivariable linear and binary logistic regression. 
Placental angiogenic markers were natural log-transformed to account for right skewness in their 
distributions and were back-transformed for display. Placental hemodynamic function measures were 
converted into Z-scores to enable comparisons across time points. 
Second, we used unbalanced repeated measurement regressions to investigate associations of 
continuously modeled early-pregnancy chemical concentrations with repeatedly measured systolic and 
diastolic BP, placental angiogenic markers and hemodynamic function during pregnancy. For BP models, 
molar concentrations of metabolite groups were additionally modeled as tertiles for display. For models 
with tertiles, concentrations of individual compounds and metabolite groups were converted to μg/g 
and μmol/g creatinine, respectively. We hypothesized that associations with trajectories of BP during 
pregnancy might be dependent on pre-pregnancy BMI and tested for interaction by continuously and 
categorically modeled pre-pregnancy BMI for both the intercept and slope. 
Third, we used multivariable multinomial logistic regression to examine associations between chemical 
concentrations and risk of gestational hypertensive disorders. 
All of the above analyses were performed for each chemical group, BPA, and bisphenol S (BPS). To 
investigate individual compounds, additional analyses were performed of individual phthalate 
metabolites that were detected in >50% of the samples. for all non-repeated measurement regression 
analyses. Repeated measurements regression analyses were performed using the Statistical Analysis 
System version 9.4 (SAS Institute Inc., Gary, NC, USA), including the Proc Mixed module. Other analyses 
were performed using the Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc, 
Chicago, IL, USA). 
Results
Subject characteristics
Maternal characteristics and investigated outcomes were similarly distributed between participants 
and non-participants (Supplementary Table S2). Women who developed gestational hypertension 
had higher pre-pregnancy BMI, were more often nulliparous, and were more likely to take folic acid 
supplements (Table 1). Compared to women who developed gestational hypertension, women with 
pre-eclampsia more often had a low education level  and were less likely to take folic acid supplements.

































































































































































































































































































































































































































































































































































































































































Early-pregnancy bisphenol and phthalate metabolite levels and placental 
angiogenic markers
Bisphenol concentrations were not associated with placental angiogenic markers (Table 2). Each log 
unit increase in HMW phthalate metabolites was associated with 0.20 ng/ml (95% CI 0.02, 0.56) higher 
sFlt-1 concentration and 141.72 (95% CI 29.13, 373.21) higher sFlt-1/PlGF ratio in early pregnancy 
(range sFlt-1/PlGF ratio in total sample 9-900): after Bonferroni correction, only the latter remained 
significant. Among individual HMW phthalate metabolites, each log unit increase in the four DEHP 
metabolites, especially mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP), was associated with higher 
sFlt-1/PlGF ratio in early pregnancy (Supplementary Table S3). In addition, each log unit increase in 
mCMHP concentration was associated with lower PlGF and higher sFlt-1 concentrations in early 
pregnancy. Each log unit increase in LMW phthalate metabolites was associated with 0.18 pg/ml (95% 
CI 0.02, 0.70) higher PlGF concentration in mid-pregnancy, which remained significant after Bonferroni 
correction (Table 2). In subanalyses, only monoethylphthalate (mEP) was associated with PlGF in mid-
pregnancy, but the results were not significant after Bonferroni correction. Additional analyses also 
showed an association of higher mono-benzylphthalate (mBzP) concentration with higher sFlt-1 in early 
and mid-pregnancy. Early pregnancy bisphenols and phthalate metabolites were not associated with 
longitudinally modeled placental angiogenic markers (Supplementary Table S4).
Early-pregnancy bisphenol and phthalate metabolite levels, placental 
hemodynamic function, and placental weight
Each log unit increase in total bisphenols was associated with 0.05 SD (95% CI 0.001, 0.10) higher 
umbilical artery PI in mid-pregnancy, while each log unit increase in DEHP metabolites was associated 
with -0.06 SD (95% CI -0.12, -0.001) lower umbilical artery PI and 0.08 SD (95% CI 0.00, 0.15) higher 
uterine artery RI in late pregnancy. Each log unit increase in DNOP metabolites was associated with 24% 
decreased odds of notching (Odds Ratio (OR) 0.76 [95% CI 0.60, 0.97]), but did not remain significant 
after Bonferroni correction (Table 3). Additional analysis of individual phthalate metabolites showed 
that each log unit increase in mono-isobutylphthalate (mIBP) concentration was associated with 24% 
lower odds of notching (OR 0.76 [95% CI 0.62, 0.93]), remaining significant after Bonferroni correction 
(Supplementary Table S5). PA was borderline associated with lower placental weight (per log unit 
increase: -8 grams [95% CI -17, 0]). 
In the repeated measures models, each log unit increase in BPA was associated with 0.15 SD (95% 
CI 0.03, 0.26) higher intercept and -0.01 SD (95% CI -0.01, -0.00) lower slope of the umbilical artery PI 
Z-score over time and -1.28 SD (95% CI -2.24, -0.33) lower intercept and 0.06 SD (95% CI 0.02, 0.11) 
higher slope of the uterine artery RI Z-score over time (Supplementary Table S6 and Supplementary Fig. 
S2). These associations remained significant after Bonferroni correction. Higher concentrations of HMW 
phthalate metabolites were associated with a lower slope of the umbilical artery PI Z-score over time, 
but did not remain significant after Bonferroni correction.  
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Early-pregnancy bisphenol and phthalate metabolite levels and longitudinal 
changes in blood pressure during pregnancy
Modeled continuously, bisphenol and phthalate metabolite concentrations showed no associations for 
the intercept or slope of systolic BP during pregnancy (Supplementary Table S7). In adjusted analysis, 
each log unit increase in DNOP metabolites was associated with lower diastolic BP from early pregnancy 
onward (-0.80 mmHg (95% CI -1.52, -0.07)) and a borderline significant increase of 0.02 mmHg (95% CI 
-0.00, 0.05) per week gestational age. Models gave no indication of a non-linear relationship between 
chemicals and BP change across pregnancy (Supplementary Table S8). Supplementary Fig. S3 shows 
a nonsignificant trend toward higher systolic and diastolic BP from early pregnancy onward among 
women in the highest tertile of PA exposure. Covariate adjustment did not change our conclusions. No 
interaction was observed between chemical concentrations and maternal pre-pregnancy BMI. 
Early-pregnancy bisphenol and phthalate metabolite levels and gestational 
hypertensive disorders
Bisphenol and phthalate metabolite concentrations were not associated with gestational hypertensive 
disorders (Table 4). Also, sub-analysis of individual phthalate metabolite concentrations did not show 
any associations with gestational hypertensive disorders (Supplementary Table S9).
Table 4. Associations of early pregnancy bisphenol and phthalate urine concentrations with gestational hypertensive 
disorders (N = 1,219)







































































Values are based on basic and multivariable multinomial regression models that reflect odds ratios and 95% 
confidence intervals for gestational hypertensive disorders per log unit increase in urinary Total bisphenols/BPA/
BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations.      
Basic models are adjusted for creatinine. Adjusted models are adjusted for maternal age, maternal pre-pregnancy 





The results of our study show no consistent associations of early-pregnancy bisphenol and phthalate 
metabolite concentrations with maternal prenatal BP, placental hemodynamic outcomes, or gestational 
hypertensive disorders. Early-pregnancy HMW phthalate metabolite concentrations were associated 
with a subclinical increase in sFlt-1/PlGF ratio in early pregnancy. 
Strengths and limitations
This analysis benefited from the size, prospective data collection, and availability of a wide range of 
covariates. BP, placental angiogenic markers, and hemodynamic function measures were assessed at 
multiple time points during pregnancy. Participants in our analysis were similar to non-participants, 
enhancing the generalizability of our results to the underlying Generation R cohort. However, compared 
to other cohorts, ours was a low-risk population with relatively few cases of gestational hypertension 
and pre-eclampsia, potentially limiting the generalizability of our results to other populations. At our 
current sample size, we were powered to detect an OR of 1.57 for gestational hypertension and 1.78 
for pre-eclampsia, but we were underpowered to perform multivariable analyses for these outcomes. 
Further studies combining data from different cohorts may be necessary to increase power. 
Information on many covariates in this study was self-reported. BP and uteroplacental vascular resistance 
measures are known to fluctuate diurnally and information on time of day when measurements were 
performed was not available. Bisphenols and phthalate metabolites, which typically have half-lives of 
24-48 hours,8,30 were measured via single spot urine samples in early pregnancy. It has been suggested 
that a single urine sample for phthalate metabolite concentrations reasonably reflects exposure for up 
to 3 months.31 All of these limitations are possible sources of non-differential misclassification leading 
to bias toward the null.
A common method to account for dilution of urinary chemical concentrations is via creatinine 
adjustment.32 Endogenous creatinine clearance, measured by 24-hr urine collection, remains the most 
precise estimation of the glomerular filtration rate in pregnant women.33 It has been suggested that 
specific gravity adjustment is a better correction method in pregnant women.34 Unfortunately, specific 
gravity measurements were not available. Additional analysis of models without creatinine adjustment 
yielded comparable results. 
To adjust for multiple testing in this exploratory analysis, we have used an adjusted Bonferroni correction, 
correcting for the number of hypotheses tested per analysis rather than the number of models run. 
Bisphenols share some of their potential mechanisms of effect with phthalates.35 In additional analyses 
we therefore tested for interaction between concentrations of total bisphenols and PA. Evident 
interaction at p-value <0.1 was observed for late pregnancy umbilical artery PI. A partial regression plot 
is given in Supplementary Fig. S4. This finding should be considered hypothesis generating and supports 
the use of mixture models in future studies.  
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Interpretation of main findings
Early-pregnancy exposure to bisphenols and phthalates may lead to early placental maladaptations and 
subsequent increased risks of higher BP in pregnancy and gestational hypertensive disorders. Several 
potential biological mechanisms have been proposed to support this hypothesis. Higher bisphenol and 
phthalate metabolite concentrations have been associated with increased oxidative stress,36,37 which 
plays a role in the onset of pre-eclampsia, potentially through the release of anti-angiogenic factors.2,38 
Results have been inconsistent for associations between oxidative stress and placental angiogenic 
factors,39,40 but one group observed a positive correlation between oxidative stress markers and BP 
during pregnancy.41 In addition, BPA has been reported to have antiproliferative and pro-apoptotic 
effects on human trophoblastic cells, potentially through estrogen-related receptor γ and tumor 
necrosis factor α,13,42 and phthalates have been shown to inhibit extravillous trophoblast invasion 
through the peroxisome proliferator-activated receptor γ.43 
Our primary finding was a positive association between early-pregnancy HMW phthalate metabolite 
concentration and the sFlt-1/PlGF ratio in early pregnancy, driven by the DEHP metabolite mCMHP. In 
line with our results, a nested case-control study among 130 mothers who delivered preterm and 352 
who delivered at term with four measurements of prentatal BPA, phthalate metabolites, and placental 
markers, also found a positive association between DEHP metabolites and sFlt-1/PlGF ratio.14 In the 
Ferguson et al. (2015) study, mCMHP was not measured and the association seemed to be dependent 
on a decrease in PlGF rather than an increase in sFlt-1, as we observed. The Ferguson et al. (2015) 
study also observed an association of BPA with a higher sFlt-1and sFlt-1/PlGF ratio. For comparison, 
we performed additional analyses focused on individual phthalate metabolites with a detection level 
of >50%. We observed an association of mBzP with higher sFlt-1 concentrations in early-pregnancy. 
The relatively large proportion of preterm deliveries in the Ferguson et al. (2015) study and the 
repeated prenatal measurements of bisphenols and phthalate metabolites may have given rise to 
differences between our results. In our study, only early-pregnancy bisphenol and phthalate metabolite 
concentrations were included. Further studies are needed to explore associations of bisphenol and 
phthalate metabolite concentrations in different periods of pregnancy with hemodynamic adaptations 
during pregnancy. 
To our knowledge, this is the first study to assess effects of prenatal bisphenol and phthalate metabolite 
concentrations on placental hemodynamic function measures and placental weight. In repeated 
measurements regression models we observed contradictory associations of BPA with umbilical artery 
PI Z-score and uterine artery RI Z-score even though both measurements represent placental resistance. 
In Generation R, both placental indices are associated with higher odds of pre-eclampsia, small size for 
gestational age at birth and preterm birth, and higher estimates were observed for  uterine artery 
RI than for umbilical artery PI.24 However, it has been suggested that the predictive value of Doppler 
indices in the low-risk population is low and should not be used in the clinical setting.44 We cannot fully 
explain our findings and it is debatable whether this increase in uterine artery RI is clinically relevant. 
Several studies have reported associations of BPA and phthalate metabolite concentrations with higher 
BP in both adults and children.45-48 The only previous paper that focused on the associations of maternal 
phthalate concentrations with BP during pregnancy was a prospective cohort study of 369 women:16 
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this study reported that a higher urinary mBzP concentration at 16 weeks of gestation was associated 
with higher maternal diastolic BP before 20 weeks of gestation. No associations were found for BP 
values after 20 weeks of gestation. This previous study included women with higher BMI levels than 
in our cohort and women using medication for high BP. MBzP concentrations and the prevalence of 
gestational hypertensive disorders were higher than in our study population. 
The associations of bisphenol and phthalate metabolite concentrations with gestational hypertensive 
disorders have been scarcely examined. Recently, a nested case-control study comprising 50 women 
with, and 432 women without, pre-eclampsia observed positive associations of BPA and mEP 
concentrations at 10 weeks of gestation with pre-eclampsia.18 In a case-control study of 58 women, 23 
with pre-eclampsia, higher concentrations of BPA were detected in placental tissue of pre-eclamptic 
women compared to normotensive pregnant women.17 
The differences between our and other study populations may explain dissimilar results. In low-risk 
populations, bisphenol and phthalate metabolite concentrations might have limited effects on risks 
of hemodynamic adaptations. This might be different in high-risk populations. It has been debated 
whether gestational hypertension and pre-eclampsia are on the same spectrum of disease or whether 
they are two distinct entities.49 An imbalance in pro- and anti-angiogenic markers has been attributed 
to pre-eclampsia but not to gestational hypertension.50 Despite our low-risk population, we observed 
associations linking HMW phthalate metabolites to a higher sFlt-1/PlGF ratio in early pregnancy and 
BPA to an increasing slope in uterine artery RI Z-score. Our results are therefore more supportive of an 
association of early pregnancy bisphenols and phthalate metabolites with risk for pre-eclampsia than 
with gestational hypertension. 
Conclusion
Bisphenols and phthalate metabolites were not associated with longitudinal changes in BP. Phthalate 
exposure may elevate subclinical associations with the sFlt-1/PlGF ratio while BPA was observed to 
increase the uterine artery RI Z-score. These effects may contribute to adverse pregnancy outcomes in 
the context of other environmental exposures. 
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Supplementary Data. Weighted molar sums: inclusion and formulae
Individual compounds were included in groups if they were detected in ≥20% of the samples, so as 
not to bias the resulting molar sums by including metabolite measures based on a preponderance 
of imputed data. Bisphenols that were detected in ≥50% of the samples were analyzed separately. 
Because machine values were not available, bisphenol and phthalate metabolite concentrations below 
the level of detection (LOD) were substituted by LOD/√2, as routinely performed in bisphenol and 
phthalate analyses.1
Phthalic acid (PA) was used separately as a proxy of total phthalate exposure.2 
Formula for weighted molar sums in nmol per liter:
((concentration compound in ng/ml) * (1 / molecular weight in g/mol) * (1 / 10^-3)) + ((concentration 
compound in ng/ml) * (1 / molecular weight in g/mol) * (1 / 10^-3)) + etc. 
Formula for creatinine adjusted compounds in μg per gram creatinine: 
((concentration compound in ng/ml) / (concentration  urinary creatinine in µg/ml)) * (1 / 10^-3)
Formula for creatinine adjusted weighted molar sums in μmol per gram creatinine: 
((concentration in µg/g creatinine) / (molecular weight in g/mol)) + ((concentration in µg/g creatinine) 
/ (molecular weight in g/mol)) + etc. 
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Supplementary Table S1. Bisphenol and phthalate urinary concentrations (n=1,233)
Median (IQR) 
(ng/mL)
Percentage of values 
below the limit of 
detection (LOD)
Total bisphenols1 9.22 (3.51, 20.28)
   Bisphenol A (BPA) 1.65 (0.72, 3.58) 21.7
   Bisphenol S (BPS) 0.35 (0.17, 1.03) 31.5
   Bisphenol F (BPF) 0.57 (0.30, 1.32) 60.0
Phthalic acid (PA) 56.99 (30.62, 124.05) 0.3
Low molecular weight (LMW) metabolites1 1087.42 (423.91, 2925.28)
   Monomethylphthalate (mMP) 5.43 (2.75, 9.75) 0.2
   Monoethylphthalate (mEP) 137.85 (41.59, 484.50) 0.1
   Mono-isobutylphthalate (mIBP) 20.69 (9.44, 45.33) 0.2
   Mono-n-butylphthalate (mBP) 15.58 (6.89, 31.00) 0.7
High molecular weight (HMW) metabolites1 219.66 (110.84, 405.51)
Di-2-ethylhexylphthalate (DEHP) metabolites1 171.33 (87.61, 323.30)
   Mono-(2-ethyl-5-carboxypentyl)phthalate (mECPP) 15.96 (8.08, 31.60) 0.2
   Mono-(2-ethyl-5-hydroxyhexyl)phthalate (mEHHP) 11.76 (5.67, 22.92) 0.2
   Mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP) 7.66 (3.46, 15,48) -
   Mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP) 13.90 (7.55, 26.26) 0.1
Di-n-octylphthalate (DNOP) 5.72 (3.10, 11.03)
   Mono(3-carboxypropyl)phthalate (mCPP) 1.44 (0.78, 2.77) -
Other high molecular weight metabolites
   Monobenzylphthalate (mBzP) 6.55 (3.06, 12.81) 8.3
   Mono-hexylphthalate (mHxP) 0.33 (0.16, 0.63) 24.0
   Mono-2-heptylphthalate (mHpP) 1.09 (0.60, 2.29) 36.7
1Groups are molar concentrations in nmol/L with non-detectable levels of separate metabolites imputed as LOD/
sqrt(2). Separate metabolites are included only if less than 80% of values was below the LOD. 
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Supplementary Table S2. Maternal characteristics of participants and eligible non-participants
Sample n = 1,233 (at least 
one blood pressure measu-
rement in pregnancy and no 
pre-existing hypertension)
Generation R n = 4,056 
(singleton live born children 
with inclusion <18w + visit 
F@5 + at least one blood 
pressure measurement in 
pregnancy and no pre-exis-
ting hypertension)
Pre-eclampsia (%) 2.0 1.9
Gestational hypertension (%) 3.3 4.5
Systolic blood pressure trimester 1 115.7 (11.6) 115.6 (11.9)
Diastolic blood pressure trimester 1 67.9 (9.3) 68.1 (9.3)
Systolic blood pressure trimester 2 115.9 (11.7) 117.1 (11.9)
Diastolic blood pressure trimester 2 66.8 (9.8) 67.2 (9.3)
Systolic blood pressure trimester 3 117.2 (11.4) 118.7 (11.8)
Diastolic blood pressure trimester 3 68.8 (9.0) 69.2 (9.1)
Maternal pre-pregnancy BMI* 22.6 (20.8, 25.1) 22.6 (20.8, 25.2)
Values represent mean (SD) or valid percentages  
*Median (IQR)  
BMI: body mass index.














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table S6. Longitudinal associations of bisphenol and phthalate concentrations and placental 
hemodynamic function markersa
Umbilical artery pulsatility index, 
SD (95% CI)
(n=1217)
Uterine artery resistance index,  
SD (95% CI) 
(n=1134)





































































aChange in umbilical artery pulsatility index and uterine artery resistance index per natural log unit increase of 
Total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations based on repeated 
measurement analysis (hemodynamic function marker Z-score = β0 + β1 * log unit compound + β2 * gestational age 
+ β3 * log unit compound * gestational age (+ βx * additional covariates)). 
bValues are regression coefficients (95% confidence intervals) from multivariable unbalanced repeated 
measurement regression models that reflect the change in hemodynamic function marker per natural log unit 
increase of Total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations (β2). 
cValues are regression coefficients (95% confidence intervals) from multivariable unbalanced repeated 
measurement regression models that reflect the change in hemodynamic function marker in mmHg per natural log 
unit increase of Total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations per 
gestational age in weeks (β4).  
Models were adjusted for maternal age, maternal pre-pregnancy BMI, parity, ethnicity, education, maternal 
smoking, maternal alcohol, folic acid supplementation and urinary creatinine. 
*P-value<0.05. † significant with Bonferroni correction.




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table S8 can be found online
Supplementary Table S9 can be found online 
Supplementary Figure S1. Flowchart for participants in the study of bisphenol and phthalate metabolites, maternal 
hemodynamics, and gestational hypertensive disorders   
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Supplementary Figure S2. Longitudinal associations of bisphenol A concentrations and placental hemodynamic 
function marker Z-scores
Figure represents the change in umbilical artery pulsatility index Z-score and uterine artery resistance 
index Z-score per each natural log unit increase in bisphenol A (BPA). Based on repeated measurement 
analysis (hemodynamic function marker Z-score = β0 + β1 * log unit compound + β2 * gestational age + β3 
* log unit compound * gestational age (+ βx * additional covariates)).     
BPA was associated with both umbilical artery pulsatility index Z-score pattern as uterine artery resistance index 
Z-score pattern, but contradictory effects were observed.       
The exact regression coefficients for gestational age-independent (intercept) and gestational age-dependent 
differences (interaction tertile and gestational age) are given for all tested bisphenols and phthalate concentrations 
in Supplementary Table SVI. 
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No significant differences were found for both the intercept and slope of tertiles of total bisphenols and phthalic acid 
for both systolic and diastolic blood pressure development during pregnancy.
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A. Systolic blood pressure during pregnancy. Change in systolic blood pressure in mmHg for women in the three 
tertiles of total bisphenols and phthalic acid metabolites based on repeated measurement analysis (systolic blood 
pressure = β0 + β1 * tertile + β2 * gestational age + β3 * gestational age
-2 + β4 * tertile * gestational age). Concentrations 
of both total bisphenols and phthalic acid metabolites were not associated with systolic blood pressure patterns 
during pregnancy. The exact regression coefficients for gestational age-independent (intercept) and gestational age-
dependent differences (interaction tertile and gestational age) are given for all tested bisphenols and phthalate 
concentrations in Supplementary Table SVIII. 
B. Diastolic blood pressure during pregnancy. Change in diastolic blood pressure in mmHg for women in the three 
tertiles of total bisphenols and phthalic acid metabolites based on repeated measurement analysis (diastolic blood 
pressure = β0 + β1 * tertile + β2 * gestational age + β3 * gestational age
0.5 + β4 * tertile * gestational age). Concentrations 
of both total bisphenol and phthalic acid metabolites were not associated with diastolic blood pressure patterns 
during pregnancy. The exact regression coefficients for gestational age-independent (intercept) and gestational age-
dependent differences (interaction tertile and gestational age) are given for all tested bisphenols and phthalate 
concentrations in Supplementary Table SVIII. 
 
Supplementary Figure S4 can be found online 
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Bisphenol and phthalate urine 
concentrations during pregnancy 
and gestational weight gain
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Background: Insufficient or excessive gestational weight gain are associated with increased risks of 
adverse birth and childhood outcomes. Increasing evidence suggests that exposure to bisphenols and 
phthalates may disrupt hormonal pathways and thereby influence gestational weight gain.
Objective: To examine the associations of early and mid-pregnancy bisphenol and phthalate urine 
concentrations with gestational weight gain.
Methods: In a population-based prospective cohort study among 1,213 pregnant women, we measured 
early and mid-pregnancy bisphenol and phthalate urine concentrations. Maternal anthropometrics 
before pregnancy were obtained by questionnaire and repeatedly measured at our research center 
during pregnancy. We used linear and logistic regressions to evaluate the associations of bisphenols and 
phthalates with total and period-specific gestational weight gain. 
Results: Higher maternal total bisphenols and bisphenol S were associated with a lower total gestational 
weight gain at nominal level. Stratification by body mass index group showed that higher total bisphenols 
and bisphenol S were associated with lower total gestational weight gain specifically in normal weight 
women (respectively -509 g [95% CI -819, -198] and -398 g [95% CI -627, -169]). Each log unit increase in 
early pregnancy total bisphenol and bisphenol A urine concentrations were associated with lower mid- 
to late pregnancy gestational weight gain in the whole group (effect estimates -218 g/log unit increase 
[95% CI -334, -102] and -132 g/log unit increase [95% CI -231, -34], respectively). These associations were 
independent of mid-pregnancy compounds. Mid-pregnancy bisphenols and phthalates concentrations 
were not associated with gestational weight gain. 
Discussion: Higher maternal bisphenol urine concentrations in early pregnancy may lead to reduced 
gestational weight in second half of pregnancy. Further research is needed to assess the effects 
of maternal bisphenols and phthalates urine concentrations on placental and fetal growth and 
development. 




Insufficient or excessive gestational weight gain are associated with increased risks of adverse birth and 
childhood outcomes. The US Institute of Medicine and others have established criteria for excessive as 
well as insufficient gestational weight gain, recognizing a substantial literature documenting increases 
in adverse pregnancy, birth and offspring outcomes among women with excessive and insufficient 
gestational weight gain.1-5 
Gestational weight gain is a multifactorial phenotype. Risk factors for excessive gestational weight 
gain include nulliparity, higher total energy intake and smoking during pregnancy.3,6 Studies reporting 
associations of increased maternal progesterone and leptin levels with greater gestational weight 
gain suggest that hormonal responses may be important mechanisms contributing to insufficient or 
excessive gestational weight gain.7,8 A substantial literature has suggested that synthetic chemicals, such 
as bisphenols and phthalates, can disrupt hormones and thereby influence gestational weight gain.9-14 
For example, mono-ethyl phthalate (MEP) has been associated with lower maternal progesterone levels 
in the second trimester of pregnancy.15 Higher maternal progesterone levels have been associated 
with increased gestational weight gain.7 A study in mice reported increased leptin concentrations in 
pregnant mice exposed to bisphenol A (BPA).16 Exposure to bisphenols and phthalates can be modified 
through behavioral modifications as well as regulatory action.17-20 To our knowledge, the associations of 
bisphenol and phthalate concentrations with maternal gestational weight gain have not been studied 
yet. 
We examined among 1,213 women participating in a population-based prospective cohort study the 
associations of early and mid-pregnancy bisphenol and phthalate urine concentrations with total and 
period-specific gestational weight gain and the risks of insufficient or excessive gestational weight gain. 
Methods
Study design and population for analysis
The present study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onwards.21 In total, 8,879 women were enrolled in pregnancy, of which 76% 
before a gestational age of 18 weeks. The study has been approved by the Medical Ethical Committee 
of the Erasmus Medical Center in Rotterdam. Written consent was obtained from all participating 
women.22 Bisphenol and phthalate urine concentrations were measured in a subgroup study among 
1,405 mothers with an available early or mid-pregnancy urine sample and whose children participated 
in postnatal studies. This subgroup included singleton pregnancies only. We excluded women without 
an available urine sample at both time points, without information on gestational weight gain until late 
pregnancy or total gestational weight gain (n=192), which led to 1,213 women included in the analysis. 
For analysis on total gestational weight gain and clinical gestational weight gain categories, we excluded 
women without information on total gestational weight gain (n=397), leading to 823 women included 




Bisphenol and phthalate urine concentrations 
As previously described, bisphenol and phthalate concentrations were measured in a spot urine sample 
obtained from each subject during the early and mid-pregnancy measurement (median gestational age 
13.1 weeks [inter-quartile range (IQR) 12.1-14.5 weeks] and 20.4 weeks [IQR 19.9-20.9], respectively). 
All urine samples were collected between February 2004 and October 2005. Details on collection, 
transportation and analysis methodology are provided elsewhere.23
We grouped urinary biomarkers for exposure to phthalates according to their use in product categories. 
These product categories were first personal care products, and second plasticizers to impart flexibility to 
plastics. Based on these categories, phthalates we grouped in low and high molecular weight phthalates. 
We calculated the weighted molar sums for low molecular weight (LMW) phthalate, high molecular 
weight (HMW) phthalate, di-2-ethylhexylphthalate (DEHP) metabolites, and di-n-octylphthalate 
metabolites. Phthalic acid (PA) was used separately as a proxy of total phthalate exposure. Among HMW 
phthalates, DEHP is of particular interest because of its widespread use in food packaging.24 DNOP is 
also of concern because, although banned from use in the European Union since 2005, its primary 
metabolite, mono(3-carboxypropyl)phthalate (mCPP), is still detectable in biosamples.23,25 Individual 
compounds were included in if they were detected in ≥20% of the samples. Also, bisphenols that were 
detected in ≥50% of the samples were analyzed separately. For bisphenol and phthalate concentrations 
below the level of detection we substituted the level of detection divided by the square root of 2, as 
routinely performed in bisphenols and phthalates.26 Table 1 shows the metabolites that were included 
in all separate groups, their values and detection rates.




Maternal height (cm) and weight (kg) were measured at enrollment without shoes and heavy clothing 
and body mass index (kg/m²) was calculated. Weight was measured repeatedly during subsequent 
visits at the research center (early pregnancy median gestational age 13.1 weeks [IQR 12.1, 14.5], 
mid pregnancy median 20.4 weeks [IQR 19.9, 20.9], and late pregnancy median 30.2 weeks [IQR 29.9, 
30.8]). Information on maternal weight just before pregnancy was obtained by questionnaire. In our 
population for analysis, 68.2% of all women were enrolled before a gestational of 14 weeks. Information 
on total weight during pregnancy was assessed by questionnaire 2 months after delivery (median 
gestational age at delivery 40.3 [IQR 39.3, 41.0]). Total gestational weight gain was calculated as the 
difference between the highest weight before birth and pre-pregnancy weight and was available in a 
subgroup of 823 mothers. For sensitivity analysis, gestational weight gain until the late pregnancy visit 
was calculated as the difference between late pregnancy weight and pre-pregnancy weight and was 
available for 1,209 mothers. Correlation of late pregnancy weight and total weight was 0.96 (P-value 
<0.001). 
According to the IOM guidelines, we classified total gestational weight gain as insufficient, sufficient 
and excessive in relation to maternal pre-pregnancy BMI.27 Weight gain was further analyzed in specific 
periods of pregnancy (weight gain between the measured weight at the early and mid-pregnancy 
visit; weight gain between the measured weight at the mid- and late pregnancy visit; and weight gain 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Covariates were selected based on previous analyses of potential determinants of first trimester 
bisphenol and phthalate concentrations.23 Information on maternal age at enrollment, educational 
level, ethnicity, parity, pre-pregnancy weight, and folic acid supplementation use was obtained from 
the first questionnaire at enrollment. Information on smoking and alcohol consumption was assessed 
by questionnaires in each trimester.28 Maternal daily dietary intake was assessed at enrollment using 
a modified version of the validated semi-quantitative food-frequency questionnaire (FFQ) of Klipstein-
Grobusch et al.29 The FFQ covered the average dietary intake over the previous three months, covering 
the dietary intake in the first trimester of pregnancy.30 We used caloric intake derived from the FFQ as 
a covariate in statistical analyses.
Statistical analysis
Differences in subject characteristics between groups of gestational weight gain were assessed using 
one-way ANOVA tests for continuous variables and chi-square tests for proportions. Non-response 
analysis was performed to assess distributions of maternal characteristics and investigated outcomes. 
For the main analyses, all bisphenol and phthalate urinary metabolite concentrations were log-
transformed to account for right skewness in the distribution. 
We performed multivariable linear and multinomial logistic regressions to evaluate associations of early 
and mid-pregnancy urinary concentrations with total gestational weight gain continuously, gestational 
weight gain per pregnancy period and  clinical categories of gestational weight gain. To investigate total 
gestational weight gain continuously and in clinical categories, early and mid-pregnancy and bisphenol 
and phthalate groupings were used simultaneously to examine the relative influence of early versus 
mid-pregnancy urinary concentrations. When testing associations of gestational weight gain in specific 
pregnancy periods, metabolite concentrations of all earlier time points were added simultaneously 
to the model to adjust for measures at other visits. Therefore, models for early-to-mid-pregnancy 
gestational weight gain included metabolite concentrations in early pregnancy only. Because detection 
rates of bisphenol S (BPS) dropped below 50% in mid-pregnancy, early pregnancy BPS concentrations 
were adjusted for total bisphenol concentrations in mid-pregnancy. 
For all significant models, subanalyses of individual bisphenol compounds or phthalate metabolites 
were performed to determine which metabolites were driving the association. Subanalysis of significant 
models with early and mid-pregnancy concentrations of bisphenols and phthalates used simultaneously 
were performed with the separate compounds of the significant group together with the total group of 
the other pregnancy period, to keep models comparable. As a sensitivity analysis, we used multivariable 
linear regression models to examine the associations between the logs of molar concentrations of the 
metabolite groups with gestational weight gain until late pregnancy. 
In all models, urinary concentrations of each bisphenol or phthalate compound or grouping were 
converted to μg/g or μmol/g creatinine to adjust for dilution.31 All models were adjusted for maternal 
age, educational level, ethnicity, parity, daily dietary caloric intake, folic acid supplement use, smoking, 
alcohol consumption. Higher pre-pregnancy BMI has been associated with a lower gestational weight 
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gain.32 Our previous studies showed that higher pre-pregnancy BMI was associated with higher bisphenol 
and phthalate concentrations in early pregnancy.23  Therefore, models with  gestational weight gain as 
outcome  were additionally adjusted for pre-pregnancy BMI. To investigate potential effect modification 
by pre-pregnancy BMI of the associations of bisphenol and phthalate concentrations with gestational 
weight gain, we have tested interaction terms with categories of pre-pregnancy BMI. Additionally 
stratified analyses have been performed for significant interactions. Non-linear effects of early and mid-
pregnancy metabolite concentrations on total gestational weight gain were assessed using quartiles.
Missing data of the covariates were imputed using multiple imputation. Five imputed data sets were 
created. Effect estimates were pooled to obtain the overall result, taking into account the within and 
between imputation variance according to Rubin’s Rules.33 The percentage of missing values within the 
population for analysis were lower than or equal to 10%, except for maternal folic acid supplementation 
use (17.0%) and daily dietary caloric intake (23.8%). To correct for multiple hypothesis testing, each 
p-value was compared with a threshold defined as 0.05 divided by the effective number of independent 
tests estimated based on the correlation between the exposures (p-value threshold of 0.011).34 All 
analyses were performed using the Statistical Package of Social Sciences version 21.0 for Windows 
(SPSS Inc, Chicago, IL, USA). 
Results
Subject characteristics
Mid-pregnancy urine concentrations of bisphenols and phthalates were generally lower than in early 
pregnancy. Also, detection rates of BPS, bisphenol F (BPF), mono-hexylphthalate (mHxP) and mono-
2-heptylphthalate (mHpP) urine concentrations were considerably lower in mid-pregnancy (Table 1). 
Characteristics of the included mothers are given in Table 2. Of all women, 19.1%, 30.0%, and 50.9% 
had insufficient, sufficient, and excessive gestational weight gain, respectively. Women with excessive 
gestational weight gain had a higher pre-pregnancy BMI and were more often younger, smokers, and 
nulliparous. As shown in Supplementary Table S1, nonresponse analysis showed similar distributions 
of sociodemographic factors and other risk factors for gestational weight gain in the subgroup study 
population as in the entire study cohort. However, the subgroup of mothers with information on total 
gestational weight gain tended to be slightly higher educated and healthier. 
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Bisphenol and phthalate urine concentrations and gestational weight gain
Early and mid-pregnancy phthalates were not associated with total gestational weight gain (Table 3). 
For total bisphenols and BPS, associations with a decreased total gestational weight gain were observed 
at nominal level. 
We observed effect modification by pre-pregnancy BMI of the associations of bisphenol and phthalate 
concentrations with total gestational weight gain (statistical interaction p-value <0.1) for early pregnancy 
total bisphenols, BPA, BPS, PA, LMW phthalate metabolites and DEHP metabolites (data not shown). 
Further stratification yielded significant results for total bisphenols and BPS in the normal weight group 
with a decreased total gestational weight gain (respectively -509 g (95% CI -819, -198) and -398 g (95% 
CI -627, -169), both p-value=0.001). To illustrate, an interquartile range increase in total bisphenols was 
associated with -864 g (95% CI -1391, -336) decrease in total gestational weight gain among normal 
weight women. Because the numbers per stratum were low for underweight and obese women these 
analyses were not presented as main analyses. Assessment of potential non-linear association of 
early and mid-pregnancy bisphenol and phthalate concentrations using quartiles did not reveal any 
indications of non-linearity (data not shown).
Each log unit increase in early pregnancy total bisphenol urine concentrations was associated with 
-218 g (95% CI -334, -102) gestational weight gain in mid- to late pregnancy. Analysis of individual 
bisphenol compounds in early pregnancy showed that maternal BPA concentrations were driving this 
association with a  -132 g (95% CI -231, -34) lower mid- to late pregnancy weight gain/log unit increase. 
The associations of early pregnancy BPS and BPF urine concentrations with gestational weight gain in 
mid-to-late pregnancy tended toward nominal significance (Table 3 and Supplementary Table S2). Early 
pregnancy DNOP metabolite concentrations were associated with mid- to late pregnancy weight gain at 
nominal level. Bisphenol and phthalate concentrations in early and mid-pregnancy were not associated 
with early-to-mid-pregnancy weight gain or late pregnancy-to-total gestational weight gain. We did not 
observe effect modification by pre-pregnancy BMI for the analyses on gestational weight gain during 
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Bisphenol and phthalate levels and clinical categories of gestational weight gain
Table 4 shows that bisphenol and phthalate urine concentrations in early and mid-pregnancy were 
not associated with insufficient or excessive gestational weight gain. Early pregnancy LMW phthalate 
metabolites were associated with higher odds of insufficient gestational weight gain, However, this 
associations attenuated into non-significance correction for multiple testing. 
Table 4. Associations of early and mid-pregnancy bisphenol and phthalate urine concentrations with clinical 
categories of gestational weight gain (n = 823)




Excessive weight gain,  





Total bisphenols 0.96 (0.82, 1.13) 0.91 (0.80, 1.03)
Bisphenol A 0.97 (0.84, 1.11) 0.96 (0.86, 1.07)
Bisphenol S1 1.03 (0.92, 1.15) 0.96 (0.88, 1.06)
Phthalic acid 1.18 (0.98, 1.41) 1.11 (0.96, 1.28)
LMW phthalate metabolites 1.18 (1.01, 1.39)* 1.03 (0.91, 1.17)
HMW phthalate metabolites 1.16 (0.94, 1.43) 1.00 (0.84, 1.18)
DEHP metabolites 1.16 (0.94, 1.42) 1.00 (0.85, 1.18)
DNOP metabolites 1.15 (0.95, 1.40) 0.97 (0.83, 1.13)
Mid pregnancy
(18-25 weeks)
Total bisphenols 0.94 (0.79, 1.12) 1.02 (0.89, 1.17)
Bisphenol A 0.94 (0.79, 1.11) 1.03 (0.90, 1.17)
Bisphenol S - -
Phthalic acid 0.97 (0.80, 1.19) 1.00 (0.86, 1.17)
LMW phthalate metabolites 0.97 (0.81, 1.16) 0.97 (0.84, 1.12)
HMW phthalate metabolites 0.92 (0.75, 1.14) 0.97 (0.82, 1.14)
DEHP metabolites 0.91 (0.74, 1.12) 0.98 (0.83, 1.15)
DNOP metabolites 0.96 (0.78, 1.19) 0.88 (0.74, 1.04)
Estimates are based on multivariate regression analyses. Reference category is sufficient weight gain. Only women 
with available information on total gestational weight gain were classified in a total gestational weight gain category. 
Increases are per log unit increase in early and mid-pregnancy urinary total bisphenols/BPA/BPS/Phthalic acid/
LMW/HMW/DEHP/DNOP metabolite concentrations per gram creatinine. Models are adjusted for maternal 
age, daily dietary caloric intake, parity, ethnicity, education, maternal smoking, maternal alcohol, and folic acid 
supplementation. Early and mid-pregnancy compounds have been used in the model simultaneously, yielding 
estimates adjusted for compounds at the other time point. 1For models of early pregnancy BPS, the total 
group of mid-pregnancy bisphenols has been used in the model simultaneously, if applicable. Estimates for 





Sensitivity analysis shows that the associations of early pregnancy bisphenols with gestational weight 
gain until late pregnancy somewhat attenuated but had the same directionality (Supplementary 
Table S3). Early pregnancy BPS concentrations were associated with gestational weight gain until late 
pregnancy at nominal level, adjusted for total bisphenol concentrations in mid-pregnancy. However, 
this associations attenuated into non-significance after correction for multiple testing.
Discussion
Results from this prospective population-based cohort study showed that among normal weight women 
total gestational weight gain was lower for women with higher total bisphenols or BPS concentrations 
in early pregnancy, independent of bisphenol concentrations in mid-pregnancy. Early pregnancy total 
bisphenols and BPA were associated with a lower gestational weight gain in mid- to late pregnancy in 
the whole group.  
Interpretation of main findings
To the best of our knowledge, this is the first prospective study that examined the associations of 
maternal bisphenols and phthalates concentrations with gestational weight gain. Our findings suggest 
that maternal bisphenol concentrations in early pregnancy are associated with a lower gestational 
weight gain, mainly in second half of pregnancy. Additionally, the findings suggest that women with a 
normal weight are most vulnerable for effects of early pregnancy bisphenols on gestational weight gain. 
We did not observe associations of bisphenol and phthalate concentrations with clinical categories of 
gestational weight gain. An additional analysis suggests that among women with insufficient weight 
gain each log unit increase in total bisphenols was associated with a stronger reduction in weight gain 
than in women with sufficient and excessive weight gain (data not shown). Since we have only used 
early and mid-pregnancy bisphenol and phthalate urine concentrations, we cannot rule out that also 
late pregnancy bisphenol and phthalate concentrations have a certain effect on gestational weight gain. 
However, this seems unlikely, since the associations of early pregnancy exposures were independent of 
mid pregnancy exposure concentrations. 
Previous cross-sectional studies investigating determinants of bisphenols and phthalates reported 
associations of higher concentrations of BPA and phthalates in pregnant women with a higher 
BMI.11,12,35-37 A recent prospective study of pregnant women reported a negative association 
between DEHP metabolites in early pregnancy and early gestational weight gain.38 Persistent organic 
pollutants (POPs) have also been examined for associations with gestational weight gain. Similar to 
bisphenols and phthalates, the majority of POPs are lipophilic chemicals, except for perfluoroalkyl 
substances (PFASs).39,40 The results from studies investigating effects of POPs on gestational weight 
gain show different associations with gestational weight gain for the PFASs and other POPs. Higher 
perfluorooctanesulfonate (PFOS) levels – a perfluoroalkyl substance - before and in early pregnancy 
have been associated with a higher gestational weight gain in normal and underweight women, 
while in overweight women this effect was not observed.41,42 Other POPs, including dichlorodiphenyl 
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dichloroethene (DDE), polychlorinated bisphenyls (PCBs) in early pregnancy and neonatal DDE, 
hexachlorocyclohexanes (HCHs), PCBs and polybrominated diphenyl ethers (PBDEs), have been 
associated with lower or even insufficient gestational weight gain.43-45 Thus our study results add to 
previous studies suggesting that various environmental exposures in specifically early pregnancy may 
influence gestational weight gain. 
Gestational weight gain is a complex phenotype.3,6 Besides increased maternal fat storage, several 
compartments could be responsible for the observed change in gestational weight gain. Information 
about maternal fat storage, measurements of body composition during pregnancy would be 
informative. However, measurements of body composition during pregnancy were not available in the 
current study. In our previous study, we did not observe associations of early pregnancy bisphenol and 
phthalate concentrations with placental weight at birth.46 A previous study within the same cohort 
suggested lower fetal growth in association with maternal BPA concentrations.47 Gestational weight 
gain, in particular in mid- and late pregnancy, is associated with birth weight.3,48 In a recent rodent study, 
early pregnancy BPA exposure was associated with impaired remodeling of the uterine spiral arteries 
and intrauterine growth restriction.49 Altogether, previous studies and our results suggest that higher 
maternal bisphenol urine concentrations in early pregnancy may lead to reduced gestational weight in 
second half of pregnancy. Further research is needed to assess the effects of maternal bisphenol and 
phthalate urine concentrations on different aspects of gestational weight gain, such as placental and 
fetal growth and development.
Strengths and limitations
Strengths of this study were the prospective data collection from early pregnancy onwards, large 
sample size of 1,213 participants with a urine sample in early and mid-pregnancy, and information 
on gestational weight gain. The subgroup of women with information on total gestational weight gain 
tended to a slightly higher educated, healthier population, which might have influenced results. However, 
sensitivity analysis of gestational weight gain until late pregnancy and period-specific gestational weight 
gain argue against biased estimates. The response rate at baseline was 61%.21 Although we cannot rule 
out selection towards a relatively healthy population, selection bias in cohort studies is more likely to 
arise from loss to follow up rather than from non-response at baseline.50 Additionally, models have 
been adjusted for several potential proxies for health, reducing the odds of biased estimates due to 
selection bias. Less variation in our study population than in the general population may have led to 
underestimation of effect estimates. Repeated exposures were analyzed using multiple regression 
analysis, enabling investigation of potential windows of vulnerability.51 In our analysis, collinearity was 
not an issue (Supplementary Table S4). Bisphenol and phthalate metabolites were measured in spot 
urine samples in early and mid-pregnancy and typically have half-lives of less than 24 hours.52,53 A 
single spot urine sample for phthalates could reasonably reflect exposure for up to three months,54 but 
bisphenols have a high temporal variability, even over the day.55 This non-differential misclassification is 
expected to lead to attenuation bias in dose-response relationships. 
A common method to account for dilution of urinary chemical concentrations is via creatinine 
adjustment.56 Endogenous creatinine clearance, measured by 24-hr urine collection, remains the most 
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precise estimation of the glomerular filtration rate in pregnant women.57 A recent study suggested that 
specific gravity adjustment is a better correction method in pregnant women.58 Unfortunately, specific 
gravity measurements were not available. Additional analysis of models without creatinine adjustment 
yielded similar results (data not shown). 
Maternal weight was measured during the visits at our research center. Information on maternal pre-
pregnancy weight and total weight during pregnancy was self-reported. Self-reported weight tends to be 
underestimated, leading to misclassification. Consequently, this might have led to biased estimates. In 
the period-specific analysis, early-to-mid and mid-to-late pregnancy analyses were based on measured 
weights only and provide therefore the most reliable estimates. Detailed information on a large 
number of potential confounding factors was available. Nonetheless, due to the observational design 
of the study, residual confounding due to unmeasured environmental exposures, socio-demographic or 
lifestyle factors still might still be an issue. 
Conclusion
Higher maternal bisphenol urine concentrations in early pregnancy may lead to reduced gestational 
weight in second half of pregnancy. Further research is needed to assess the effects of maternal 
bisphenols urine concentrations on placental and fetal growth and development.
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Sample n = 1,213 
Information on 
maximum gestati-
onal weight gain or 
gestational weight 
gain until late preg-
nancy
Sample n = 3,927 
Sample from 
original cohort 
not included in 
subgroup study on 
maternal bisphenol 
and phthalate urine 
concentrations
Maternal pre-pregnancy BMI (kg/
m2) 2
22.4 (20.7, 24.8) 22.7 (20.8, 25.3) 22.6 (20.8, 25.3)
Maximum GWG (kg) 15.0 (5.6) 15.0 (5.6) 15.0 (5.8)
GWG until late pregnancy (kg) 10.5 (4.3) 10.4 (4.7) 10.5 (4.8)
IOM classification
  Insufficient weight gain 19.1 19.1 18.4
  Sufficient weight gain 30.0 30.0 30.4
  Excessive weight gain 50.9 50.9 51.3
Maternal age (y) 31.0 (4.5) 30.6 (4.8) 30.4 (4.9)
Daily dietary caloric intake 2109 (499) 2080 (508) 2054 (544)
Parity (% nulliparous) 64.4 61.2 59.9
Ethnicity (% Dutch/European) 71.3 62.6 64.7
Education (% high) 58.0 50.6 48.8
Maternal smoking (% nonsmoking) 79.2 76.4 73.8
Maternal alcohol use (% no alcohol) 39.4 43.3 42.4
Maternal folic acid supplement use 
(% periconceptional)
54.0 48.2 45.6
1Values represent means (standard deviation) or valid percentages 
2Median (IQR)
Supplementary Table S2. Subanalysis of associations of early pregnancy bisphenol F with mid- to late gestational 
weight gain 
Gestational weight gain 
mid- to late pregnancy (grams) 
(95% Confidence Interval)
(n=1,207)
Bisphenol F -116 (-234, 1)
Estimates are based on multivariate regression analyses. Increases are per log unit increase in early pregnancy urinary BPF 
concentrations per gram creatinine, adjusted for mid-pregnancy total bisphenols concentration. Models are adjusted for 
maternal age, maternal pre-pregnancy BMI, daily dietary caloric intake, parity, ethnicity, education, maternal smoking, 




Supplementary Table S3. Associations of early and mid-pregnancy bisphenol and phthalate urine concentrations 
with gestational weight gain until late pregnancy (n=1,209)
Gestational weight gain until late pregnancy 
(grams) 
(95% Confidence Interval)
Early pregnancy (<18 weeks)
Total bisphenols -159 (-354, 36)
Bisphenol A -47 (-212, 119)
Bisphenol S1 -142 (-282, -2)*
Phthalic acid 32 (-200, 265)
LMW phthalate metabolites 26 (-174, 226)
HMW phthalate metabolites -52 (-306, 203)
DEHP metabolites -13 (-261, 235)
DNOP metabolites -101 (-348, 147)
Mid-pregnancy (18-25 weeks)
Total bisphenols -79 (-302, 144)
Bisphenol A -58 (-270, 155)
Bisphenol S -
Phthalic acid -217 (-462, 28)
LMW phthalate metabolites -59 (-286, 168)
HMW phthalate metabolites -127 (-386, 131)
DEHP metabolites -52 (-306, 202)
DNOP metabolites -261 (-541, 19)
Estimates are based on multivariate regression analyses. Increases are per log unit increase in early and mid-pregnancy 
urinary total bisphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations per gram 
creatinine. Models are adjusted for maternal age, maternal pre-pregnancy BMI, daily dietary caloric intake, parity, 
ethnicity, education, maternal smoking, maternal alcohol, and folic acid supplementation. Early and mid-pregnancy 
compounds have been used in the model simultaneously, yielding estimates adjusted for compounds at the other time 
point. 1For models of early pregnancy BPS, the total group of mid-pregnancy bisphenols has been used in the model 
simultaneously, if applicable. Estimates for second trimester total bisphenols in these models are not presented. 
*p-value<0.05 





































































































































































































































































































































































































































































































































































































































































































































Exposures to phthalates and 
bisphenols in pregnancy and 
postpartum weight gain
2.5




Background: Experimental evidence suggests that exposures to phthalates and bisphenols may interfere 
with processes related to glucose and lipid metabolism, insulin sensitivity, and  body weight. Few studies 
have considered the possible influence of chemical exposures during pregnancy on maternal weight 
gain or metabolic health outcomes postpartum.
Objective: To examine the associations of early and mid-pregnancy bisphenol and phthalate urine 
concentrations with maternal weight gain 6 years postpartum.
Methods: We analyzed urine samples for bisphenol, phthalate and creatinine concentrations from 
early and mid-pregnancy in 1,192 women in a large, population-based birth cohort in Rotterdam, the 
Netherlands, and examined postpartum weight gain using maternal anthropometrics before pregnancy 
and 6 years postpartum. We have used covariate-adjusted linear regressions to evaluate associations 
of early and mid-pregnancy bisphenols and phthalate metabolites with weight change. Mediator and 
interaction models have been used to assess the role of gestational weight gain and breastfeeding, 
respectively. Sensitivity analysis is performed among women without subsequent pregnancies.
Results: Among all 1,192 mothers included in the analysis, each log unit increase in the average 
bisphenol A and all assessed phthalate groupings were associated with increased maternal weight gain. 
As a proxy for phthalate exposure, each log unit increase in averaged phthalic acid was associated with 
734 g weight gain (95% CI 273-1196 g) between pre-pregnancy and 6 years postpartum. Mediation 
by gestational weight gain was not present. Breastfeeding and ethnicity did not modify the effects. 
Stratification revealed these associations to be strongest among overweight and obese women. 
Among women without subsequent pregnancies (n=373) associations of bisphenols, HMW phthalate 
metabolites and di-2-ethylhexylphthalate metabolites attenuated. For phthalic acid, LMW phthalate 
metabolites and di-n-octylphthalate metabolites associations increased. Similarly to the whole group, 
stratification yielded significant results among overweight and obese women. 
Discussion: In a large population-based birth cohort, early and mid-pregnancy phthalate exposures are 
associated with weight gain 6 years postpartum, particularly among overweight and obese women. 
These data support ongoing action to replace phthalates with safer alternatives.




Prevalence rates of overweight and obesity among women are staggering, reaching upwards of 40% 
worldwide, and current trends suggest that these rates are increasing.1 Pregnancy represents a critical 
life course event for women that is associated with physiologic and metabolic changes and substantial 
weight gain, all of which may contribute to the development of overweight and obesity among women.2 
Although lifestyle and behavioral factors, notably diet and physical activity, are strong predictors of 
retention of pregnancy-related weight gain,3 exposures to other environmental factors, such as 
endocrine disrupting chemicals, may have a causal role.4 A growing body of evidence indicates that 
pregnancy is a period of increased susceptibility to potentially long-term physiological changes due to 
exposure to endocrine disrupting chemicals, with persistent effects.5 Among the many changes that 
occur during pregnancy, sex steroids generally increase throughout pregnancy. Sex steroids are involved 
in the complex regulation of appetite, eating and energy metabolism. During pregnancy, remarkable 
physiological adaptations of appetite and body composition occur.6 Dysregulation of sex steroids during 
pregnancy due to exposure to environmental chemicals might lead to maternal weight gain, which 
could persist into postpartum. Maternal fat accumulation takes place mainly in the first two trimesters 
of pregnancy, which is mainly the result of enhanced insulin sensitivity.7 Peroxisome proliferator-
activated receptor γ (PPARγ), which is highly expressed  in adipose tissue, has a key role in adipogenesis, 
lipid metabolism and insulin sensitivity.8 Enhanced activation of PPARγ by environmental chemicals 
might lead to changes in adipose tissue function which might track into postpartum. Pregnancy-related 
metabolic changes might affect the metabolism of these chemicals, leading to increased biological 
availability or prolongation of exposure and effects.9 
Phthalates and bisphenols, such as bisphenol A (BPA) and its replacements (e.g. bisphenol S (BPS)), 
are ubiquitous endocrine disrupting chemicals that are used in various consumer, personal care, and 
industrial products and are detectable in most humans.10,11  Experimental evidence demonstrated 
that these chemicals may interfere with processes related to glucose and lipid metabolism, energy 
balance, and insulin sensitivity, subsequently influencing body weight and metabolic health through 
binding steroid receptors and PPARs.11-15 Among pregnant and non-pregnant women, cross-sectional 
studies report positive associations of urinary concentrations of phthalates and BPA with Body Mass 
Index (BMI) and waist circumference.16-20 Additionally, a longitudinal analysis of the Nurses’ Health 
Study found that higher baseline concentrations of BPA and specific phthalate metabolites (phthalic 
acid, monobenzylphthalate (mBzP), and butyl phthalates) were associated with modestly faster rates 
of weight gain during a 10-year follow up.21 In the Women’s Health Initiative, researchers observed 
associations of several phthalates with short term weight gain in postmenopausal women.22 Obesogenic 
effects of bisphenols other than BPA in women, specifically, have not been investigated, though it is 
thought they have similar endocrine disrupting capabilities.23,24
Few studies have considered the possible influence of prenatal chemical exposures on weight gain 
or metabolic health outcomes in women, either during pregnancy or the postpartum. A recent study 
investigating associations of prenatal phthalate exposure with maternal weight gain up to 10 years 
postpartum observed that mono-3-carboxypropylphthalates (mCPP) was associated with an higher 
weight gain per year, while mono-benzylphthalate (mBzP) was associated with a lower weight gain 
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per year.25 In rodents, low dose administration of BPA during pregnancy disrupted normal pregnancy-
induced insulin resistance, leading to higher body weight, plasma insulin, leptin, and triglyceride levels 
and greater insulin resistance during the postpartum period, as compared to controls.26 Similarly, female 
mice exposed to environmentally relevant levels of dietary di-2-ethylhexyl phthalate (DEHP) prior to 
pregnancy resulted in increased weekly food intake, body weight, and visceral adipose tissue, as well 
as altered mRNA and plasma levels of hormones related to fat metabolism (e.g. leptin and adiponectin) 
compared to unexposed mice.27 In women, monoethylphthalate (mEP) was associated with impaired 
glucose tolerance and excessive gestational weight gain,28 which is considered the strongest risk factor 
of postpartum weight retention.29 Conversely, we previously reported that higher maternal bisphenol 
urine concentrations in early pregnancy were associated with reduced gestational weight gain in the 
second half of pregnancy.30 These findings suggest that prenatal chemical exposures may have a lasting 
influence on women’s weight and metabolic health. The pregnancy period is an important period with 
great opportunities for prevention. 
In the current analysis, we utilize longitudinal data from women participating in a large, population-
based prospective birth cohort to determine whether urinary concentrations of bisphenols and 
phthalate metabolites measured during early and mid-pregnancy are associated with weight gain 
between pre-pregnancy and 6 years postpartum. 
Methods
Study design and population for analysis
The present study was embedded in the Generation R Study, a population-based prospective cohort 
study from early pregnancy onward.31 In total, 8,879 women were enrolled between 2002-6, 76% 
before gestational age of 18 weeks. The study has been approved by the Medical Ethical Committee of 
the Erasmus Medical Centre in Rotterdam and New York University School of Medicine. Written consent 
was obtained from all participating women.32
Urine samples were collected at three time points in pregnancy (<18 weeks, 18-25 and >25 weeks) from 
2004 onward (n=2,038).  Bisphenol and phthalate concentrations were measured among a subgroup of 
1,405 women who delivered singletons in whom early and mid-pregnancy urine samples were available 
and whose children also participated in postnatal studies at 6 years of age. Of these, 1,381 women 
had both urine samples available for analysis. Another 189 women were excluded due to missing 
information to estimate maternal weight change. A total of 1,192 participants were included in the 
final analytic sample. Of these, only 373 women did not have another pregnancy during the follow-up 
period. 
Urinary bisphenol and phthalate measurements 
Bisphenol, phthalate and creatinine concentrations were measured in spot urine sample obtained from 
each subject at the early and mid-pregnancy visit (median gestational age 12.9 weeks [inter-quartile 
range 12.1-14.5 weeks] and 20.4 weeks [inter-quartile range 19.9-20.9 weeks], respectively). All urine 
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samples were collected between February 2004 and October 2005. Urine samples were collected 
between 8 am and 8 pm in 100-mL polypropylene urine collection containers, stored at 4 °C and 
transported within 24 h of receipt to the STAR-MDC laboratory before being distributed manually in 
25 mL polypropylene vials to be frozen at -20 °C. The urine specimens were shipped on dry ice in 4 mL 
polypropylene vials to the Wadsworth Center, New York State Department of Health, Albany, New York 
for analysis of bisphenol and phthalate concentrations. Quantitative detection of phthalate metabolites 
was achieved utilizing a solid-phase extraction (SPE) method followed by enzymatic deconjugation 
of the glucuronidated phthalate monoesters coupled with high performance liquid chromatography 
electrospray ionization-tandem mass spectrometry (HPLC-ESI-MS/MS), as previously used.33 
Quantitative detection of bisphenols was achieved utilizing a liquid-liquid extraction (LLE) method 
followed by enzymatic deconjugation of the glucuronidated bisphenols coupled with HPLC-ESI-MS/MS. 
Assay precision is improved by incorporating isotopically-labeled internal standards to allow for rapid 
detection. The majority of limits of detection (LOD) for phthalates were in the range of 0.008-0.3 ng/ml. 
The majority of LODs for bisphenols were in the range of 0.03 and 0.18 ng/ml. Samples were analyzed 
for creatinine using HPLC-ESI-MS/MS, improved by incorporating 2D3-creatinine. Quantification of 
calibration check standards resulted in an LOD of 0.30 ng/ml. Further details on analysis methodology 
are provided elsewhere.34 
Urinary bisphenols and phthalate metabolites were analyzed both individually and in groups for data 
analysis. We grouped phthalate metabolites according to their molecular weight categories. Phthalate 
metabolites were only included in the phthalate groupings if detected in >20% of the sample. The same 
applied for bisphenols. For individual compound analysis, compounds were only included if detected in 
>50% of the sample in both pregnancy periods. Concentrations of individual phthalate metabolites and 
groups represented by only one metabolite, as well as individual bisphenols, were reported in ng/ml. 
We calculated the weighted molar sums for groups representing total bisphenols, low molecular weight 
(LMW) phthalates, high molecular weight (HMW) phthalates, the intermediate molecular weight di-2-
ethylhexyl phthalate (DEHP), and di-n-octylphthalate (DNOP) using the formula: ((concentration in ng/
ml compound 1) * (1 / molecular weight compound 1) * (1 / 10^-3)) + ((concentration in ng/ml compound 
2) * (1 / molecular weight compound 2) * (1 / 10^-3)) + etc., resulting in concentrations expressed 
in nmol/L. Phthalic acid (PA) was analyzed separately as a proxy for total phthalate exposure.35 For 
bisphenol and phthalate concentrations below the LOD we substituted values with a LOD value divided 
by the square root of 2 (LOD/√2), as performed earlier 36. Bisphenol and phthalate compounds included 
in the weighted molar sums for early and mid-pregnancy groupings are shown in Supplementary Table 
S1.
Maternal anthropometrics
Maternal height (cm) was measured at enrollment without shoes. Information on maternal weight 
just before pregnancy was obtained by questionnaire in early pregnancy. Self-reported maternal pre-
pregnancy weight was highly correlated with measured early pregnancy weight (median  gestational 
age 12.9 weeks [inter-quartile range 12.1-14.5 weeks]) (Spearman’s correlation coefficient 0.951). 
Weight at 6 years postpartum (median child age 5.87 years [inter-quartile range 5.79-5.97 years]) was 
measured without shoes and heavy clothing during a visit at the research center. Maternal postpartum 
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weight gain was based on pre-pregnancy weight and calculated as: maternal weight 6 years postpartum 
– maternal pre-pregnancy weight. Body mass index (BMI) (kg/m²) before pregnancy was calculated. 
Covariates
Potential covariates, effect modifiers, and variables for sensitivity analyses were selected based on 
previous research, literature review and causal diagram (Supplementary Figure S1).34 All potential 
covariates were checked for collinearity by using correlations and collinearity diagnostics. Information 
on parity (primiparity/multiparity), educational level (low/high) and maternal ethnicity (Dutch or 
European/Non-European) was obtained from the first questionnaire at enrollment (median gestational 
age 12.9 weeks [inter-quartile range 12.1-14.5 weeks]). Low educational level was defined as no 
education, or finished primary or secondary education. High educational level was defined as finished 
higher professional education or university. We considered maternal age at the 6 year postpartum visit 
as a covariate. Information on pre-pregnancy weight (kg) was obtained from the first questionnaire 
at enrollment. Information on postpartum smoking (current/previously smoked/never) and maternal 
alcohol use during pregnancy (yes/no) was assessed by questionnaire.  
Maternal daily dietary intake was assessed at enrollment using a modified version of the validated semi-
quantitative food-frequency questionnaire (FFQ) of Klipstein-Grobusch et al.37 The FFQ covered the 
average dietary intake over the previous three months, covering the dietary intake in the first trimester 
of pregnancy.38  We used caloric intake derived from the FFQ as a covariate in statistical analyses. 
Gestational weight gain was calculated by subtracting pre-pregnancy weight from the last measured 
weight in pregnancy (median 30.2 weeks gestation, inter-quartile range 29.9-30.8 weeks). Breastfeeding 
was used continuously, did not have to be exclusive and did only relate to the index pregnancy. 
Information on subsequent pregnancies was determined from postnatal follow-up questionnaires.
Statistical Analysis
After description of the final analytic sample, qualitative comparison was also made for sociodemographic 
and other relevant risk factors between the final analytic sample and the population of women who 
delivered live born singletons and had available weight data until 6 years postpartum. Description of 
the urinary concentrations of phthalates and bisphenols revealed substantial right skew, requiring 
log-transformation prior to inclusion in multivariable models. Urinary concentrations of bisphenols 
and phthalates were converted to μg/g (for individual compounds) or µmol/g (for compound groups) 
creatinine. Additionally, all models have been adjusted for creatinine concentration by adding creatinine 
concentrations as covariates (Method 6, i.e. regression models with biomarker measures standardized 
for creatinine that also include creatinine as a covariate 39). 
To evaluate the degree of potential confounding, we performed univariate regressions of postpartum 
weight gain against potential sociodemographic, lifestyle and dietary confounders. Separate regressions 
were performed to evaluate changes in maternal weight in the period from before pregnancy until 
6 years postpartum in relationship to early and mid-pregnancy urinary concentrations of phthalates, 
their metabolites and bisphenols separately. Multivariable regressions controlled for maternal age, 
Bisphenols, phthalates and postpartum weight gain
211 
2.5
parity, ethnicity, education, dietary caloric intake during early pregnancy, pre-pregnancy BMI maternal 
smoking and alcohol during pregnancy. For analyses, bisphenol and phthalate urinary concentrations 
(standardized for creatinine) in early and mid-pregnancy were averaged. Non-linear effects of averaged 
bisphenol and phthalate urinary concentrations on postpartum weight gain were assessed using 
quartiles. To investigate mediation by gestational weight gain, we used the bootstrap method according 
to Hayes using model 4 (i.e. for mediation analysis) obtaining 5000 bootstrap samples.40,41 To assess 
effect modification by breastfeeding, pre-pregnancy BMI and ethnicity we tested interaction terms 
and performed stratified analyses if the interaction p-value <0.1. We performed additional analyses to 
assess associations of individual compounds with weight gain. These analyses include the confounder, 
mediator and interaction models, for averaged individual phthalate compounds. To examine potential 
confounding of the associations among women who had subsequent pregnancies, we performed 
sensitivity analyses among women who did not have any subsequent pregnancies.
Missing data of the covariates were imputed using multiple imputation by fully conditional specification 
(FCS), assuming missingness at random (MAR). The percentage of missing values within the population 
for analysis were lower than or equal to 15% except for daily dietary caloric intake (23.7%) and 
breastfeeding (19.5%). Qualitative comparison of patterns of missing values showed that missingness 
was predominantly accounted for by other measured variables, assuming MAR. To increase imputation 
precision, we have used all 1,405 participants and both covariates and outcomes as predictors.42 Five 
imputed datasets were created and pooled for analyses, taking into account the within and between 
imputation variance according to Rubin’s Rules.43 Imputation diagnostics were checked for potential 
changes in distributions of imputed variables. We did not observe any changes in distributions. All 
analyses were performed using the Statistical Package of Social Sciences version 21.0 for Windows 
(SPSS Inc, Chicago, IL, USA). Bootstrapping was performed using PROCESS v3.3 for SPSS. 
Results
Subject characteristics
Compared to the entire Generation R sample, the study population generally was of a similar 
sociodemographic profile and prevalence of other relevant risk factors for weight gain (Table 1 and 
Supplementary Table S2). Urinary concentrations of bisphenols and phthalates were similar in early and 
mid-pregnancy, with the exception of a qualitatively higher detection rate for bisphenols S and F, and 
for  mono-hexylphthalate (mHxP) and mono-2-heptylphthalate (mHpP) in early pregnancy compared to 
mid-pregnancy (Table 2).  Univariate regressions (Supplementary Table S3) of postpartum weight gain 
against the sociodemographic, lifestyle and dietary covariates revealed significant associations with 
maternal age (inverse), pre-pregnancy BMI (inverse), gestational weight gain (positive), parity (lower 
among multiparous mothers), ethnicity (higher among non-Dutch/non-European women), education 
(higher in lower education group), alcohol use (higher among those reporting no consumption in 
pregnancy) and smoking (higher among mothers who smoked during pregnancy). Also mid-pregnancy 
creatinine urinary concentrations were associated with a higher weight gain. 
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Table 1. Subject characteristicsa
 Total
 n = 1,192
Maternal age at follow-up(years) 36.8 (4.7)
Missing NA












Dietary caloric intake during pregnancy 2077 (508)
Missing 282 (23.7)
Gestational weight gain (until late pregnancy) 10.3 (4.7)
Missing 5 (0.4)
Pre-pregnancy BMI (kg/m2) b 22.7 (20.8, 25.3)
Missing NA
Creatinine early pregnancy (μg/mL) b 1019 (486, 1656)
Missing NA






Alcohol consumption during pregnancy
No alcohol use 480 (40.3)
Alcohol use 635 (53.3)
Missing 77 (6.5)
Breastfeeding (months) b 3.5 (1.5, 6.5)
Missing 233 (19.5)
Maternal weight change (kg) 4.7 (7.2)
Missing NA
a Values are means (standard deviation) or numbers of subjects (percentage). 
b Median (IQR range)           
NA: not applicable




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Unadjusted for potential covariates, all averaged bisphenol and phthalate groupings were associated 
with an increased maternal weight gain (Supplementary Table S4). Among all 1,192 mothers included 
in the analysis, each log unit increase in the average bisphenol A was associated with 364 g weight 
gain (95% Confidence Interval (CI) 10-718 g) between pre-pregnancy and 6 years postpartum (Table 
3). PA and all assessed phthalate groupings were associated with maternal weight gain. As a proxy 
for total phthalate exposure, each log unit increase in averaged PA was associated with 734 g weight 
gain (95% CI 273-1196 g). DNOP metabolites were strongest associated with weight gain (each log 
unit increase in averaged DNOP metabolites was associated with 840 g weight gain (95% CI 347-1332 
g). Assessment of potential non-linear association averaged bisphenol and phthalate concentrations 
using quartiles did not reveal any indications of non-linearity (data not shown). Mediation analysis using 
bootstrapping did not obtain a significant indirect effect (i.e. no mediation) via gestational weight gain. 
No effect modification by breastfeeding or ethnicity was observed, therefore, stratified models have 
not been performed (data not shown). Interaction terms for pre-pregnancy BMI were p-value <0.1 for 
total bisphenols and DNOP metabolites. Stratified analysis showed no significant associations for total 
bisphenols, but each log unit increase in averaged DNOP metabolites was associated with 671 g weight 
gain  (95% CI 226-1116 g) among normal weigh women and 3893 g weight gain (95% CI 2-7784 g) 
among obese women (Supplementary Table S5).
Table 3. Multivariable associations of averaged early and mid-pregnancy bisphenol and phthalate urine concentrations 
with maternal weight change from pre-pregnancy up to until 6 years postpartum (n=1,192)
Maternal weight change, g (95% CI)
Total bisphenols 379 (-14, 772)
Bisphenol A 364 (10, 718)
Phthalic acid 734 (273, 1196)
LMW phthalate metabolites 678 (328, 1029)
HMW phthalate metabolites 724 (233, 1215)
DEHP metabolites 588 (115, 1061)
DNOP metabolites 840 (347, 1332)
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary total bisphenols/BPA/
Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations per gram creatinine. All models were additionally 
adjusted for early and mid-pregnancy creatinine concentrations (ng/mL). Models have been adjusted for maternal 
age, parity, ethnicity, education, dietary caloric intake during early pregnancy, pre-pregnancy BMI, maternal smoking 
during pregnancy and maternal alcohol use during pregnancy.  
Further examination of individual phthalate urinary metabolites showedassociations for all examined 
individual phthalate compounds except for 2 DEHP metabolites, mono-(2-ethyl-5-hydroxyhexyl)
phthalate (mEHHP) and mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP) (Supplementary Table 
S6). Monomethylphthalate (mMP) was strongest associated with weight gain (per log unit averaged 
increase 856 g weight gain [95% CI 433-1279 g]). Similarly to the groupings, gestational weight gain was 
not a mediator and no effect modification by breastfeeding or ethnicity was found (data not shown). 
Significant interaction was observed for pre-pregnancy BMI with mMP and mCPP. Further stratification 
yielded significant results for mMP and mCPP among obese women with an increased weight gain (for 
each log unit increase of averaged compounds 3461 g  [95% CI 232-6689 g] for mMP and 3893 g weight 




Among women without subsequent pregnancies (n=373) associations of bisphenols, HMW phthalate 
metabolites and DEHP metabolites attenuated (Table 4). For PA, LMW phthalate metabolites and 
DNOP metabolites associations increased (per log unit increase of averaged compounds 1193 g [95% 
CI 293-2092 g], 797 g [95% 186-1407 g] and 1007 g weight gain [95% CI 211-1803 g], respectively). A 
consistent pattern was observed for individual phthalate compounds, with similar to the whole group 
the strongest association with weight gain for mMP (per log unit averaged increase 1378 g weight 
gain [95% CI 608-2147 g]) (Supplementary Table S7). Gestational weight gain did not mediate the 
effects and no effect modification by breastfeeding or ethnicity was observed (data not shown). We 
observed effect modification by pre-pregnancy BMI of the associations of total bisphenols, PA, LMW 
phthalate metabolites and DNOP metabolites with weight gain (statistical interaction p-value<0.1) (data 
not shown). Stratified analysis could not be performed for underweight women due to an insufficient 
number of samples (n=8). Stratification yielded significant results for PA in the overweight group 
(per log unit increase of averaged PA 3168 g weight gain [95% CI 802-5535 g]), for LMW phthalate 
metabolites in the overweight and obese group (per log unit increase of averaged LMW 1723 g [95% CI 
185-3262 g] for overweight and 5939 g weight gain [95% CI 1326-10553 g]) and for DNOP metabolites 
in the obese group with increased weight gain (per log unit increase of averaged DNOP 8184 g weight 
gain [95% CI 1916-14453 g]) (Supplementary Table S8). For individual phthalate metabolites, effect 
modification was by pre-pregnancy BMI was observed for mMP, mono-isobutylphthalate (mIBP), mono-
n-butylphthalate (mBP), mCMHP, mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP) and mCPP (statistical 
interaction p-value<0.1) (data not shown). Further stratification yielded significant results for mMP and 
mBP in both overweight and obese women (respective weight gain for overweight and obese women 
per log unit increase of averaged mMP 3143 g [95% CI 832-5453 g] and 9052 g  weight gain [95% 4663-
13441 g] and for mBP 2667 g [95% CI 519-4816 g] and 6237 g weight gain [95% CI 1932-10541 g]) (data 
not shown). Stratification of mCPP yielded the same estimates as for DNOP. 
Table 4. Multivariable associations of averaged early and mid-pregnancy bisphenol and phthalate urine 
concentrations with maternal weight change from pre-pregnancy up to until 6 years postpartum in women without 
subsequent pregnancies (n=373)
Maternal weight change, g (95% CI)
Total bisphenols 327 (-385, 1040)
Bisphenol A 221 (-445, 887)
Phthalic acid 1193 (293, 2092)
LMW phthalate metabolites 797 (186, 1407)
HMW phthalate metabolites 720 (-172, 1612)
DEHP metabolites 581 (-275, 1438)
DNOP metabolites 1007 (211, 1803)
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary total bisphenols/BPA/
Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations per gram creatinine. All models were additionally 
adjusted for early and mid-pregnancy creatinine concentrations (ng/mL). Models have been adjusted for maternal 
age, parity, ethnicity, education, dietary caloric intake during early pregnancy, pre-pregnancy BMI, maternal smoking 
during pregnancy and maternal alcohol use during pregnancy. 




We identified associations of early and mid-pregnancy phthalate exposure with weight gain 6 years 
postpartum. PA, LMW phthalate metabolites and DNOP metabolites were associated with increased 
weight gain. The associations of bisphenols and HMW phthalates attenuated when women with 
subsequent pregnancies were excluded. Stratification revealed these associations to be strongest 
among overweight and obese women. 
Interpretation of main findings
The study findings build upon chiefly cross-sectional studies in adults that suggest associations of 
phthalates with increases in body mass.16-20 The only previous longitudinal study in pregnant women 
found prenatal mCPP to be associated with a 300 g/year maternal weight gain during 10 years 
postpartum.25 In contrast to our results, this study found inverse associations for mBzP with maternal 
weight gain. A study nested within the Nurses’ Health Study I and II intended to examine type 2 
diabetes in association with BPA and phthalate exposure identified 170-210 g/year greater weight gain 
among the most highly exposed half of the samples for BPA, PA, mBzP and mBP.21 For mEP and DEHP 
metabolites non-monotonic associations were observed. In this current study, we did not find any 
nonlinear associations. Associations for BPA attenuated when women with subsequent pregnancies 
were excluded. It is notable that we see similar annual increases (~100-175 g/year) as in the Nurses’ 
Health Study despite examining these exposures in a younger and purely premenopausal population. 
These similar annual increases might suggest that although pregnancy might be a period with increased 
susceptibility to these compounds, the observed associations may also be independent of pregnancy 
status. Additionally, our results suggest that overweight and obese women are most vulnerable for 
effects of phthalate exposure during pregnancy on long-term maternal weight gain. Women with more 
adipose tissue may be more vulnerable for exposure to these chemicals. However, we cannot exclude 
reversed causation by means that these women might have a less healthy lifestyle leading to higher 
bisphenol and phthalate exposure and weight increase independent of exposure levels. 
Strengths and limitations
A strength of our study is our use of two urine samples in pregnancy to capture exposure more accurately. 
Bisphenol and phthalate metabolites were measured in spot urine samples in early and mid-pregnancy 
and typically have half-lives of less than 24 hours.44,45 A single spot urine sample for phthalates could 
reasonably reflect exposure for up to three months,46 but bisphenols have a high temporal variability, 
even over the day.47 Within and between correlations for early and mid-pregnancy compounds was low 
(Supplementary Table S9). This non-differential misclassification is expected to lead to attenuation bias 
in dose-response relationships. We therefore assume averaged models to provide a better estimation of 
the result, especially for bisphenols. As one exposure measurement may not fully characterize exposure 
levels, we used averaged exposure measurements. Furthermore, our sensitivity analysis excluding 
women with subsequent pregnancies limits possible confounding. A weakness is the absence of serial 
measures of exposure longitudinally that would permit evaluation whether chronic exposure is more 
or less impactful than antecedent exposure years prior to weight gain. Also information on postpartum 
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exposure levels and weight between birth and 6 years postpartum is missing, disabling investigation of 
associations independent of pregnancy status, persistence of exposure levels and weight gain patterns. 
Our study population is exclusively female, a similar limitation to the Nurses’ Health Study, though it 
is somewhat more diverse in that substantial Surinames, Turkish, Moroccan, Dutch Antillean and Cape 
Verdean populations are included though we are also unable to evaluate effects in Hispanic populations 
in whom obesity is especially prevalent.48 The present study relies on a single time point, in contrast to 
the biannual evaluations performed in the Nurses’ Health Study.21 Residual confounding is always an 
alternative explanation of findings such as ours, though we note careful control for multiple potential 
confounders.  
Phthalates are a heterogeneous group of synthetic chemicals with diverse uses and effects. Obesogenic 
effects of bisphenols and phthalate metabolites have been linked to peroxisome proliferator-activated 
receptor g (PPARg) activation.49,50 PPARg is expressed predominantly in adipose tissue and to a lesser 
extent the macrophage and liver, acts as regulator for adipocyte differentiation, lipid metabolism and 
reduces inflammation resulting in improved insulin sensitization. Di-2-ethylhexylphthalate (DEHP), 
di-n-butylphthalate (DBP), di-iso-butylphthalate (DiBP) and BPA have been reported as weak PPARg 
activators, while butylbenzylphthalate (BBP) and its main metabolite mBzP showed strong activation of 
PPARg. In contrast, we did not observe associations of DEHP, BPA and mBzP with increased weight gain 
among women without subsequent pregnancies. We did observe associations with increased weight 
gain for mBP and mIBP, metabolites from DBP and DiBP. An alternative explanation of the associations 
of LMW phthalates may be by sex-steroid dysregulation which has been described,51 though it should 
be noted these are thought to have mainly anti-androgenic effects.52 Further studies are needed to 
evaluate these potential mechanisms, through epigenetics, metabolomics and/or evaluation of sex 
steroids.
Diet has been considered the major source of phthalate exposure, mainly due to contamination from 
processing and packaging.53,54 Our previous study did not show strong associations of nutrition related 
factors in the previous three months with bisphenol and phthalate urine concentrations.34 Given 
the short biological half-lives of bisphenols and phthalates, this might have resulted in undetectable 
exposure-response associations. Together with the fact that the same study showed that obese women 
had higher concentrations of bisphenols and phthalate metabolites, we cannot rule out that higher 
bisphenol and phthalate urinary concentrations reflect unhealthy nutrition patterns. A recent review 
observed that healthier food choices were associated with lower urinary bisphenol and phthalate 
metabolite concentrations among pregnant women.55 We cannot rule out that women with more fat 
tissue have higher adipose stores of lipophilic chemicals, such as phthalates, and bisphenols to some 
extent. However, women with more adipose tissue may be more vulnerable for exposure to these 
chemicals or they might make less healthy food choices leading to a higher bisphenol and phthalate 
exposure. A reduction of adipose tissue through physical activity, dieting or weight loss surgery may 
decrease the adipose stores of chemicals such as phthalates. On the other hand, physical activity could 
influence the chemical metabolism, for example by changes in the renal excretion. Dieting and weight 
loss surgery might affect the associations as observed. Unfortunately, information on physical activity, 
dieting and weight loss surgery was not available. Smoking postpartum could not be included due to high 
correlation with smoking during pregnancy and potential not-random missingness. We cannot exclude 
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that the missing information on these variables are a source of residual confounding. Gestational weight 
gain has been calculated from the last measured weight during pregnancy and pre-pregnancy weight. 
Maximum pregnancy weight was self-reported, had over 30% of missingness and was probably not 
missing at random. Therefore, we have used the last measured  weight during pregnancy. Weight at late 
pregnancy and maximum pregnancy weight were highly correlated (Spearman’s regression coefficient 
0.954).
For the current study, we have used bisphenol and phthalate urinary concentrations in early and 
mid-pregnancy. We hypothesize early and mid-pregnancy compounds to be of the most importance, 
because the majority of physiologic and metabolic changes occurs in these periods. Mid-pregnancy 
bisphenol and phthalate urinary concentrations were generally lower than in early pregnancy. Samples 
were batched randomly, but analyzed in the order of pregnancy period. No batch effects have been 
observed. During laboratory analysis, contamination that arises from laboratory materials and solvents 
was monitored by the analysis of procedural blanks. All values remained below the LOD and were 
subtracted. In mid-pregnancy, maternal plasma volume has increased largely. Therefore, we hypothesize 
that the decline in concentrations and detection rate reflects dilution due to increased maternal plasma 
volume in mid-pregnancy. We cannot exclude that this decline is caused by metabolic changes and 
thereby might not represent tissue exposure. 
A common method to account for dilution of urinary chemical concentrations is via creatinine 
adjustment.39 Endogenous creatinine clearance, measured by 24-hr urine collection, remains the most 
precise estimation of the glomerular filtration rate in pregnant women.56 However, creatinine might not 
be a precise indicator of urinary dilution during periods of rapid growth and metabolic change, such 
as pregnancy. A recent study suggested that specific gravity adjustment is a better correction method 
in pregnant women.57 Unfortunately, specific gravity measurements were not available in our cohort. 
We have tested for the robustness of results using several methods described by O’Brien et al. Using 
both the standardized biomarker measure as well as including creatinine in the model as a covariate 
is hypothesized to control better for variation due to hydration and to block back-door paths between 
creatinine and risk factors related to both creatinine and disease as also covariates are being adjusted 
for creatinine.39 In the current study, mid-pregnancy creatinine concentrations were associated with 
weight gain. Models with both standardized compounds and creatinine concentrations as covariates 
had a better fit compared to models with standardized compounds only. 
Phthalate exposures have been estimated to contribute to 5,900 newly incident cases of obesity in the 
US among adult women, and another 53,900 in the EU.58,59  This obesity also carries an economic toll, 
on the order of $1.7 billion annually in the US and $20.8 billion in the EU. Exposures to phthalates can 
be modified through behavioral modifications 60,61 as well as regulatory action. We note substantial 
reductions in DEHP metabolites in the US between 2001-2010 62 due to additional regulatory attention 
that perhaps explain the greater attributable obesity and costs in the EU compared to US.58,59 This 
however does not rule out effects on obesity from phthalates which are increasingly replacing DEHP 
(e.g. di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP)), may have the same metabolic effects, 
and are associated with insulin resistance and blood pressure in children.63,64 Additional studies will 





In a large population-based birth cohort, early and mid-pregnancy phthalate exposures are associated 
with weight gain 6 years postpartum. These data support ongoing action to replace phthalates with 
safer alternatives. 
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Supplementary Table S1. Bisphenol and phthalate groupings as used in the main analyses (n=1,192)
EARLY PREGNANCY MID-PREGNANCY
Total bisphenols Total bisphenols
   Bisphenol A (BPA)    Bisphenol A (BPA)
   Bisphenol S (BPS)    Bisphenol S (BPS)
   Bisphenol F (BPF)   
Phthalic acid (PA) metabolites Phthalic acid (PA) metabolites
Low molecular weight (LMW) metabolites Low molecular weight (LMW) metabolites
   Monomethylphthalate (mMP)    Monomethylphthalate (mMP)
   Monoethylphthalate (mEP)    Monoethylphthalate (mEP)
   Mono-isobutylphthalate (mIBP)    Mono-isobutylphthalate (mIBP)
   Mono-n-butylphthalate (mBP)    Mono-n-butylphthalate (mBP)
High molecular weight (HMW) metabolites High molecular weight (HMW) metabolites
Di-2-ethylhexylphthalate (DEHP) metabolites Di-2-ethylhexylphthalate (DEHP) metabolites
   Mono-(2-ethyl-5-carboxypentyl)phthalate (mECPP)    Mono-(2-ethyl-5-carboxypentyl)phthalate (mECPP)
   Mono-(2-ethyl-5-hydroxyhexyl)phthalate (mEHHP)    Mono-(2-ethyl-5-hydroxyhexyl)phthalate (mEHHP)
   Mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP)    Mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP)
   Mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP)    Mono-[(2-carboxymethyl)hexyl]phthalate (mCMHP)
Di-n-octylphthalate (DNOP) Di-n-octylphthalate (DNOP)
   Mono(3-carboxypropyl)phthalate (mCPP)    Mono(3-carboxypropyl)phthalate (mCPP)
Other high molecular weight metabolites Other high molecular weight metabolites
   Monobenzylphthalate (mBzP)    Monobenzylphthalate (mBzP)
   Mono-hexylphthalate (mHxP)    
   Mono-2-heptylphthalate (mHpP)    
Supplementary Figure S1. Causal diagram describing the hypothesized relations among bisphenols and phthalate 
metabolites, postpartum weight gain and potential covariates
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Supplementary Table S2. Nonresponse analysisa
Sample n = 1,192  
(information on 
maternal weight gain 
between pre-pregnancy 
and 6 y postpartum)
Sample = 373  
(information on 
maternal weight gain 
between pre-pregnancy 
and 6 y postpartum 
and no subsequent 
pregnancies)
Generation R n = 3,909 
(singleton live born 
children + inclusion 
<18w + visit F@5 + in-
formation on maternal 
weight gain between 
pre-pregnancy and 6 y 
postpartum)
Maternal age (years) 36.8 (4.7) 38.7 (4.6) 37.0 (4.8)
   Missing NA NA NA
Gestational weight gain (kg) 10.3 (4.7) 9.9 (5.0) 10.5 (4.8)
   Missing 0.4 0.1 3.0
Pre-pregnancy BMIb 22.7 (20.8, 25.3) 22.7 (20.8, 25.8) 22.6 (20.8, 25.3)
   Missing NA NA 0.2
Daily dietary caloric intake  
during pregnancy
2077 (508) 2044 (656) 2038 (546)
   Missing 23.7 25.2 17.7
Parity (% nulliparous) 61.2 35.9 59.6
   Missing NA NA 0.1
Ethnicity (% Dutch/European) 62.2 60.6 64.6
   Missing 0.4 0.3 0.4
Maternal education (% high) 49.2 44.2 47.7
   Missing 2.9 3.5 2.2
Smoking during pregnancy (% 
yes)
22.2 25.5 25.0
   Missing 6.5 8.3 4.4
Alcohol use during pregnancy 
(% yes)
53.3 54.7 54.8
   Missing 6.5 8.6 4.6
Breastfeeding (months) b 3.5 (1.5, 6.5) 3.5 (1.5, 8.5) 3.5 (1.5, 6.5)
   Missing 19.5 19.3 33.5
Maternal weight change 
   (6 y postpartum –  
   pre-prenancy weight)
4.1 (7.1) 5.1 (7.5)
   Missing NA NA NA
aValues represent means (standard deviation) or percentages 
bMedian (IQR range)
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Supplementary Table S3. Univariate associations of potential covariates with weight change
Maternal weight change, 
g (95% CI)
p-value
Maternal age 6 years postpartum (years) -162 (-247, -76) <0.001
Daily dietary caloric intake (kcal) 0 (-1, 1) 0.637
Pre-pregnancy BMI (kg/m2) -126 (-219, -32) 0.018
Gestational weight gain (kg) 456 (373, 538) <0.001
Parity 0.010
   Nulliparous Reference
   Multiparous -1081 (-1904, -258)
Ethnicity <0.001
   Dutch/European Reference
   non-Dutch/non-European 2294 (1472, 3116)
Education <0.001
   Low 2357 (1559, 3155)
   High Reference
Alcohol use during pregnancy <0.001
   No 1734 (914, 2553)
   Yes Reference
Smoking during pregnancy <0.001
   No Reference
   Yes 1934 (996, 2873)
Breastfeeding (months) -19 (-176, 137) 0.751
Early pregnancy creatinine concentration (ng/mL) 0 (0, 1) 0.325
Mid-pregnancy creatinine concentration (ng/mL) 0 (0, 1) 0.066
Univariate analysis of potential confounders with maternal weight change between pre-pregnancy weight and maternal 
weight 6 years postpartum. Analysis performed with multiply imputed data.      
Supplementary Table S4. Unadjusted associations of averaged early and mid-pregnancy bisphenol and phthalate 
urine concentrations with maternal weight change (n=1,192)     
Maternal weight change, g (95% CI)
Total bisphenols 418 (16, 820)
Bisphenol A 414 (53, 775)
Phthalic acid 947 (483, 1411)
LMW phthalate metabolites 864 (512, 1216)
HMW phthalate metabolites 973 (479, 1466)
DEHP metabolites 794 (314, 1273)
DNOP metabolites 885 (380, 1390)
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary total bisphenols/BPA/
Phthalic acid/LMW/HMW/DEHP/DNOP metabolite concentrations per gram creatinine. All models were additionally 
adjusted for early and mid-pregnancy creatinine concentrations (in ng/mL). 
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Supplementary Table S5. Multivariable associations of averaged early and mid-pregnancy bisphenol and phthalate 
urine concentrations with maternal weight change from pre-pregnancy up to until 6 years postpartum stratified for 
pre-pregnancy BMI (n=1,192)









Total bisphenols 1268 (-405, 2942) 71 (-298, 439) 516 (-472, 1504) 2179 (-454, 4813)
DNOP metabolites 1403 (-1928, 4735) 671 (226, 1116) 854 (-413, 2122) 3893 (2, 7784)
Interaction terms of BPA, PA, LMW, HMW and DEHP metabolites with pre-pregnancy BMI were p-value>0.1. 
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary total bisphenols/DNOP 
metabolite concentrations per gram creatinine. All models were additionally adjusted for early and mid-pregnancy 
creatinine concentrations (ng/mL). Models have been adjusted for maternal age, parity, ethnicity, education, dietary 
caloric intake during early pregnancy, pre-pregnancy BMI, maternal smoking during pregnancy and maternal alcohol 
use during pregnancy. 
Supplementary Table S6. Multivariable associations of averaged early and mid-pregnancy individual phthalate 
metabolite urine concentrations with maternal weight change from pre-pregnancy up to until 6 years postpartum 
(n=1,192) 
Maternal weight change, 
g (95% CI)
mMP 856 (433, 1279)
mEP 437 (153, 722)
mIBP 531 (115, 947)
mBP 720 (252, 1187)
mECPP 650 (189, 1112)
mEHHP 389 (-70, 848)
mEOHP 501 (62, 939)
mCMHP 453 (-25, 930)
mCPP 840 (347, 1332)
mBzP 583 (205, 961)
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary phthalate metabolite 
concentrations per gram creatinine. All models were additionally adjusted for early and mid-pregnancy creatinine 
concentrations (ng/mL). Models have been adjusted for maternal age, parity, ethnicity, education, dietary caloric 
intake during early pregnancy, pre-pregnancy BMI, and maternal alcohol use and smoking during pregnancy. 
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Supplementary Table S7. Multivariable associations of averaged early and mid-pregnancy individual phthalate 
metabolite urine concentrations with maternal weight change from pre-pregnancy up to until 6 years postpartum in 
women without subsequent pregnancies (n=373) 
Maternal weight change, 
g (95% CI)
mMP 1378 (608, 2147)
mEP 473 (-27, 973)
mIBP 1197 (475, 1918)
mBP 1202 (447, 1958)
mECPP 723 (-120, 1566)
mEHHP 463 (-357, 1282)
mEOHP 639 (-157, 1436)
mCMHP 329 (-545, 1203)
mCPP 1007 (211, 1803)
mBzP 530 (-187, 1247)
Increases are per natural log unit increase in averaged early and mid-pregnancy urinary phthalate metabolite 
concentrations per gram creatinine. All models were additionally adjusted for early and mid-pregnancy creatinine 
concentrations (ng/mL). Models have been adjusted for maternal age, parity, ethnicity, education, dietary caloric 
intake during early pregnancy, pre-pregnancy BMI, and maternal alcohol use and smoking during pregnancy
Supplementary Table S8. Multivariable associations of averaged early and mid-pregnancy bisphenol and phthalate 
urine concentrations with maternal weight change from pre-pregnancy up to until 6 years postpartum in women 
without subsequent pregnancies stratified for pre-pregnancy BMI (n=373)







Total bisphenols -175 (-848, 498) 796 (-944, 2536) 2661 (-1304, 6626)
Phthalic acid 281 (-506, 1068) 3168 (802, 5535) 5502 (-1775, 12779)
LMW phthalate metabo-
lites
389 (-144, 922) 1723 (183, 3262) 5939 (1326, 10553)
DNOP metabolites 374 (-327, 1076) 1270 (-864, 3404) 8184 (1916, 14453)
Interaction terms of BPA, HMW and DEHP metabolites with pre-pregnancy BMI were p-value>0.1. Increases are per 
natural log unit increase in averaged early and mid-pregnancy urinary total bisphenols/ Phthalic acid/LMW/DNOP 
metabolite concentrations per gram creatinine. All models were additionally adjusted for early and mid-pregnancy 
creatinine concentrations (ng/mL). Models have been adjusted for maternal age, parity, ethnicity, education, dietary 
caloric intake during early pregnancy, pre-pregnancy BMI, maternal smoking during pregnancy and maternal alcohol 


































































































































































































































































































































































































































































































































































































































































































































































Changes in parental smoking 
during pregnancy and risks of 
adverse birth outcomes and 
childhood overweight
3.1




Background: Fetal smoke exposure is a common and key avoidable risk factor for birth complications 
and seems to influence later risk of overweight. It is unclear whether this increased risk is also present if 
mothers smoke during the first trimester only or reduce the number of cigarettes during pregnancy, or 
when only fathers smoke. We aimed to assess the associations of parental smoking during pregnancy, 
specifically of quitting or reducing smoking and maternal and paternal smoking combined, with preterm 
birth, small size for gestational age, and childhood overweight. 
Methods and findings: We performed an individual participant data meta-analysis among 229,158 
families from 28 pregnancy/birth cohorts from Europe and North America. All 28 cohorts had 
information on maternal smoking, and 16 also had information on paternal smoking. In total, 22 
cohorts were population-based, with birth years ranging from 1991 to 2015. The mothers’ median 
age was 30.0 years, and most mothers were medium or highly educated. We used multilevel binary 
logistic regression models adjusted for maternal and paternal sociodemographic and lifestyle-related 
characteristics. Compared with nonsmoking mothers, maternal first trimester smoking only was not 
associated with adverse birth outcomes but was associated with a higher risk of childhood overweight 
(odds ratio [OR] 1.17 [95% CI 1.02–1.35], P value = 0.030). Children from mothers who continued 
smoking during pregnancy had higher risks of preterm birth (OR 1.08 [95% CI 1.02–1.15], P value = 0.012 
), small size for gestational age (OR 2.15 [95% CI 2.07–2.23], P value < 0.001), and childhood overweight 
(OR 1.42 [95% CI 1.35–1.48], P value < 0.001). Mothers who reduced the number of cigarettes between 
the first and third trimester, without quitting, still had a higher risk of small size for gestational age. 
However, the corresponding risk estimates were smaller than for women who continued the same 
amount of cigarettes throughout pregnancy (OR 1.89 [95% CI 1.52–2.34] instead of OR 2.20 [95% CI 
2.02–2.42] when reducing from 5–9 to ≤4 cigarettes/day; OR 2.79 [95% CI 2.39–3.25] and OR 1.93 
[95% CI 1.46–2.57] instead of OR 2.95 [95% CI 2.75–3.15] when reducing from ≥10 to 5–9 and ≤4 
cigarettes/day, respectively [P values < 0.001]). Reducing the number of cigarettes during pregnancy did 
not affect the risks of preterm birth and childhood overweight. Among nonsmoking mothers, paternal 
smoking was associated with childhood overweight (OR 1.21 [95% CI 1.16–1.27], P value < 0.001) but 
not with adverse birth outcomes. Limitations of this study include the self-report of parental smoking 
information and the possibility of residual confounding. As this study only included participants from 
Europe and North America, results need to be carefully interpreted regarding other populations.
Conclusions: We observed that as compared to nonsmoking during pregnancy, quitting smoking in 
the first trimester is associated with the same risk of preterm birth and small size for gestational age, 
but with a higher risk of childhood overweight. Reducing the number of cigarettes, without quitting, 
has limited beneficial effects. Paternal smoking seems to be associated, independently of maternal 
smoking, with the risk of childhood overweight. Population strategies should focus on parental smoking 
prevention before or at the start, rather than during, pregnancy. 




One in five women of reproductive age are expected to be tobacco users by 2025.1 Although strategies 
to prevent smoking are globally implemented, up to 25% of women in Western countries smoke during 
pregnancy.2 This is a major public health concern, particularly since smoking during pregnancy not only 
affects women’s own health but is also associated with adverse birth and offspring outcomes, such as 
preterm birth, low birth weight, and childhood overweight.3-13 Preterm birth and low birth weight are 
major causes of perinatal morbidity and mortality, and childhood overweight is related to a higher risk 
of cardiovascular disease, premature death, and disability in adulthood.14-16
A vast number of studies observed consistent associations of continued maternal smoking during 
pregnancy with increased risks of preterm birth, low birth weight, and childhood overweight.7,10,11 
However, evidence on critical windows of vulnerability to maternal smoking and changes in smoking 
behavior during pregnancy remain inconclusive, potentially reflecting between-study heterogeneity of 
outcome measures and small study sample sizes. Previous studies focused on maternal smoking in 
first trimester of pregnancy only, consistently showing no associations with preterm birth, but showed 
conflicting results for the risks of low birth weight and childhood overweight.8,9,17-21 Also, the associations 
of paternal smoking during pregnancy with preterm birth, low birth weight, and childhood overweight 
have been scarcely studied and remain unclear.20,22,23 Paternal smoking might affect offspring outcomes 
through direct gamete or passive smoking intrauterine effects. However, comparisons of maternal 
and paternal smoking associations can also be used to disentangle direct uterine programming effects 
and confounding by shared or family-based lifestyle or socioeconomic variables. To our knowledge, 
no large sample size studies assessed the associations of maternal smoking during first trimester only, 
of reducing the number of cigarettes during pregnancy, or of paternal smoking only with birth and 
childhood outcomes. 
We conducted an individual participant data meta-analysis among 229,158 singleton births from 28 
pregnancy and birth cohort studies in Europe and North America to assess the associations of parental 
smoking during pregnancy with preterm birth, small size for gestational age (SGA), and childhood 
overweight. We were specifically interested in the associations of quitting or reducing smoking during 
pregnancy and of combined maternal and paternal smoking patterns with birth and offspring outcomes.
Methods
Inclusion criteria and participating cohorts
This study was part of an international LifeCycle Project (https://lifecycle-project.eu) collaboration on 
maternal obesity and childhood outcomes.24-28 Pregnancy and birth cohort studies were eligible for 
inclusion if they included mothers with singleton live-born children who were born from 1989 onwards, 
had information available on maternal prepregnancy/early-pregnancy body mass index (BMI), and had 
at least one offspring measurement (birth weight or childhood BMI). We identified eligible cohorts from 
existing collaborations on childhood health (EarlyNutrition Project, CHICOS Project, www.birthcohorts.
net assessed until July 2014). Fifty cohorts from Europe, North America, and Oceania were identified 
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and invited, of which 39 cohorts agreed to participate. The cohorts were approved by their local 
institutional review boards, and written informed consent from all participants or parents was obtained. 
Eleven cohorts were excluded from the current analysis because there was no information on maternal 
smoking patterns or only nonsmoking mothers in their cohort. In total, 28 cohorts comprising data on 
229,158 singleton births were included (Figure 1). Twenty-two of the 28 cohorts defined themselves 
as regionally or nationally based studies, four as hospital-based (Co.N.ER, EDEN, GASPII, LUKAS), one 
as internet users–based (NINFEA), and one as studying selected populations (FCOU). The plan for 
analyses given to the cohorts when inviting them to participate in this paper from the LifeCycle Project 
collaboration is provided in S1 Text. Based on data availability and additional research questions, it 
was decided among the collaborators to refine the existing questions and to extend the project with 
additional questions to be addressed. Analyses that were not in the original plan are marked in S1 Text. 
Associations of smoking with early- and late-childhood BMI were excluded because of low numbers. All 
cohorts provided written informed consent for using their data. Anonymized datasets were stored on a 
single central secured data server with access for the main analysts (EP, SS) only. This study is reported 
according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guideline (S1 PRISMA Checklist).
Figure 1. Flowchart of the cohorts and participants
BMI, body mass index.
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Parental tobacco smoking 
Parental smoking information was obtained by questionnaires (cohort-specific information in S1 Table). 
We used trimester-specific maternal smoking information to categorize smoking during pregnancy 
in three groups (nonsmoking; first-trimester-only smoking; continued smoking [as being any second 
or third trimester smoking]). Trimester-specific maternal smoking information was categorized 
into nonsmoking, ≤4 cigarettes/day, 5–9 cigarettes/day, and ≥10 cigarettes/day. We combined the 
information about maternal smoking in first and third trimester to examine the change in smoking 
behavior. Information on paternal nonsmoking/smoking was used. To explore the combined effects 
of maternal and paternal smoking, we combined the maternal and paternal smoking information into 
six categories: maternal and paternal nonsmoking (used as reference category); maternal nonsmoking 
and paternal smoking; maternal first-trimester-only smoking and paternal nonsmoking; maternal first-
trimester-only smoking and paternal smoking; maternal continued smoking and paternal nonsmoking; 
and maternal continued smoking and paternal smoking.
Birth complications and childhood overweight
Information on gestational age at birth, birth weight, and childhood weight and height was measured, 
derived from clinical records, or reported (cohort-specific information in S1 Table). Preterm birth was 
defined as <37 weeks of gestation, and full-term birth (≥37 weeks) was used as the reference group in 
the analyses.29 We created sex- and gestational age–adjusted birth weight standard deviation scores 
(SDSs) based on a North European reference chart.30 SGA at birth was defined per cohort as sex- and 
gestational age–adjusted birth weight below the 10th percentile. The reference group used in the 
analyses comprises children born at appropriate and large size for gestational age (i.e., cohort-specific 
sex- and gestational age–adjusted birth weight above the 10th percentile). BMI measurements in mid-
childhood (≥5 to <10 years) were used. If there were multiple measurements of a child available within 
the age interval, we used the measurement at the highest age. We created sex- and age-adjusted SDSs 
of childhood BMI using World Health Organization (WHO) reference growth charts (Growth Analyzer 
4.0, Dutch Growth Research Foundation).31,32 Childhood normal weight, overweight, and obesity were 
defined using WHO cutoffs.31,32 For the analyses, we combined the overweight and obesity group, 
hereafter referred to as the overweight group. Normal weight was used as the reference group in 
childhood overweight analyses. 
Covariates
Information on covariates was mostly assessed using questionnaires. Most covariates were provided 
by cohorts as categorical variables: child’s sex, maternal educational level (low, medium, high), parity 
(nulliparous, multiparous), and alcohol consumption during pregnancy (yes, no). To allow handling 
of missing data, continuous covariates were categorized: maternal age (defined on the basis of data 
availability: <25.0 years, 25.0–29.9 years, 30.0–34.9 years, and ≥35.0 years) and prepregnancy or early-
pregnancy maternal and paternal BMI (underweight [<18.5 kg/m2], normal weight [18.5–24.9 kg/
m2], overweight [25.0–29.9 kg/m2], and obesity [≥30.0 kg/m2]). Maternal ethnicity was not included, 
since most cohorts were largely of European descent and there was a high percentage of missing data. 




We conducted 1-stage meta-analyses, in which we analyzed individual participant data from all cohorts 
simultaneously in binary logistic multilevel mixed-effects models, accounting for clustering of 
participants within cohorts.33 First, we examined the associations of maternal smoking (across different 
trimesters; dose-response) with the risks of preterm birth, SGA, and childhood overweight. When 
examining the dose-response effects of first trimester maternal smoking, mothers who continued 
smoking were excluded from the analysis. Second, we used similar models to investigate the associations 
of change in maternal smoking behavior from first to third trimester with the risks of preterm birth, 
SGA, and childhood overweight. Finally, we used similar models to investigate the combined associations 
of both maternal and paternal smoking with the risks of these outcomes. We assessed whether the risk 
estimates between categories statistically differed using the formula 34. 
We adjusted all analyses focused on maternal smoking for maternal age, educational level, parity, 
prepregnancy or early-pregnancy BMI, alcohol consumption during pregnancy, and paternal smoking. 
We adjusted all analyses focused on combined maternal and paternal smoking for the same covariates 
and paternal BMI. As sensitivity analyses, we repeated all models for gestational age at birth, sex- 
and gestational age–adjusted birth weight SDSs, and childhood sex- and age-adjusted BMI SDSs. 
Also, we conducted two-stage random-effects meta-analyses for the core associations and tested for 
heterogeneity between the cohorts estimates with the I2 test.33,35 To express the uncertainty associated 
with I2 estimates, we calculated the corresponding 95% confidence intervals (CIs).36 All covariates were 
categorized and missing values were added as an additional group to prevent exclusion of noncomplete 
cases. If information on a covariate was available for less than 50% of the cohort sample used for each 
analysis, available information was not used and the corresponding data for that full cohort sample 
were assigned to the missing category. We conducted a sensitivity analysis with complete cases only. 
Also, to explore the influence on our results of using maternal age and BMI as categorical covariates, we 
repeated the complete cases’ analysis using these covariates continuously. The statistical analyses were 
performed using the Statistical Package of Social Sciences version 24.0 for Windows (SPSS, Chicago, IL, 
United States of America) and Review Manager (RevMan) version 5.3 of the Cochrane Collaboration 
(The Nordic Cochrane Centre, Copenhagen, Denmark).
Results 
Participants’ characteristics
Information about the main characteristics per cohort is given in Table 1. Overall, 14.4% (range 5.5–
26.8) of mothers and 27.5% (range 16.9–83.8) of fathers smoked during pregnancy. Children were born 
at a median gestational age of 40.0 weeks (95% range 35.7–42.3) and a median birth weight of 3,530 
grams (95% range 2,390–4,580). In total, 4.7% of children were born preterm, 10.0% were SGA at birth, 
and 20% were in the overweight group. Additional information about maternal smoking is given in S3 
Table. 
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Changes in maternal smoking habits during pregnancy and the risks of preterm 
birth, SGA, and childhood overweight
Table 2 shows that maternal first trimester smoking only was not associated with adverse birth outcomes 
but was associated with higher risks of childhood overweight (odds ratio [OR] 1.17 (95% CI 1.02–1.35), 
P value = 0.030). Compared with children from mothers who did not smoke during pregnancy, those 
from mothers who continued smoking had higher risks of preterm birth (OR 1.08 [1.02–1.15], P value 
= 0.012), SGA (OR 2.15 [2.07–2.33], P value < 0.001), and childhood overweight (OR 1.42 [1.35–1.48], 
P value < 0.001). We observed dose-response relationships for third trimester smoking starting at ≤4 
cigarettes/day. We observed similar results when we used the continuous outcomes, except for the 
association of first-trimester-only smoking with childhood BMI SDS, which was in the same direction 
but no longer significant (S4 Table). We observed similar results when using two-stage random-effects 
models (Figure 2, 3, and 4). We observed low to moderate heterogeneity between the cohorts’ 
estimates (I2 estimates range from 0% to 47%; corresponding CIs are presented in the footnotes of 
Figures 2, 3, and 4). Only the cohort-specific results for the associations of maternal continued smoking 
with SGA showed high heterogeneity between estimates (I2 75% [95% CI 56%–86%]). Almost all cohorts 
were included in the analyses for continued smoking, whereas only roughly half had information on 
first-trimester-only smoking. When restricting the two-stage continued smoking models to the cohorts 
also with information on first-trimester-only smoking, we observed a lower heterogeneity between 
estimates (I2 23% [95% CI 0%–65%]), but the pooled risk estimate remained similar (S1 Figure).
Table 3 shows that, compared with mothers who did not smoke during pregnancy, mothers who quit 
smoking from first to third trimester had similar risks of delivering SGA infants. Reducing the number 
of cigarettes, without quitting, from first to third trimester lowered the risks of delivering SGA infants, 
but risks were still higher compared with those of nonsmoking mothers (OR 1.89 [1.52–2.34] when 
reducing from 5–9 to ≤4 cigarettes/day; 2.79 [2.39–3.25] and 1.93 [1.46–2.57] when reducing from 
≥10 to 5–9 and ≤ 4 cigarettes/day, respectively [all P values < 0.001]). Mothers who increased the 
number of cigarettes from first to third trimester increased their risks of delivering SGA infants (OR 2.43 
[2.05–2.89] and 2.47 [1.71–3.58] when increasing from ≤4 to 5–9 and ≥10 cigarettes/day, respectively; 
and 2.70 [2.35–3.10] when increasing from 5–9 to ≥10 cigarettes/day [all P value < 0.001]). Changes in 
maternal smoking from first to third trimester did not influence the risks of preterm birth and childhood 
overweight. Similar results were observed when assessing the associations of the changes in maternal 
smoking during pregnancy with the continuous outcomes (S5 Table).
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Table 2. Maternal smoking with risks of birth complications and childhood overweight
Maternal smoking Preterm birth Small size for  
gestational age at birth
Childhood overweight 
Odds ratio  
(95% confidence interval)
Odds ratio  
(95% confidence interval)




ncases/total = 8,586/188,357 ncases/total = 16,879/190,873 ncases/total = 17,530/92,434
Only first trimester 
smoking
1.03 (0.85–1.25) 0.99 (0.85–1.15) 1.17 (1.02–1.35)*
ncases/total = 120/2,116 ncases/total = 200/2,144 ncases/total = 329/1,084
First trimester dosage
≤4 cigarettes/day
0.99 (0.70–1.39) 0.96 (0.75–1.22) 1.02 (0.78–1.33)
ncases/total = 36/828 ncases/total = 77/826 ncases/total = 78/340
5–9 cigarettes/day
1.00 (0.58–1.72) 0.90 (0.59–1.36) 1.37 (0.92–2.06)
ncases/total = 14/288 ncases/total = 25/288 ncases/total = 35/136
≥10 cigarettes/day
0.81 (0.45–1.46) 0.88 (0.57–1.35) 1.31 (0.89–1.93)
ncases/total = 12/273 ncases/total = 23/271 ncases/total = 40/152
Continued smoking
1.08 (1.02–1.15)* 2.15 (2.07–2.23)** 1.42 (1.35–1.48)**




1.01 (0.89–1.14) 1.57 (1.45–1.70)** 1.30 (1.18–1.42)**
ncases/total = 288/5,866 ncases/total = 836/6,034 ncases/total = 688/2,792
5–9 cigarettes/day
1.07 (0.95–1.19) 2.40 (2.25–2.56)** 1.42 (1.30–1.55)**
ncases/total = 367/7,115 ncases/total = 1,341/7,162 ncases/total = 813/3,284
≥10 cigarettes/day
1.11 (1.01–1.22)* 2.93 (2.76–3.10)** 1.55 (1.43–1.67)**
ncases/total = 524/9,771 ncases/total = 2,001/9,743 ncases/total = 1,137/4,139
Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed-effects models that reflect 
the risk of preterm birth, small size for gestational age, and childhood overweight per smoking group compared 
with the reference group (no maternal smoking).        
Number of cigarettes used as continued smoking dosage was based on third trimester information. Preterm 
birth is defined as birth before the gestational age of 37 weeks. Small size for gestational age is defined as the 
lowest 10% of sex- and gestational age–adjusted birth weight standard deviation score per cohort. Childhood 
overweight is overweight and obesity together according to the World Health Organization criteria. Models 
are adjusted for maternal age, educational level, parity, prepregnancy or early-pregnancy body mass index, 
alcohol consumption during pregnancy, and paternal smoking.       
*P value < 0.05.           
**P value < 0.001. 
Parental smoking and birth and offspring outcomes
247 
3.1
Figure 2. Maternal smoking with risks of preterm birth assessed by 2-stage random-effects models 
 
(A) First trimester smoking versus nonsmoking, (B) continued smoking versus nonsmoking. Values are odds ratios 
(95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of preterm birth per 
smoking pattern (first-trimester-only smoking or continued smoking) compared to that of nonsmoking. Models are 
adjusted for maternal age, educational level, parity, prepregnancy or early-pregnancy body mass index, alcohol 
consumption during pregnancy, and paternal smoking. The cohorts for which no estimate was provided had no data 
available for that particular analysis. The heterogeneity between the estimates of each cohort was 0% (95% CI 0%–
57%) and 4% (95% CI 0%–47%) for first-trimester-only smoking and continued smoking, respectively. CI, confidence 
interval, IV, instrumental variable
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Figure 3. Maternal smoking with risks of small size for gestational age assessed by two-stage random-effects models
(A) First trimester smoking versus nonsmoking, (B) continued smoking versus nonsmoking. Values are odds 
ratios (95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of small size 
for gestational age per smoking pattern (first-trimester-only smoking or continued smoking) compared to that of 
nonsmoking. Models are adjusted for maternal age, educational level, parity, prepregnancy or early-pregnancy body 
mass index, alcohol consumption during pregnancy, and paternal smoking. The cohorts for which no estimate was 
provided had no data available for that particular analysis. The heterogeneity between the estimates of each cohort 
was 21% (95% CI 0%–65%) and 75% (95% CI 56%–86%) for first-trimester-only smoking and continued smoking, 
respectively. CI, confidence interval, IV, instrumental variable
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Figure 4. Maternal smoking with risks of childhood overweight assessed by two-stage random-effects models
(A) First trimester smoking versus nonsmoking, (B) continued smoking versus nonsmoking. Values are odds ratios 
(95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of childhood overweight 
per smoking pattern (first-trimester-only smoking or continued smoking) compared to that of nonsmoking. Models 
are adjusted for maternal age, educational level, parity, prepregnancy or early-pregnancy body mass index, alcohol 
consumption during pregnancy, and paternal smoking. The cohorts for which no estimate was provided had no 
data available for that particular analysis. The heterogeneity between the estimates of each cohort was 0% (95% 
CI 0%–60%) and 47% (95% CI 1%–72%) for first-trimester-only smoking and continued smoking, respectively. CI, 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Parental smoking during pregnancy and the risks of preterm birth, SGA, and 
childhood overweight
Among mothers who did not smoke during pregnancy, paternal smoking tended to be associated with 
higher risks of preterm birth (OR 1.06 [1.00–1.12], P value = 0.05), SGA (OR 1.04 [1.00–1.09], P value 
= 0.05), and childhood overweight (OR 1.21 [1.16–1.27], P value < 0.001) (Table 4). Among mothers 
who smoked during first trimester only, paternal smoking was not associated with preterm birth or SGA 
but was associated with a higher risk of childhood overweight (OR 1.36 [1.02–1.80], P value = 0.036). 
Among mothers who continued smoking during pregnancy, paternal smoking further increased the 
risks of SGA and childhood overweight (both Z-score P value for differences in effect sizes between 
categories <0.0001) but not the risk of preterm birth. Children whose mothers continued smoking 
during pregnancy and whose fathers also smoked had the highest risks of being born preterm (OR 
1.10 [1.02–1.19], P value = 0.016) and SGA (OR 2.37 [2.26–2.49], P value < 0.001) and of childhood 
overweight (OR 1.76 [1.65–1.87], P value < 0.001). Similar results were observed for the combined 
maternal and paternal smoking with the continuous outcomes (S6 Table).
Discussion
In this study, maternal continued smoking during pregnancy was associated, in a dose-response manner, 
to higher risks of preterm birth, being SGA at birth, and childhood overweight. Maternal smoking 
during the first trimester of pregnancy only was not associated with risks of preterm birth and SGA but 
was associated with a higher risk of childhood overweight. Reducing the number of cigarettes during 
pregnancy without quitting may be beneficial for the risk of SGA but seems not to influence the risks of 
preterm birth and childhood overweight. Paternal smoking seems to be associated, independently of 
maternal smoking, with the risks of childhood overweight.
Maternal smoking is a major public health concern.1 The associations of maternal continued smoking 
during pregnancy and increased risks of preterm birth and SGA are well established.7,10,18 Also, several 
studies have suggested associations of fetal smoke exposure with childhood overweight and obesity.11,22 
In line with these previous studies, we observed that children whose mothers continued smoking 
during pregnancy have higher risks of preterm birth, being SGA at birth, and overweight in childhood. 
The risks of preterm birth were somewhat weaker than reported previously,7,9,18 potentially because no 
information was available about induced or spontaneous preterm birth.
Results from previous studies focused on the associations of maternal early smoking cessation and of 
reducing the number of cigarettes during pregnancy with child health outcomes are inconsistent.8,17,19,21,22 
Results from prospective studies in the Netherlands and Australia previously suggested that quitting 
smoking after the first trimester was not associated with risks of adverse birth outcomes.18,19 A large 
US study with more than 21,000 first trimester smokers reported that smoking of any duration during 
pregnancy was associated with an increased risk of fetal growth restriction with decreasing risk the 
earlier that cessation occurred.17 Similarly, a recent study from the UK Millennium Cohort Study 
suggested that two-thirds of the total adverse smoking impact on birth weight occurs in the second 
trimester and that cutting smoking intensity by the third month in pregnancy leads to infants of the 
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Table 4. Associations of maternal and paternal smoking with risks of birth complications and childhood overweight
Maternal and paternal  
smoking
Preterm birth Small size for gestational 
age at birth
Childhood overweight 
Odds ratio  
(95% confidence interval)
Odds ratio  
(95% confidence interval)





ncases/total = 5,232/123,666 ncases/total = 10,746/123,328 ncases/total = 10,298/59,395
Paternal smoking
1.06 (1.00–1.12) 1.04 (1.00–1.09) 1.21 (1.16–1.27)**
ncases/total = 1,505/31,890 ncases/total = 3,030/33,691 ncases/total = 3,199/15,474
Maternal first trimester 
smoking
Paternal nonsmoking
0.64 (0.36–1.15) 0.78 (0.53–1.13) 1.36 (0.98–1.87)
ncases/total = 12/412 ncases/total = 30/412 ncases/total = 54/233
Paternal smoking
1.03 (0.70–1.51) 1.05 (0.80–1.39) 1.36 (1.02–1.80)*
ncases/total = 29/626 ncases/total = 59/625 ncases/total = 70/305
Maternal continued  
smoking
Paternal nonsmoking
1.04 (0.93–1.15) 2.06 (1.94–2.20)** 1.33 (1.23–1.44)**
ncases/total = 405/8,768 ncases/total = 1,366/8,723 ncases/total = 877/3,872
Paternal smoking
1.10 (1.02–1.19)* 2.37 (2.26–2.49)** 1.76 (1.65–1.87)**
ncases/total = 810/15,806 ncases/total = 2,896/15,967 ncases/total = 1,785/6,661
Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed-effects models that reflect the risk 
of preterm birth, small size for gestational age, and childhood overweight per smoking group compared with the reference 
group (no parental smoking).          
Preterm birth is defined as birth before the gestational age of 37 weeks. Small size for gestational age is defined 
as the lowest 10% of sex- and gestational age–adjusted birth weight standard deviation score per cohort. 
Childhood overweight is overweight and obesity together according to the World Health Organization criteria. 
Models are adjusted for maternal age, maternal body mass index, paternal body mass index, maternal education, 
parity, and maternal alcohol consumption during pregnancy.      
*P value < 0.05.   
**P value < 0.001. 
same  weight as those infants born to persistent light smokers.37 A recent study investigating associations 
of parental smoking with fetal growth using additional methods of mendelian randomization and 
parental negative control showed consistent linear dose-dependent associations of maternal smoking 
with fetal growth from early second trimester onward.38 These studies suggest that smoking cessation 
programs should focus on the benefit of quitting as early in pregnancy as possible. A previous analysis 
using data from the Nurses’ Health Study showed that first-trimester-only maternal smoking was not, 
or was only to a limited extent, associated with obesity in later life.20 However, in the same cohort, 
first-trimester-only maternal smoking was associated with type 2 diabetes in the offspring.39 In the 
current study, maternal first-trimester-only smoking was not associated with the risks of preterm birth 
or SGA but was associated with an increased risk of childhood overweight. A biological explanation 
might be that maternal first-trimester-only smoking already leads to specific adaptations, which might 
have lifelong consequences for body composition and metabolic health in later life, but the fetal smoke 
exposure is not long enough to affect birth outcomes. Reducing the number of cigarettes from first to 
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third trimester lowered the risks of SGA, but risks were still elevated compared with those in infants 
born to nonsmoking mothers. This association was not observed for preterm birth and childhood 
overweight. Thus, our findings suggest that quitting smoking in the first trimester of pregnancy might 
optimize birth outcomes but might not reduce the risk of adverse metabolic effects in the offspring 
to the level of nonsmoking. Also, reducing the number of cigarettes from first trimester onward may 
reduce risks of fetal growth restriction.
The role of paternal smoking during pregnancy on child health outcomes remains unclear.23,40,41 Paternal 
smoking has been associated with reduced semen quality and fertility and higher risks of spontaneous 
abortion, birth defects, and, in the long-term, attention-deficit/hyperactivity disorder and several 
cancers.42-45 A recent meta-analysis showed that paternal smoking was associated with increased risks 
of preterm birth and SGA.44 In a previous Dutch study, paternal smoking during pregnancy among 
nonsmoking mothers was associated with higher childhood BMI.12 A small study from the US using 
self-reported smoking and serum cotinine measurements found a higher BMI at 2 and 3 years of age 
in children whose mothers were exposed to passive smoking during pregnancy.40 In the current study, 
paternal smoking among nonsmoking mothers was associated with a higher risk of childhood overweight 
and tended to be associated with higher risks of preterm birth and SGA. This suggests that paternal 
smoking may be, independently of maternal smoking, associated with childhood overweight. However, 
we cannot exclude the possibility of residual confounding by factors not or insufficiently measured 
in the studies. Previous studies used comparisons of maternal and paternal smoking associations to 
explore potential mechanisms.12,46 In the current study, if only one parent smoked, the risks of SGA 
were much higher among maternal smokers than among paternal smokers, whereas the risks of 
preterm birth for maternal and paternal smoking were similar. The similar associations of maternal 
and paternal smoking and preterm birth may suggest that the underlying mechanisms include shared 
family-based characteristics, such as environmental exposures and lifestyle. The stronger associations 
of maternal smoking, compared with paternal smoking, with SGA may suggest that these associations 
are mainly explained by intrauterine mechanisms. Since paternal smoking among nonsmoking 
mothers was not associated with SGA, the risk increase when both parents smoked may represent an 
additional mechanistic pathway through shared family-based characteristics. The risk of overweight 
was slightly higher among children whose mothers smoked than whose fathers smoked. However, the 
risks increased significantly if both parents smoked. These findings suggest that, although intrauterine 
programming mechanisms might play a role, shared family-based lifestyle and genetic characteristics 
are potential underlying mechanisms. Whether these findings also reflect transgenerational epigenetic 
inheritance through the gametes needs to be further studied.
Various components of tobacco smoke might be involved in the mechanistic pathway toward adverse 
birth outcomes and childhood overweight. Both nicotine and carbon monoxide are reported to reduce 
placental blood flow.47 Nicotine stimulates acetylcholine receptors, which release a multitude of 
vasoactive catecholamines and peptides, which in turn reduce blood flow through vasoconstriction.47 
Carbon monoxide competes with oxygen for binding sites on the transport protein hemoglobin, causing 
hypoxia.48 Chronic hypoxia interferes with the maternal circulatory adjustments to pregnancy which 
can be another cause of reduced placental blood flow.49 Uterine blood flow is essential for uterine, 
placental, and fetal growth. Several mechanisms for nicotine-induced alterations in overweight risks 
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have been proposed, including stimulation of the fetal hypothalamic-pituitary axis.50 It has been 
suggested that cadmium, present in tobacco smoke, modulates oxytocin receptor function, proposing 
a role in the pathophysiology of preterm birth.48 Recent studies have found an association between 
maternal smoking during pregnancy and birth weight with a mediating role of DNA methylation.51-53 
Further research is needed to assess such possible mechanisms. During the last few years, e-cigarettes 
have been widely used as substitutes for smoking. Evidence from recently started cohorts is needed to 
clarify whether e-cigarettes are any safer during pregnancy. 
We performed an individual participant data meta-analysis of prospective cohort studies to investigate 
the associations of parental smoking during pregnancy with preterm birth, SGA, and childhood 
overweight. We included data from cohort studies in Europe and North America, so our findings are 
mainly applicable to populations in developed countries. Inclusion of data from other regions could 
have led to differences in prevalence of maternal and paternal smoking, birth complications, childhood 
overweight, and ethnic and sociodemographic characteristics, complicating or limiting the possibility 
of doing a meta-analysis. Among study limitations, our outcomes might not be generalizable to 
populations from low-income and middle-income countries, which need to be further studied. The 
large sample size enabled us to investigate the effects of changing smoking habits and paternal smoking. 
However, our study might have been underpowered to detect associations in the analyses looking at 
maternal-only first trimester smoking and the change in smoking habits from first to third trimester, 
due to small sample sizes. Since we used original, individual participant data, we did not formally assess 
the quality of the individual studies included. We are aware that our study cannot overcome potential 
limitations of individual studies in terms of their design and conduct, differences in the definitions 
of exposure and outcome data, and variation in missing data. Parental smoking information during 
pregnancy was self-reported. For active smoking, correlations between cotinine measurements and 
self-reported smoking habits are high.54 We have no information on the specific question asked or the 
timing in which it was asked, which might have differed across cohorts and influenced our results. It 
has been suggested that using maternal nonsmokers as a reference group without considering the 
impact of passive smoke exposure may contribute to an underestimation of the estimated effects.40 
To limit this misclassification, all analyses on maternal smoking were adjusted for paternal smoking. 
Although smoking in the preconception period has been reported not to be associated with fetal growth 
restriction, studies considering its effect on childhood overweight are lacking.17 In the current study, 
information on smoking in the preconception period was missing. Further research is needed to assess 
the associations of smoking in the preconception period with offspring outcomes. It has been suggested 
that exposure to smoking during childhood amplifies the association between prenatal smoke exposure 
and childhood BMI outcomes.55 Many women resume smoking shortly after birth. Six weeks after birth, 
approximately 25% of women resumed smoking, and 1 year after birth these numbers are up to 80%.56 
In our study, information on exposure to smoking during childhood was not available for most cohorts. 
Further research is needed to assess whether childhood BMI outcomes are additionally influenced 
by exposure to smoking during childhood. Overall, we observed low to moderate heterogeneity in 
the 2-stage random-effects models, which might be due to the inclusion of mostly high-income and 
Caucasian cohorts. However, we observed high heterogeneity between the cohorts for the associations 
of maternal continued smoking with SGA. This might be in part explained by differences in pattern and 
dosage of maternal and paternal smoking between cohorts. When we restricted the 2-stage continued 
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smoking models to the cohorts that also had information on first-trimester-only smoking, we observed 
a substantially lower heterogeneity between estimates. Missing values of covariates were used as an 
additional group. This approach has been commonly used in large meta-analyses of individual participant 
data because of the constraints in applying more advanced imputation strategies. Although we cannot 
disregard the possibility of bias, we consider it unlikely considering the relatively small percentage of 
missing data.57 We observed similar results when we conducted a complete case analysis (S7 Table). 
Also, similar associations were observed when adjusting for maternal age and BMI as categorical or 
continuous covariates (S7 and S8 Tables). Although we adjusted for multiple lifestyle-related factors, we 
cannot exclude residual confounding by other environmental lifestyle-related factors. From the current 
observational data, no conclusions can be drawn on the causality of the observed associations.
Our results suggest that as compared to mothers who continued smoking throughout pregnancy, 
mothers who quit smoking during the first trimester have a reduced risk of birth complications. Reducing 
the number of cigarettes without quitting during pregnancy is still associated with an increased risk of 
birth complications. The observed risk estimates were small to moderate but are important from a public 
health perspective, since smoking is a common adverse exposure and preterm birth and SGA are among 
the most frequent birth complications. Also, preterm birth, SGA, and childhood obesity are related with 
adverse health consequences later in life. Our findings suggest that it is of great importance to invest 
in prevention of smoking in women of reproductive age before or at the start of pregnancy. Pregnant 
women should still be motivated to reduce smoking, even later in pregnancy. The current guidelines 
focus only on quitting smoking and not reducing, which can be discouraging for women who find it 
difficult to quit smoking. These women should be provided with sufficient information about the risks of 
continued smoking but also about the benefits of reducing their number of cigarettes. Future research 
should investigate whether quitting smoking in the first trimester or reducing the number of cigarettes 
during pregnancy is also beneficial for other adverse birth and offspring outcomes. Although we cannot 
exclude a role of residual confounding and shared family-based characteristics in the associations of 
paternal smoking with childhood overweight, we recommend that fathers are more closely involved in 
preconception and pregnancy consultations focused on smoking reduction. 
Our results suggest that maternal smoking during the first trimester only is not associated with the 
risks of SGA and preterm birth but is associated with a higher risk of childhood overweight. Reducing 
the number of cigarettes during pregnancy without quitting may be beneficial for the risk of SGA but 
does not influence the risks of preterm birth and childhood overweight. Paternal smoking seems to 
be associated, independently of maternal smoking, with the risks of childhood overweight. Population 
strategies should focus on parental smoking prevention before or at the start of, rather than during, 
pregnancy. 




1. Samet JM, Yoon SY. Women and the tabacco epidemic: challenges for the 21st century: WHO, Institute for 
Global Tabacco Control, Johns Hopkins School of Public Health; 2011.
2. Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy 
in the general population: a systematic review and meta-analysis. Lancet Glob Health. 2018;6(7):e769-e76.
3. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, 
and pregnancy outcomes. Nicotine Tob Res. 2004;6 Suppl 2:S125-40.
4. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review 
based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17(5):589-604.
5. Marufu TC, Ahankari A, Coleman T, Lewis S. Maternal smoking and the risk of still birth: systematic review and 
meta-analysis. BMC Public Health. 2015;15:239.
6. Zhang K, Wang X. Maternal smoking and increased risk of sudden infant death syndrome: a meta-analysis. 
Leg Med (Tokyo). 2013;15(3):115-21.
7. Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association 
between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol. 2000;182(2):465-72.
8. Raisanen S, Sankilampi U, Gissler M, Kramer MR, Hakulinen-Viitanen T, Saari J, et al. Smoking cessation in the 
first trimester reduces most obstetric risks, but not the risks of major congenital anomalies and admission to 
neonatal care: a population-based cohort study of 1,164,953 singleton pregnancies in Finland. J Epidemiol 
Community Health. 2014;68(2):159-64.
9. Moore E, Blatt K, Chen A, Van Hook J, DeFranco EA. Relationship of trimester-specific smoking patterns and 
risk of preterm birth. Am J Obstet Gynecol. 2016.
10. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World 
Health Organ. 1987;65(5):663-737.
11. Rayfield S, Plugge E. Systematic review and meta-analysis of the association between maternal smoking in 
pregnancy and childhood overweight and obesity. J Epidemiol Community Health. 2016.
12. Durmus B, Heppe DH, Taal HR, Manniesing R, Raat H, Hofman A, et al. Parental smoking during pregnancy 
and total and abdominal fat distribution in school-age children: the Generation R Study. Int J Obes (Lond). 
2014;38(7):966-72.
13. Albers L, Sobotzki C, Kuss O, Ajslev T, Batista RF, Bettiol H, et al. Maternal smoking during pregnancy and 
offspring overweight: is there a dose-response relationship? An individual patient data meta-analysis. Int J 
Obes (Lond). 2018;42(7):1249-64.
14. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 
2008;371(9608):261-9.
15. Daniels SR, Jacobson MS, McCrindle BW, Eckel RH, Sanner BM. American Heart Association Childhood Obesity 
Research Summit Report. Circulation. 2009;119(15):e489-517.
16. Ludvigsson JF, Lu D, Hammarstrom L, Cnattingius S, Fang F. Small for gestational age and risk of childhood 
mortality: A Swedish population study. PLoS Med. 2018;15(12):e1002717.
17. Blatt K, Moore E, Chen A, Van Hook J, DeFranco EA. Association of reported trimester-specific smoking 
cessation with fetal growth restriction. Obstet Gynecol. 2015;125(6):1452-9.
18. Jaddoe VW, Troe EJ, Hofman A, Mackenbach JP, Moll HA, Steegers EA, et al. Active and passive maternal 
smoking during pregnancy and the risks of low birthweight and preterm birth: the Generation R Study. 
Paediatr Perinat Epidemiol. 2008;22(2):162-71.
19. McCowan LM, Dekker GA, Chan E, Stewart A, Chappell LC, Hunter M, et al. Spontaneous preterm birth and 




20. Harris HR, Willett WC, Michels KB. Parental smoking during pregnancy and risk of overweight and obesity in 
the daughter. Int J Obes (Lond). 2013;37(10):1356-63.
21. Grzeskowiak LE, Hodyl NA, Stark MJ, Morrison JL, Clifton VL. Association of early and late maternal smoking 
during pregnancy with offspring body mass index at 4 to 5 years of age. J Dev Orig Health Dis. 2015;6(6):485-
92.
22. Durmus B, Kruithof CJ, Gillman MH, Willemsen SP, Hofman A, Raat H, et al. Parental smoking during 
pregnancy, early growth, and risk of obesity in preschool children: the Generation R Study. Am J Clin Nutr. 
2011;94(1):164-71.
23. Inoue S, Naruse H, Yorifuji T, Kato T, Murakoshi T, Doi H, et al. Impact of maternal and paternal smoking on 
birth outcomes. J Public Health (Oxf). 2016.
24. LifeCycle Project-Maternal O, Childhood Outcomes Study G, Voerman E, Santos S, Inskip H, Amiano 
P, et al. Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes. JAMA. 
2019;321(17):1702-15.
25. Voerman E, Santos S, Patro Golab B, Amiano P, Ballester F, Barros H, et al. Maternal body mass index, 
gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant 
data meta-analysis. PLoS Med. 2019;16(2):e1002744.
26. Santos S, Voerman E, Amiano P, Barros H, Beilin LJ, Bergstrom A, et al. Impact of maternal body mass index 
and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of 
European, North American and Australian cohorts. BJOG. 2019;126(8):984-95.
27. Santos S, Eekhout I, Voerman E, Gaillard R, Barros H, Charles MA, et al. Gestational weight gain charts 
for different body mass index groups for women in Europe, North America, and Oceania. BMC Med. 
2018;16(1):201.
28. Patro Golab B, Santos S, Voerman E, Lawlor DA, Jaddoe VWV, Gaillard R, et al. Influence of maternal obesity 
on the association between common pregnancy complications and risk of childhood obesity: an individual 
participant data meta-analysis. Lancet Child Adolesc Health. 2018;2(11):812-21.
29. Tucker J, McGuire W. Epidemiology of preterm birth. BMJ. 2004;329(7467):675-8.
30. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish reference 
standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta 
Paediatr Scand. 1991;90(8-9):756-62.
31. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, 
weight and age. Acta Paediatr Suppl. 2006;450:76-85.
32. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference 
for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660-7.
33. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD. Individual participant data meta-analysis for a 
binary outcome: one-stage or two-stage? PLoS One. 2013;8(4):e60650.
34. Paternoster R, Brame R, Mazerolle P, Piquero A. Using the correct statistical test for equality of regression 
coefficients Criminology. 1998;36(4):859-66.
35. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 
2003;327(7414):557-60.
36. Thorlund K, Imberger G, Johnston BC, Walsh M, Awad T, Thabane L, et al. Evolution of heterogeneity (I2) 
estimates and their 95% confidence intervals in large meta-analyses. PLoS One. 2012;7(7):e39471.
37. Yan J, Groothuis PA. Timing of prenatal smoking cessation or reduction and infant birth weight: evidence from 
the United Kingdom Millennium Cohort Study. Matern Child Health J. 2015;19(3):447-58.
38. Brand JS, Gaillard R, West J, McEachan RRC, Wright J, Voerman E, et al. Associations of maternal quitting, 
reducing, and continuing smoking during pregnancy with longitudinal fetal growth: Findings from Mendelian 
randomization and parental negative control studies. PLoS Med. 2019;16(11):e1002972.
Parental smoking and birth and offspring outcomes
259 
3.1
39. Jaddoe VW, de Jonge LL, van Dam RM, Willett WC, Harris H, Stampfer MJ, et al. Fetal exposure to parental 
smoking and the risk of type 2 diabetes in adult women. Diabetes Care. 2014;37(11):2966-73.
40. Braun JM, Daniels JL, Poole C, Olshan AF, Hornung R, Bernert JT, et al. Prenatal environmental tobacco smoke 
exposure and early childhood body mass index. Paediatr Perinat Epidemiol. 2010;24(6):524-34.
41. Qiu J, He X, Cui H, Zhang C, Zhang H, Dang Y, et al. Passive smoking and preterm birth in urban China. Am J 
Epidemiol. 2014;180(1):94-102.
42. Borges E, Jr., Braga D, Provenza RR, Figueira RCS, Iaconelli A, Jr., Setti AS. Paternal lifestyle factors in relation to 
semen quality and in vitro reproductive outcomes. Andrologia. 2018:e13090.
43. Wang L, Yang Y, Liu F, Yang A, Xu Q, Wang Q, et al. Paternal smoking and spontaneous abortion: a population-
based retrospective cohort study among non-smoking women aged 20-49 years in rural China. J Epidemiol 
Community Health. 2018;72(9):783-9.
44. Oldereid NB, Wennerholm UB, Pinborg A, Loft A, Laivuori H, Petzold M, et al. The effect of paternal factors 
on perinatal and paediatric outcomes: a systematic review and meta-analysis. Hum Reprod Update. 
2018;24(3):320-89.
45. Zhu JL, Olsen J, Liew Z, Li J, Niclasen J, Obel C. Parental smoking during pregnancy and ADHD in children: the 
Danish national birth cohort. Pediatrics. 2014;134(2):e382-8.
46. Brion MJ, Leary SD, Smith GD, Ness AR. Similar associations of parental prenatal smoking suggest child blood 
pressure is not influenced by intrauterine effects. Hypertension. 2007;49(6):1422-8.
47. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20(2):115-
26.
48. Ion R, Bernal AL. Smoking and Preterm Birth. Reprod Sci. 2015;22(8):918-26.
49. Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt 
Med Biol. 2003;4(2):141-56.
50. Koshy G, Delpisheh A, Brabin BJ. Dose response association of pregnancy cigarette smoke exposure, 
childhood stature, overweight and obesity. Eur J Public Health. 2011;21(3):286-91.
51. Richmond RC, Simpkin AJ, Woodward G, Gaunt TR, Lyttleton O, McArdle WL, et al. Prenatal exposure to 
maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal 
Study of Parents and Children (ALSPAC). Hum Mol Genet. 2015;24(8):2201-17.
52. Kupers LK, Xu X, Jankipersadsing SA, Vaez A, la Bastide-van Gemert S, Scholtens S, et al. DNA methylation 
mediates the effect of maternal smoking during pregnancy on birthweight of the offspring. Int J Epidemiol. 
2015;44(4):1224-37.
53. Morales E, Vilahur N, Salas LA, Motta V, Fernandez MF, Murcia M, et al. Genome-wide DNA methylation study 
in human placenta identifies novel loci associated with maternal smoking during pregnancy. Int J Epidemiol. 
2016;45(5):1644-55.
54. Mattsson K, Kallen K, Rignell-Hydbom A, Lindh CH, Jonsson BA, Gustafsson P, et al. Cotinine Validation of Self-
Reported Smoking During Pregnancy in the Swedish Medical Birth Register. Nicotine Tob Res. 2016;18(1):79-
83.
55. Moller SE, Ajslev TA, Andersen CS, Dalgard C, Sorensen TI. Risk of childhood overweight after exposure to 
tobacco smoking in prenatal and early postnatal life. PLoS One. 2014;9(10):e109184.
56. Feeney A, Britton G. Counseling Women on Smoking Relapse Prevention During Postpartum. MCN Am J 
Matern Child Nurs. 2016;41(5):287-92.
57. Groenwold RH, White IR, Donders AR, Carpenter JR, Altman DG, Moons KG. Missing covariate data in clinical 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































S3 Table. Cohort-specific description of maternal smoking variables
Cohort name,  
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Cohort name,  

















































































































































































Values are expressed as number of participants (valid %). NA, not available or not applicable. Maternal first trimester 
smoking refers to all maternal smoking in first trimester no matter if mothers stop or continue smoking after first trimester. 
aNumbers of smoking (no/yes) in first trimester are second trimester smoking numbers. To prevent exclusion due 
to no information on first trimester smoking, nonsmokers from second trimester were used as nonsmoking during 
pregnancy (ABCD and MoBa).         
bSubset of participants with follow-up completed at 4 years of child’s age by the time of data transfer (March 2015). 
Data on number of cigarettes/day smoked in pregnancy were not used for this manuscript.
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S4 Table. Associations of maternal smoking with gestational age at birth, birth weight, and childhood BMI
Gestational age at  
birth in weeks  
(95% Confidence Interval) 
Gestational age-adjusted 
birth weight SDS  
(95% Confidence Interval)





































































Values are beta’s (95% confidence intervals) from multilevel linear mixed effects models that reflect the differences in 
gestational age at birth in weeks, gestational age-adjusted birth weight in standard deviation scores and childhood body 
mass index in standard deviation scores per smoking group compared with the reference group (no maternal smoking). 
Number of cigarettes used as continued smoking dosage were based on third trimester information. Models are adjusted for 
maternal age, educational level, parity, pre- or early pregnancy body mass index, alcohol consumptionduring pregnancy 
and paternal smoking.      
*P-value<0.05; **P-value<0.001.       
BMI, body mass index; SDS, standard deviation score.
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S1 Figure. Maternal conti nued smoking with risks of small size for gestati onal age assessed by two-stage random-
eff ects models
Conti nued smoking vs non-smoking
Values are odds rati os (95% confi dence intervals) per cohort and pooled from binary logisti c regression models 
that refl ect the risk of small size for gestati onal age for conti nued smoking compared to non-smoking. Models are 
adjusted for maternal age, educati onal level, parity, pre- or early pregnancy body mass index, alcohol consumpti on 
during pregnancy and paternal smoking. Analysis was restricted to cohorts with informati on on fi rst trimester only 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































S6 Table. Associations of maternal and paternal smoking with gestational age at birth, birth weight, and childhood 
BMI
Gestational age 





SDS (95% Confidence 
Interval)


















































Values are beta’s (95% confidence intervals) from multilevel linear mixed effects models that reflect the differences 
in gestational age at birth in weeks, gestational age-adjusted birth weight in standard deviation scores and childhood 
BMI in standard deviation scores per smoking group compared with the reference group (no parental smoking). 
Models are adjusted for maternal age, maternal BMI, paternal BMI, maternal education, parity and 
maternal alcohol consumption during pregnancy.      
*P-value<0.05; **P-value<0.001. BMI, body mass index; SDS, standard deviation score.
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S7 Table. Complete cases analysis of maternal smoking with risks of birth complications and childhood overweight 
(with maternal age and BMI in categories)
Preterm 
birth 
Odds Ratio (95% Confi-
dence Interval) 
Small size for gestatio-
nal age at birth
Odds Ratio (95% Confi-
dence Interval)
Childhood overweight 
























Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed effects models that reflect 
the risk of preterm birth, small size for gestational age and childhood overweight per smoking group compared 
with the reference group (no maternal smoking).        
Preterm birth is defined as birth before the gestational age of 37 weeks. Small size for gestational age is defined as 
the lowest 10% of sex and gestational age adjusted birth weight standard deviation score per cohort. Childhood 
overweight is overweight and obesity together according to the World Health Organization criteria. Models are 
adjusted for maternal age, educational level, parity, pre- or early pregnancy BMI, alcohol consumption during 
pregnancy and paternal smoking, all categorized. *P-value<0.05; **P-value<0.001. BMI, body mass index.
S8 Table. Complete cases analysis of maternal smoking with risks of birth complications and childhood overweight 
(with maternal age and BMI continuously)
Preterm 
birth 
Odds Ratio (95% Confi-
dence Interval) 
Small size for gestatio-
nal age at birth
Odds Ratio (95% Confi-
dence Interval)
Childhood overweight 
























Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed effects models that 
reflect the risk of preterm birth, small size for gestational age and childhood overweight per smoking group 
compared with the reference group (no maternal smoking).      
Preterm birth is defined as birth before the gestational age of 37 weeks. Small size for gestational age is defined as 
the lowest 10% of sex and gestational age adjusted birth weight standard deviation score per cohort. Childhood 
overweight is overweight and obesity together according to the World Health Organization criteria. Models are 
adjusted for maternal age, educational level, parity, pre- or early pregnancy BMI, alcohol consumption during 
pregnancy and paternal smoking. Except for maternal age and pre- or early pregnancy BMI, all covariates were 












Environmental exposures, including environmental pollutants and adverse lifestyle behavior, have a 
significant contribution to the etiology of chronic non-communicable diseases leading to morbidity 
and mortality worldwide.1 Among those, endocrine disrupting chemicals (EDCs) such as bisphenols 
and phthalates are of increasing interest. In the last decade, an increasing body of evidence suggests 
that exposure to bisphenols and phthalates may contribute to the development of cardiometabolic 
diseases.2,3 Growing concern over human exposure has led to several governmental embargoes 
concerning bisphenol A and several phthalates, concurrently stimulating the industries to switch to 
synthetic bisphenol analogues and phthalate replacements.4 Information on adverse effects from 
synthetic bisphenol analogues and phthalate replacements is still limited. Following the developmental 
origins of health and disease (DOHaD) hypothesis, the bulk of studies investigated effects of prenatal 
exposure on fetal programming. However, exposure effects of bisphenols and phthalates in adults have 
been scarcely examined. A growing body of evidence indicates that for women pregnancy is a period 
of increased susceptibility to potential short and long-term physiological changes due to exposure to 
bisphenols and phthalates, some with persistent effects.5  Therefore, studies in this thesis were focused 
on associations of bisphenols and phthalate exposure during pregnancy with maternal pregnancy and 
postpartum outcomes. 
Although smoking prevalence is generally declining, globally smoking is still in the top five of attributable 
disease-adjusted life-years (DALYs).6 In the last few decades, smoking prevalence is increasing among 
women. One in five women of reproductive age is expected to be smoking by 2025.7 Effects of maternal 
smoking during pregnancy on birth outcomes have been examined in a large number of studies, 
showing strong associations tending to causal pathways.8-12 Also, maternal smoking has been associated 
with childhood overweight.13-15 However, the specific windows of vulnerability during pregnancy and 
the role of paternal tobacco usage are not yet clear. Further insight into these windows of vulnerability 
to parental smoking during pregnancy are needed to develop adequate preventive strategies. 
The general aim of this thesis was to investigate the associations of well-known adverse exposures, 
namely endocrine disruptors and parental smoking during pregnancy with maternal, fetal and childhood 
outcomes. The main findings have been presented and discussed in the previous chapters of this thesis. 
This chapter will provide a general discussion of main findings of the studies in this thesis, consider the 
general methodological issues, and give suggestions for future research and implications for clinical 
practice and policy.
Interpretation of main findings
The paragraphs below give an interpretation of the main findings. Figure 1 presents the most important 









































Exposure to bisphenols and phthalates during pregnancy
Effects of early exposure on cardiometabolic outcomes in pregnancy and childhood, a 
narrative review
Exposure to bisphenols and phthalates is believed to induce pathways towards several adverse 
health effects. In this narrative review (Chapter 1.2), we outlined the available evidence on bisphenol 
and phthalate routes of exposure, metabolism and mechanisms of action. Further, we summarized 
associations of exposure to bisphenols and phthalates during pregnancy with effects on maternal, 
fetal and childhood cardiometabolic outcomes. Little is known about maternal health outcomes during 
pregnancy. Exposure during fetal life may have a substantial influence on perinatal and postnatal 
cardiometabolic programming, although evidence concerning the majority of investigated outcomes 
shows contradictory results. However, the majority of the existing human evidence is limited by 
methodological difficulties that complicate interpretation. Most studies determined exposure in only 
one single sample, not giving a reliable estimate of tissue exposure due to short biological half-lives and 
within person-variability leading to attenuation bias in dose-response relationships. Variations in the 
timing of exposure measurement further complicate conclusions regarding causal inference. 
Conclusions on effects of early exposure to bisphenols and phthalates and cardiometabolic 
outcomes
• Exposure to bisphenols and phthalates during pregnancy may affect maternal health and 
offspring perinatal and postnatal cardiometabolic programming
• The majority of existing human evidence is limited by methodological difficulties that complicate 
interpretation
Determinants of bisphenol and phthalate concentrations 
Bisphenols and phthalate metabolites have been observed in various Western studies, including a 
significant number of studies among pregnant women.16-20 During the last decade, several changes have 
been observed in exposure levels, mainly due to several governmental embargoes and subsequent use 
of replacements.21-23 The study as presented in this thesis  (Chapter 2.1) is the only human biomonitoring 
study before 2010 reporting on bisphenol S and bisphenol F. 
Diet is considered the most important source of phthalate exposure and, to a lesser extent, of 
bisphenols, predominantly through food packaging.24-28 Previous observational studies reported several 
associations, including of higher bisphenol A concentrations among women with higher canned food 
consumption and of higher DEHP metabolite concentrations among women with frequent consumption 
of meat, poultry and fish.16,29-31 A recent review reported that lower concentrations of bisphenol A and 
phthalates were associated with healthy food choices.32 In the study presented in this thesis, we did 
not observe any association of nutrition related factors, including daily dietary caloric intake and food 
groups, with bisphenol and phthalate metabolite urine concentrations. However, we did detect some 
trends towards lower compound concentrations among healthy food consumption patterns. In our 
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study, we have used a food frequency questionnaire capturing the average intake in the past three 
months. Dietary sources of phthalate exposure are known to be more variable than other phthalate 
sources.33 Given the short biological half-lives of bisphenols and phthalates, this might have resulted in 
undetectable exposure-response associations. 
Overall, previous studies identified younger maternal age, lower socio-economic status and unhealthy 
behavior such as overweight and smoking as determinants of higher bisphenol and phthalate 
concentrations during pregnancy.16,34-37 Also among postmenopausal women such a pattern was 
observed.38 Some studies, however, observed differences for LMW and HMW phthalate metabolites, 
with unhealthy behavior patterns as determinants for higher levels of LMW phthalate metabolites 
and healthy behavior patterns as determinants for higher levels of HMW phthalate metabolites.30,39 
We observed that women with adverse lifestyle related factors, such as obesity and lack of folic acid 
supplement use, had higher first trimester bisphenol and phthalate metabolite urine concentrations. In 
line with previous studies, a trend was observed for multiparity, low educational level, non-European 
descent, and smoking with higher bisphenol and phthalate metabolite concentrations. Again, previous 
studies did not apply multiple testing corrections and may consequently have reported associations 
that we interpreted as trends. Similar to our results, a few studies also observed higher concentrations 
of bisphenol A and phthalate metabolites among non-European  women.35,40 Several association studies 
have identified ethnicity-specific associations of bisphenols and phthalates with childhood BMI and 
diabetes risks.41-43 Although these associations might indicate variations in bisphenol and phthalate 
metabolism, we cannot rule out that this is a result from residual confounding by unmeasured lifestyle 
related factors. 
The observed associations of bisphenols and phthalates with smoking might reflect lifestyle related 
factors, but may also be a direct effect from smoking as bisphenol A and phthalates are used in some 
cigarette filters.44 While previous studies showed inconsistent associations between higher maternal 
BMI and levels of HMW phthalate metabolite concentrations, we observed strong associations between 
pre-pregnancy BMI in the obesity range and higher HMW phthalate metabolite concentrations.30,34,37,39,45 
Obesogenic effects of phthalate exposure might have induced a higher pre-pregnancy BMI. Phthalates, 
and bisphenols to some extent, are lipophilic chemicals and might therefore accumulate in adipose 
tissue.46 However, we cannot rule out that obese women are more exposed to HMW phthalates or that 
this is a result from residual confounding by unmeasured lifestyle or nutrition related factors. Further 
investigation of the toxicokinetics of these chemicals is needed to unravel these associations. 
To date, the study presented in this thesis is the only study investigating maternal folic acid supplement 
use as a determinant of bisphenol and phthalate metabolite concentrations. Several studies, including 
one of our own (Chapter 2.2) identified insufficient folic acid supplement use as an effect modifier in 
several associations of bisphenols and phthalates.47,48 Although epigenetic effects of bisphenols and 
phthalates are not yet clear, methyl donors have been proposed as a potential point of engagement 
to prevent potential epigenetic effects.49 It is most likely that the observed association between a lack 
of folic acid supplement use and higher DNOP metabolite concentrations reflects unmeasured lifestyle 
related factors., but a lack of folic acid supplement use might increase the vulnerability of these women 




A recent study comparing the contribution of dietary and non-dietary exposure found diet to be 
responsible for >99.9% of bisphenol A and 63% of DEHP exposure.28 For phthalates, several studies 
found associations with the use of personal care products, household products and materials used for 
flooring and walls.34,50 Therefore, we cannot rule out that the associations of bisphenols and phthalates 
with lifestyle related factors in this study are rather a proxy for unhealthy lifestyle habits in general, 
comprising unmeasured food consumption patterns and harmful product exposure than that these 
factors actually increase exposure or urinary excretion. 
Conclusions on determinants of bisphenol and phthalate concentrations
• Bisphenol S and F exposure was highly prevalent among pregnant women as early as 2004-5.
• Nutritional determinants were not associated with first trimester bisphenol or phthalate 
metabolite urine concentrations.
• Adverse lifestyle related factors, such as obesity and lack of folic acid supplement use, seem 
to be associated with higher phthalate metabolite urine concentrations in pregnant women. 
Time to pregnancy
Previous studies did not observe associations of bisphenols with time to pregnancy.51-53 For phthalates, 
results have been inconsistent, both among prospective cohorts and pregnancy studies using recalled 
time to pregnancy.51-55 A recent study among women undergoing infertility treatment reported that high 
urinary bisphenol A concentrations were associated with lower probabilities of implantation, clinical 
pregnancy, and live birth, among women who consumed <400 μg/day of dietary folate.56 In line with 
this study, we observed (Chapter 2.2) reduced fecundability ratios for those without preconception 
folic acid supplementation supporting our hypothesis that bisphenols and phthalates may influence 
fecundability by inducing changes in DNA methylation. We did not observe associations of first trimester 
urinary bisphenol and phthalate metabolite concentrations with fecundability in unstratified models. 
Null findings in previous studies might be explained by dismissed diet interactions. DNA methylation has 
been identified as a potential mechanism in the association of persistent organic pollutants and reduced 
fecundability by global DNA methylation in sperm and methylation of the implantation-associated gene 
Homeobox A10 (HOXA10).57,58 However, the role of preconception folic acid supplementation has not 
been examined in this association. 
Cross-sectional studies are at risk for reversed causation. Women who experience difficulties 
conceiving are more likely to obey preconceptional recommendations, including the use of folic acid 
supplementation. Therefore, the observed interaction with folic acid supplementation use negates 
potential reversed causation induced by preconceptional behavioral changes in women taking longer to 
conceive. We cannot rule out that the reduced fecundability ratios for women without preconceptional 
folic acid supplementation use reflect unmeasured lifestyle related factors. Maternal pre-pregnancy 
BMI was not selected as a confounder in this association for the fitted models, even though a higher 
maternal pre-pregnancy BMI is generally associated with a longer time to pregnancy and women in the 
obesity range tend to have higher chemical concentrations (Chapter 2.1). However, obesity has been 
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reported to affect short-term folate pharmacokinetics leading to higher folate requirements.59 The use 
of reported folic acid supplementation use instead of maternal folate concentrations might therefore 
have led to an underestimation of the observed effects. Thus, results from this thesis showed that 
preconceptional folic acid supplementation may counteract effects from bisphenols and phthalates on 
fecundability. This finding is hypothesis generating for methods of action of bisphenols and phthalates 
and should be tested in other potential associations.  
Conclusions on time to pregnancy
• Higher concentrations of bisphenols and phthalates were associated with a longer time to 
pregnancy among mothers who did not use preconception folic acid supplementation.
Maternal hemodynamics and gestational hypertensive disorders 
Gestational hypertension and preeclampsia are hypothesized to originate in early pregnancy.60 
Bisphenols and phthalates may induce early placental maladaptation, subsequently leading to 
increased risks of gestational hypertensive disorders and higher blood pressure in pregnancy. Previous 
studies, however, did not show consistent associations of phthalates with gestational hypertensive 
disorders, although the larger part of studies investigating bisphenol A reported positive associations 
between bisphenol A and gestational hypertensive disorders.61-65 Several studies showed associations 
of bisphenol A and phthalate metabolite concentrations with higher blood pressure in both adults and 
children,66-69 although results among pregnant women have been inconsistent.61,70,71 Pro- and anti-
angiogenic factors are important for placental growth and angiogenesis. An imbalance in these factors 
has been associated with impaired placentation, subsequent  placental dysfunction and increased risks 
of gestational hypertensive disorders.72 Only one previous study investigated associations of bisphenols 
and phthalates with placental function markers, observing associations of urinary bisphenol A and 
DEHP metabolite concentrations with altered placental angiogenic markers.73 Indices of placental 
vascular resistance of the uterine and umbilical artery have been used to identify placental dysfunction, 
leading to adverse pregnancy outcomes such as preeclampsia and fetal growth restriction.74 Thus 
far, the role of bisphenols and phthalates in placental hemodynamics has not been investigated in 
humans. In rodents, early pregnancy bisphenol A exposure was not associated with increased placental 
resistance indices.75 To our knowledge, only one other study examined associations of bisphenols and 
phthalates with placental weight, reporting an association of monocarboxyisononylphthalate and lower 
placental weight.76 However, both small and large placentas have been associated with preeclampsia.77 
In our study (Chapter 2.3), we observed that bisphenols and phthalate metabolites in early pregnancy 
were not associated with longitudinal changes in blood pressure or increased risks of gestational 
hypertensive disorders. Early pregnancy phthalate exposure was associated with altered placental 
angiogenic markers, while bisphenol A was associated with altered placental hemodynamic function 
measures, both at a subclinical level. Dissimilar results might be explained by differences between our 
and other study populations in disease prevalence and other characteristics. 
Several potential mechanisms have been proposed to support the observed associations. Bisphenols 
and phthalates are reported to induce oxidative stress, which plays a role in the onset of preeclampsia, 




between oxidative stress and placental angiogenic factors have been reported.79,80 Bisphenol A has 
been accounted for antiproliferative and pro-apoptotic effects on human trophoblastic cells, potentially 
through estrogen-related receptor γ, proinflammatory cytokines (tumor necrosis factor α, interleukin-
1β and interleukin-6) and anti-inflammatory mediators.81-83 Phthalates have been found to inhibit 
extravillous trophoblast invasion through the peroxisome proliferator-activated receptor γ and to 
inhibit cell proliferation through aberrant progesterone secretion.84,85 Early pregnancy bisphenol A and 
phthalate exposure have been reported to induce altered methylation of placental genes changing the 
placental transcriptome, potentially leading to impaired implantation.86,87  
Conclusions on maternal hemodynamics and gestational hypertensive disorders
• Bisphenols and phthalate metabolites were not associated with longitudinal changes 
in blood pressure in pregnancy.
• Phthalates were associated with the sFlt-1/PlGF ratio and bisphenol A with placental 
hemodynamics. 
Gestational weight gain 
To our knowledge, there are no previous studies investigating associations of maternal bisphenols 
and phthalate metabolite concentrations with gestational weight gain over the course of pregnancy. A 
recent study investigating phthalate metabolites and early gestational weight gain reported a negative 
association between DEHP metabolites in early pregnancy and early gestational weight gain.88 Another 
novel study among Mexican pregnant women also observed an inverse association between phthalate 
metabolite concentrations during pregnancy and maternal weight at delivery.89 Previous cross-sectional 
studies, including our own (Chapter 2.1), reported associations of higher concentrations of BPA and 
phthalates among pregnant women with a higher BMI.30,34,36,37,39,90 A recent study on determinants of 
phenols and phthalates observed higher BPA concentrations among women with a greater gestational 
weight gain in univariate associations.91 Among other environmental exposures, persistent organic 
pollutants (POPs) have been examined for associations with gestational weight gain. Although the 
direction of effect differs by the specific POP, the majority of studies consistently identified exposure 
during early pregnancy as a window of vulnerability for associations with gestational weight gain.92-96 
In line with these findings, we observed (Chapter 2.4) associations of early pregnancy higher total 
bisphenols and bisphenol S with a lower gestational weight gain, especially among normal weight 
women. Investigation of weight gain per pregnancy period showed the strongest reduction in weight 
gain for mid-to-late pregnancy, driven by bisphenol A. Several body compartments could be responsible 
for the observed change in gestational weight gain, including maternal fat, intra- and extravascular fluid 
volumes, breast mass and intrauterine components being the fetus, placenta and amniotic fluid. As 
mentioned previously, we did not observe an association between first trimester bisphenols or phthalate 
metabolites and placental weight (Chapter 2.3). Gestational weight gain, particularly in mid- and late 
pregnancy, is associated with birth weight.97,98 However, a recent meta-analysis of eight studies did not 
observe associations between fetal bisphenol A exposure and birth weight.99 Contradicting our results, a 
very recent subsequent study among the same cohort as presented in this thesis observed associations 
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of higher maternal bisphenol S concentrations, especially in the first trimester of pregnancy, with higher 
fetal weight.100 We therefore conclude that the findings from this thesis suggest that early pregnancy 
maternal bisphenol exposure might affect gestational weight gain through changes in maternal body 
composition. 
Several mechanisms might be responsible for the associations of bisphenols and reduced gestational 
weight gain. Bisphenols are weak xenoestrogens and have been reported to increase the level of 
17β-estradiol and are also reported to promote progesterone levels. Although the evidence is limited, 
estradiol levels have not been associated with gestational weight gain and a small positive effect has 
been observed for progesterone, contradicting our results.101 Bisphenols tend to have anti-androgen 
capacities and  to decrease cortisol levels. Both maternal testosterone levels and cortisol levels have 
been associated with increased gestational weight gain, however both associations were with late 
pregnancy hormone levels and associations have not been replicated so far.102,103 Also other potential 
mechanisms, such as through oxidative stress, adipocytokines and peroxisome proliferator-activated 
receptor activation are not likely to lead to reduced gestational weight gain. Potential mechanisms 
should be further investigated in future studies. 
Conclusions on maternal weight gain
• Higher maternal total bisphenols and bisphenol S concentrations in early pregnancy were 
associated with a lower total gestational weight gain, especially among normal weight women.
Postpartum weight gain
Phthalates have been associated with increased body mass in mainly cross-sectional studies.104-108 A 
longitudinal study nested within the Nurses’ Health Study I and II identified a 170-210 g/year increased 
weight gain among those most highly exposed for BPA, PA, mBzP and mBP metabolites. For mEP and 
DEHP metabolites non-monotonic associations were observed.109 A recent study among Mexican 
pregnant women reported a slower rate of weight loss in the first year postpartum for women that 
were higher exposed to bisphenol A and several phthalates.89 The only previous study among pregnant 
women with a longer follow up duration observed an association of higher mCPP with 300 g/year 
maternal weight gain during 10 years postpartum.110 We observed (Chapter 2.5) associations of 
averaged early and mid-pregnancy phthalate exposure with increased weight gain 6 years postpartum. 
PA, LMW phthalate and DNOP metabolites were associated with increased weight gain among women 
without subsequent pregnancies, with similar annual increases as observed in the Nurses’ Health 
Study. Yet, our associations were all linear. Stratification revealed these associations to be driven by 
overweight and obese women. Women with more adipose tissue may be more vulnerable for exposure 
to these chemicals. However, we cannot exclude reversed causation by means that these women might 
make less healthy food choices leading to higher bisphenol and phthalate exposure and weight increase 
independent of exposure levels. 
Results from this thesis suggest that exposure to phthalates may have long-term effects on weight gain. 




might be a period with increased susceptibility to these compounds, the observed associations may be 
independent of pregnancy status. Obesogenic effects of bisphenols and phthalates have been linked to 
peroxisome proliferator-activated receptor γ activation.111,112 However, the phthalate metabolites that 
are reported as activators of this pathway were not associated with increased weight gain among women 
without subsequent pregnancies. Other proposed mechanisms may be by sex-steroid dysregulation, 
epigenetics or metabolomics. Further studies are needed to evaluate these potential mechanisms.  
Conclusions on postpartum weight gain
• Averaged early and mid-pregnancy phthalate exposure was associated with increased maternal 
weight gain 6 years postpartum, especially among overweight and obese women.
Parental smoking
Adverse birth outcomes and childhood overweight
Maternal smoking during pregnancy has been associated with increased risks of adverse birth 
outcomes, such as congenital abnormalities, stillbirth, sudden infant death syndrome, preterm birth 
and low birth weight, and overweight in childhood.11-13,113 Evidence on critical windows of vulnerability 
and effects of changes in maternal smoking behavior during pregnancy remain inconclusive.113-119 
Results from the individual participant meta-analysis presented in this thesis (Chapter 3.1) confirm 
associations of maternal continued smoking during pregnancy with increased risks of preterm birth, 
being small size for gestational age at birth and overweight in childhood. The risks of preterm birth 
were somewhat weaker than reported previously, possibly due to no information available about 
induced or spontaneous preterm birth.11,114,116 A recent study using additional methods of Mendelian 
randomization and parental negative control reported consistent linear dose-dependent associations 
of maternal smoking with fetal growth from early second trimester onwards.120 In line with these 
findings, we observed that maternal smoking in first trimester only was not associated with small size 
for gestational age and preterm birth. Reducing the number of cigarettes from first-to-third trimester 
lowered the risks of small size for gestational age but not preterm birth. However, risks of small size for 
gestational age among mothers with reduced smoking intake were still elevated compared to infants 
born to non-smoking mothers. These findings confirm previous reports that the majority of maternal 
smoking impact on birth weight occurs after the first trimester of pregnancy.120,121 Maternal smoking 
in first trimester only was associated with an increased risk of overweight in childhood and reducing 
maternal smoking intake did not seem beneficial. In the Nurses’ Health Study, adiposity risks at the age 
of 18 years old of daughters whose mothers smoked during the first trimester only were not increased, 
but the risk of type 2 diabetes was.122,123 Altogether, these findings suggest that maternal first trimester 
smoking might already lead to metabolic adaptations with lifelong consequences for body composition 
and metabolic health. Thus, findings from this thesis suggest that quitting smoking in the first trimester 
of pregnancy might optimize birth outcomes, but might not reduce the risk of adverse metabolic effects 
in the offspring to the level of non-smoking. For risks of fetal growth restriction it might still be beneficial 
to reduce smoking consumption from first trimester onwards. 
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In literature, passive smoking and paternal smoking are being used interchangeably, whilst being 
two different exposures. Paternal smoking is of particular interest because besides a potential direct 
intrauterine effect through maternal secondhand smoking, paternal smoking might additionally induce 
mutagenic effects. The role of paternal smoking during pregnancy on preterm birth, low birth weight 
and childhood overweight has been scarcely examined and remains unclear.119,122,124 A recent meta-
analysis reported that paternal smoking was associated with increased risks of preterm birth and small 
size for gestational age.125 In a previous Dutch study, paternal smoking during pregnancy among non-
smoking mothers was associated with a higher childhood BMI.14 We observed that paternal smoking 
among non-smoking mothers was associated with a higher risk of childhood overweight and tended 
to be associated with higher risks of preterm birth and small size for gestational age. Among mothers 
who continued smoking during pregnancy, paternal smoking further increased the risks of small size for 
gestational age and childhood overweight, but not the risk of preterm birth. These results suggest that 
paternal smoking might be associated with childhood overweight, independent of maternal smoking. 
We cannot exclude that paternal smoking also represents passive smoking of the mothers, which might 
explain the observed associations. 
Various components of tobacco smoke might be involved in the mechanistic pathways towards adverse 
birth outcomes and childhood overweight. With regards to fetal growth restriction, both nicotine and 
carbon monoxide are reported to reduce placental blood flow, respectively through vasoconstriction 
and hypoxia.126-128 In the last few years, several studies found a mediating role of DNA methylation in the 
association between maternal smoking and birth weight.129,130 Several mechanisms for nicotine-induced 
alterations in overweight risks have been proposed, including stimulation of the fetal hypothalamic-
pituitary axis.131 Previous studies used comparisons of maternal and paternal smoking associations to 
explore potential mechanisms.14,132 The study as presented in this thesis observed higher risks of small 
size for gestational age among maternal smokers than among paternal smokers, while risks of preterm 
birth for maternal and paternal smoking were similar. The similarity of associations of maternal and 
paternal smoking with preterm birth may indicate that underlying mechanisms must be seen in the 
light of shared family-based characteristics, such as environmental exposures and lifestyle, rather than 
the actual smoking exposure. However, we cannot exclude that smoking does affect risks of preterm 
birth. Stronger maternal than paternal associations for small size for gestational age may suggest an 
intrauterine effect. However, the risk increase when both parents smoked may represent an additional 
mechanistic pathway through shared family-based characteristics, since paternal smoking among non-
smoking mothers was not associated with small size for gestational age. Comparison of maternal and 
paternal smoking effect estimates for childhood overweight showed a slightly higher risk for children 
whose mother smoked. However, risks increased significantly if both parents smoked. These findings 
suggest that, although intrauterine programming mechanisms play a role, we cannot exclude the role 
of transgenerational epigenetic inheritance, shared family-based lifestyle and genetic characteristics as 




Conclusions on parental smoking and adverse birth outcomes and childhood overweight
• Maternal first trimester only smoking was not associated with adverse birth outcomes but was 
associated with a higher risk of childhood overweight. 
• Children from mothers who continued smoking during pregnancy had higher risks of preterm 
birth, small size for gestational age babies and childhood overweight. 
• Women who reduced the number of cigarettes after first trimester still had an increased but 
lower risk of small size for gestational age babies. 
• Among non-smoking mothers, paternal smoking was associated with childhood overweight, 
but not with adverse birth outcomes. 
Methodological considerations
Strengths and limitations for each study individually are described in Chapters 2 and 3 of this thesis. In 
the following paragraphs, general methodological considerations regarding selection bias, information 
bias, confounding and causality are discussed.
Selection bias
Selection bias may arise from the procedure used to select study participants or factors that influence 
the study participation, leading to a difference in the relation between exposure and outcome for 
those who participate and those that were eligible but were not included. Selection bias within the 
Generation R study may have occurred either from selective non-response at baseline or from selective 
loss to follow up. Of all children eligible at birth, 61%  participated at baseline. This non-response is not 
likely to be random. Participating women were less often from ethnic minorities and had a higher socio-
economic status than would have been expected from population numbers in the study population. 
Furthermore, participating women had less medical complications during pregnancy and unfavorable 
pregnancy outcomes, such as gestational hypertensive disorders or low birth weight, suggesting a more 
healthy study population.133 Selection bias may also arise from selective loss to follow up. Participation 
rate at the child age of 6 years old was 85% of the original cohort, of whom 80% visited the research 
center.134 Bisphenol and phthalate metabolite concentrations were measured in a subgroup of women 
comprising 16% of the total study sample who were included in early pregnancy and whose children 
participated in postnatal studies. This subgroup included singleton pregnancies only. Maternal 
characteristics were similarly distributed between participants and non-participants that would have 
been eligible for inclusion. However, mothers that did not participate in the follow up measurements 
at the child age of 6 years old had a lower educational level and more unhealthy lifestyle habits than 
the women who did participate in follow up studies. This selection in the Generation R Study and more 
profoundly in our subgroup towards a more affluent and healthy study population could lead to biased 
estimates if determinants of participation are related to both exposure and outcome measures. Several 
studies showed that in cohort studies the influence of non-response at baseline on effect estimates 
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was limited and that additional adjustment for covariates associated with loss to follow up decreases 
selection bias.135 Therefore, we do not assume that this non-response has influenced our results. 
However, this selection towards a healthier population will probably lower the prevalence rates of the 
outcomes of interest and thereby reduce statistical power and the generalizability of our results.
Information bias
Information bias may arise from measurement error of a determinant or outcome and is also referred 
to as misclassification. Two types of information bias can occur: differential and non-differential 
misclassification. Differential misclassification may occur when the probability of the determinant being 
misclassified is non-random and dependent on the outcome, and vice versa. As a result, this can lead 
to underestimation or overestimation of the results. Non-differential misclassification is a random error 
and unrelated to other study variables, leading to a bias towards the null value. 
Information on the determinants and outcomes in the studies described in this thesis were obtained 
prospectively by physical and ultrasound examinations, blood and urine analyses and parental 
questionnaires. In environmental exposure research, an important concern is correct assessment of 
the exposure. For this thesis, we have used urinary bisphenols and phthalate metabolites to estimate 
tissue exposure. Urinary bisphenols and phthalate metabolites were analyzed independent of outcome 
measures. Therefore, differential misclassification of bisphenol and phthalate exposure seems unlikely. 
However, several issues concerning potential non-differential misclassification should be addressed. 
Urinary samples have been stored at -20°C for approximately 10 years. It has been suggested that -80°C 
would be a more optimal storage temperature,136 however there are no studies investigating differences 
between these specific temperatures and effects of long-term storage. Therefore, we cannot exclude that 
there has been some biological activity during the storage period leading to potential non-differential 
misclassification and underestimation of the effects. The analytical techniques allowed for detection of 
both unconjugated (free) compounds as well as glucuronidated and sulfated bisphenol and phthalate 
conjugates. As diet is the primary source of bisphenol and phthalate exposure, ingestion will be followed 
by a first-pass metabolism.28 For phthalates, and for bisphenols to a lesser extent, a substantial fraction 
of exposure is through non-dietary sources such as transdermal exposure to personal care products and 
thermal paper or inhalation of indoor dust. Following exposure through other routes than ingestion, the 
first-pass effect is initially bypassed, provoking higher bioavailability and tissue exposure. Measurement 
of urinary metabolites might therefore underestimate tissue exposure to phthalates, leading to non-
differential misclassification and subsequent bias towards the null.137 
Quantitative detection of environmental compounds, such as bisphenols and phthalates, is always 
complicated by left censoring due to non-detectable concentrations. Several methods have been 
proposed to handle left-censored data, including deletion, simple replacement, extrapolation or 
maximum likelihood estimation. In the studies comprising this thesis we applied a simple replacement 
technique by substituting the values below the limit of detection (LOD) for LOD/√2, as standard 
practice.138,139 Such replacement techniques are convenient but may affect the variability of the 
distribution and may thereby distort regression coefficients and reduce power. However, when only 




the studies comprising this thesis, individual bisphenols or phthalate metabolites were included in the 
groups when >20% of values were detected and bisphenols were analyzed individually when >50% of 
the values were detected. Almost all included phthalate metabolites had very high detection rates, 
allowing for simple replacement techniques. Detection rates for bisphenols were lower, which might 
have complicated the detection of associations. 
Urinary concentrations of bisphenols and phthalate metabolites were measured in a single spot urine 
sample in the majority of studies in this thesis. A few studies used two spot urine samples to measure 
exposure levels. Both bisphenols and phthalates have short biological half-lives (less than 24h).141,142 
Despite of the reported short biological half-lives, it has been suggested that one single urine sample 
for phthalate concentrations reasonably reflects exposure for up to three months or even longer.143,144 
Phthalate exposure sources such as personal care products and indoor environments are relatively 
consistent, while dietary sources of phthalate exposure are known to be more variable.33 Within-person 
variability of bisphenol urinary concentrations is reported to be high, constraining the value of one 
single urine sample for bisphenol measurement.145 This non-differential misclassification is expected to 
lead to attenuation bias in dose-response relationships. 
It has been suggested that exposure to phthalate esters with long side chains is easily underestimated 
if only a few metabolites are being measured.146 For the studies in this thesis, 18 phthalate metabolites 
were measured including phthalate acid. Phthalate acid is a common endpoint of phthalate metabolism 
and can be used as a proxy for total phthalate exposure.147 Therefore, we do not expect underestimation 
of phthalate exposure due to limited metabolite measurements. Urinary concentrations of bisphenols 
and phthalate metabolites are subject to dilution. To correct for dilution several methods are applied. 
In the studies comprising this thesis we applied creatinine adjustments with measured creatinine levels 
from each spot urine sample. Endogenous creatinine clearance, measured by 24-hr urine collection, 
remains the most precise estimation of glomerular filtration rate in pregnant women.148 It has been 
suggested that specific gravity adjustment is a better correction method in pregnant women.149 
Unfortunately, specific gravity measurements were not available.
Self-reported lifestyle habits, such as parental smoking or lifestyle and nutrition related factors 
investigated as potential determinants of bisphenols and phthalates, may have been underreported or 
overreported by the parents since most parents are aware of potential negative effects of these habits. 
Since parents were unaware of specific research questions, differential misclassification seems unlikely, 
but non-differential misclassification may have resulted in attenuation of the studied associations. 
The majority of outcomes in this thesis were hands-on measurements of weight or growth, medical 
diagnoses, ultrasound measurements or laboratory analyses. Observers of these outcomes were 
unaware of exposure status, which makes differential misclassification unlikely. Some of the outcomes 
were self-reported and recalled, including time to pregnancy, pre-pregnancy weight and highest 
weight before birth. Self-reported weight tends to be underestimated, leading to non-differential 
misclassification. Only one study investigated recall error for prospectively measured and recalled time 
to pregnancy, showing a reasonable validity.150 Although misclassification might be present, differential 




Confounding is present when all or part of the observed association between the exposure and the 
outcome is in fact explained by other variables associated with the outcome without being affected 
by the exposure themselves.151 If a confounding factor is not taken into account, results might be 
biased obscuring the true exposure effect. In this thesis, we have used several approaches to explore 
the role of confounding in the studied associations. To take account for confounding, we adjusted all 
analyses for multiple potential confounders. We selected covariates based on their associations with 
the exposures and outcomes of interest in our or previous studies or a change in effect estimate of 
more than 10%. As in any observational study, residual confounding might still be present due to 
unknown or unmeasured confounding variables. Some of the unmeasured confounding can relate to 
other environmental exposures, medical history, genetics, and unmeasured sociodemographic and 
lifestyle factors, including maternal diet and activity. Also, information about several confounders was 
self-reported and measurement error might have occurred, contributing to residual confounding and 
an under- or overestimation of the observed effect estimates. To help understanding whether the 
associations of maternal smoking with adverse birth outcomes and childhood adiposity are explained by 
direct intrauterine mechanisms or confounded by environmental, lifestyle or genetic characteristics, we 
compared associations of maternal and paternal smoking exposure during pregnancy. A similar effect 
size for the maternal and paternal association would suggest that the association of maternal smoking 
with adverse birth outcomes and childhood adiposity is explained by shared family-based lifestyle and 
genetic characteristics, rather than intrauterine programming. 
Causality
The causality of the associations observed in this thesis remains to be established. The Bradford 
Hill criteria can be used to provide evidence of the causal relationship between an exposure and an 
outcome, including strength, consistency, specificity, temporality, dose-response relationship, biological 
plausibility, coherence, experiment and analogy.152 Overall, if an association is observed at all, our 
associations are relatively small. Notwithstanding that stronger associations are more likely to be causal, 
weak associations may also be causal. For many of the associations investigated in this thesis, evidence 
so far is limited, complicating effect interpretation. However, the majority of findings is consistent with 
previous studies, potential biological mechanisms and animal studies. Environmental exposures are 
not likely to be specific and give rise to only one single outcome. Except for the studies concerning 
determinants of bisphenols and phthalates and time to pregnancy, all studies were longitudinal 
supporting temporality between exposures and outcomes. Although some previous studies suggested 
non-monotonic effects from bisphenols and phthalates, all our associations were linear showing a dose-
response effect. Also for associations of smoking, strong dose-response relationships were observed, 
consistent with previous studies and potential mechanisms, primarily for fetal growth restriction. As 
this thesis is based on observational research, the criterion of experiment is not addressed in this thesis 
and would not be ethically responsible. Also the analogy criterion is not being addressed in this thesis. 
Altogether, this thesis was not designed to clarify causality of these associations, but some of our 
observational  studies seem to provide some evidence for causal relationships based on the Bradford 





As stated previously, environmental exposures such as bisphenols, phthalates and smoking have a 
significant share in chronic non-communicable diseases worldwide and exposure during pregnancy is 
a window of vulnerability for both mother and child. Findings from this thesis provide some evidence 
that bisphenol and phthalate exposure during pregnancy may affect maternal health in the short and 
long term, including time to pregnancy, placental hemodynamics, adequate gestational weight gain 
and postpartum weight gain. For parental smoking, findings suggest that maternal smoking affects 
risks for small size for gestational age through a direct intra-uterine effect and may therefore benefit 
from quitting maternal smoking during pregnancy. Contrariwise, parental smoking associations with 
childhood adiposity seem rather based on shared family-based and genetic characteristics than a direct 
intra-uterine effect. However, the following major issues remain to be addressed in future studies. 
Causality
Although we found some evidence for causality in our studies based on the Bradford Hill criteria, the 
causality of the associations of bisphenols and phthalates during pregnancy with maternal health 
outcomes observed in this thesis remains unclear. Associations as observed between maternal smoking 
during pregnancy and fetal growth restriction met with multiple Bradford Hill criteria for causality. 
However, a causal relationship still has not been confirmed. For preterm birth and childhood adiposity 
the causality of the associations as observed in this thesis remains unclear. 
Randomized controlled trials are the golden standard study design to establish causality, however this 
is not possible for environmental chemicals like bisphenols and phthalates. For the association with 
fetal growth, previous randomized smoking cessation trials have shown an increased birth weight for 
the quitters compared to the continued smokers, but do not take into account the time of quitting and 
do not report on effects in the group that does not quit completely but does reducing their smoking 
intake.153,154 
Parental negative control studies and sibling comparison studies allow control for shared family-based 
characteristics. Sibling comparison studies additionally allow control for maternal genotype that are 
shared among siblings. This study design is difficult for bisphenol and phthalate exposure. Few studies 
have used this design to investigate the associations between smoking during pregnancy and fetal 
growth restriction.120,155 However, as other characteristics such as lifestyle may differ between parents 
or siblings, this design may lead to biased estimates.156 
Mendelian randomization studies use genetic variants that are robustly associated with the exposure 
of interest, not affected by confounding and therefore are an adequate design to examine causal 
relationships. Further investigation of genetic variants associated with bisphenol and phthalate 
metabolism might shed light on the most vulnerable populations and may allow for Mendelian 
randomization studies. Our study on time to pregnancy revealed an association of bisphenols and 
phthalates with reduced fecundability among women who did not use preconception folic acid 
supplements. This finding is hypothesis generating suggesting that the mechanism by which bisphenols 
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and phthalates impair reproductive potential may involve changes in DNA methylation. Further research 
is needed to investigate these mechanisms and to obtain more evidence on maternal folate levels that 
counteract these effects. 
Among Europeans, the common variant rs1051730 is robustly associated with smoking quantity and is 
associated with a reduced ability to quit smoking during pregnancy.157,158 This genotype was associated 
with reduced birth weight among current maternal smokers but not among quitters and non-smokers, 
strengthening the evidence that maternal cigarette smoking during pregnancy is causally related to a 
lower birth weight.120,159 However, due to a small number of individuals in the group of quitters, these 
findings should be taken with caution. Also, the role of smoking in the preconception period has to be 
further assessed. To further increase evidence for causality, future studies should assess larger groups 
of quitters, reducers and smoking in the preconception period. 
For preterm birth and childhood adiposity, these studies are lacking. For childhood adiposity, further 
studies are needed to assess the role of exposure to smoking during childhood, as many women who 
quitted during pregnancy resume smoking shortly after birth.160 While potential mechanisms between 
smoking and fetal growth restriction are rather established, mechanisms for preterm birth and 
childhood adiposity are not yet clear. Further research is needed to assess such possible mechanisms. 
Assessment of exposures and outcomes
As mentioned previously, potential misclassification of bisphenol and phthalate exposure might be 
present in the studies comprising this thesis. To reduce this risk of misclassification and bias due to high 
exposure temporal variability, future studies should include a large number of urine samples, preferably 
also during the preconception period and in very early pregnancy. To reduce the additional costs of 
laboratory analysis of a large number of samples, samples could be pooled as reported previously.33 
However, the adequate number of samples for bisphenols and phthalates with variable exposure 
sources such as diet should be further investigated. As urinary samples are often stored before 
laboratory analysis, further studies should investigate optimal storage conditions and effects of long-
term storage. The studies in this thesis use creatinine correction to correct for urinary dilution. It has 
been suggested that specific gravity is a better correction method in pregnant women.149 Future studies 
of maternal urinary bisphenol and phthalate metabolite concentrations should preferably use specific 
gravity measurements to correct for urinary dilution. Parental smoking information was self-reported. 
Measured cotinine levels might be used to confirm smoking status and to quantify passive smoking in 
order to reduce the risk for misclassification and bias.
During pregnancy, women are not only exposed to bisphenols or phthalates but to a whole spectrum of 
environmental chemicals. Not much is known about these chemical mixtures, e.g. the value of individual 
chemical agents, potential interactions and potential cumulative exposure to multiple agents.161 Only 
few studies have quantified the impact of aggregate exposure to multiple chemicals, but none have for 
the outcomes investigated in this thesis. Several methods to investigate chemical mixtures have been 
proposed,162 however it still remains difficult to address exposure variability issues at the same time. 
Moreover, not only exposures during pregnancy may affect maternal health during and after pregnancy, 




experiences in a lifetime and how those exposures relate to health.163 This exposome does not only 
include environmental chemicals, but also the ecosystem and socio-economic and lifestyle factors. 
Investigation of the exposome is challenging and complex, but might reveal further insight in disease 
etiology and give opportunities for prevention.  
Concerning the outcomes, many were self-reported and some were even recalled, such as time to 
pregnancy, pre-pregnancy weight and highest weight during pregnancy before birth. Prospectively 
measured outcomes might reduce the risk for misclassification and bias. For outcomes like weight gain 
and adiposity, measurements of body composition such as magnetic resonance imaging measurements 
might provide further insight into the underlying mechanism. To optimize, repeated measurements of 
weight, growth and body composition are needed to allow for investigation of specific weight gain and 
growth patterns. Additional measures of cardiometabolic function postpartum and during childhood, 
such as blood pressure, insulin/glucose metabolism and endothelial function might be of interest to 
gain more knowledge about long-term cardiometabolic changes. 
Implications for clinical practice and policy
Maternal exposure to bisphenols and phthalates during pregnancy might affect maternal health on the 
short and long term. The observed effect estimates were, if an association was observed, small. However, 
these small effects might contribute to the total burden of disease due to environmental exposures 
during the human life course. Even subclinical differences in maternal health during pregnancy might 
influence fetal outcomes and potentially induce transgenerational effects. As pregnancy is a window of 
vulnerability to metabolic changes in the mother, small effects during or shortly after pregnancy might 
track into later life contributing to the development of cardiovascular and metabolic disease. Further 
studies are needed to investigate potential causal effects. Although further governmental embargoes 
may seem beneficial, it may also stimulate the use of even more harmful substitutes. As exposure 
to bisphenols and phthalates seems associated with adverse lifestyle habits, preventive strategies or 
interventions should focus on motivating women to make lifestyle changes during the preconception 
period and pregnancy. Although lifestyle medicine is an emerging field of interest and governmental 
policies follow slowly, the focus is rather on secondary prevention than on primary prevention among 
fertile man and women. Since preconception consultations are not standard in the Netherlands, health 
professionals should address these issues during regular appointments, even when the woman is 
already pregnant. Governmental campaigns including promotion of preconception consultations might 
increase awareness among man and women who are planning to start a family. 
The study in this thesis provides solid evidence that maternal smoking during pregnancy affects fetal 
growth through a direct intra-uterine effect with beneficial effects from quitting and even reducing 
smoking intake during pregnancy. For childhood adiposity, parental smoking effects seem rather based 
on shared family-based lifestyle and genetic characteristics than a direct intra-uterine effect. The 
associations as observed for preterm birth were small. However, our results might be important from 
an etiological and preventive perspective since preterm birth, fetal growth restriction and childhood 
adiposity are related with adverse health consequences in later life. These findings imply that it is of 
the greatest importance to invest in prevention of smoking in women of reproductive age, but they 
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also vote for an ongoing support of smoking pregnant women to motivate them to reduce smoking, 
even in advanced pregnancy. Current guidelines focus only on quitting and not reducing smoking, while 
reducing could be beneficial for women who find it difficult to quit completely. Our results concerning 
childhood adiposity advocate for preventive strategies or interventions focused on lifestyle changes 
in the preconception period for both parents. Fathers should therefore be more closely involved in 
preconception and also pregnancy consultations.  
Conclusion
Findings from this thesis suggest that environmental exposures during pregnancy, such as bisphenols, 
phthalates and smoking may affect maternal and child health outcomes in the short and long term. 
The observed associations are relatively small, but may contribute to the total burden of morbidity and 
mortality due to non-communicable diseases. Further research with more precise exposure assessment 
including assessment of chemical mixtures and exposure during the periconception, pregnancy and 
postpartum periods is needed to provide more solid information about potential causal effects as a 
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In Chapter 1, the background for the studies presented in this thesis is described. Chapter 1.1 provides 
the background, hypothesis, aims and design for this thesis. Environmental exposures are omnipresent 
throughout the human life course and may have a vast influence on human health. An increasing body 
of evidence suggests that exposure to bisphenols and phthalates may lead to several adverse short and 
long-term health effects, including the development of cardiometabolic diseases. Thus far, only few 
studies have assessed the associations of bisphenols and phthalates with the course of pregnancy and 
maternal health. Also, smoking remains highly prevalent among women of reproductive age, posing 
a risk for children born to smoking mothers. Maternal smoking has been associated with increased 
risks of adverse birth outcomes and childhood overweight. It remains unknown to what extent 
maternal smoking in early pregnancy only, changing maternal smoking behavior and paternal smoking 
influence these outcomes. The studies presented in this thesis used data from the Generation R Study, 
a population-based cohort from fetal life onwards in Rotterdam, the Netherlands, and the LifeCycle 
Project, an international consortium of European cohorts that started during pregnancy or childhood. In 
Chapter 1.2, we summarized available evidence on bisphenols and phthalates, including on their routes 
of exposure, metabolism and potential mechanisms of effect. We also reviewed existing evidence on 
the associations of bisphenols and phthalates with maternal, fetal and child growth outcomes. Although 
the amount of studies focused on maternal outcomes, such as time to pregnancy, gestational diabetes 
mellitus and gestational hypertensive disorders, is limited, potential adverse effects have already been 
described. Evidence from observational studies shows a mainly negative effect of phthalates and 
negative or no effect of bisphenol A on gestational age and body size measures at birth. Studies of 
effects on childhood growth show contradictory results, but do suggest a potential modifying role for 
sex, stage of puberty and ethnicity. 
Chapter 2 describes studies on the associations of bisphenols and phthalate metabolites with 
maternal determinants and outcomes. In Chapter 2.1, we observed that bisphenol S and F exposure 
was highly prevalent in pregnant women in the Netherlands as early as 2004-5. Nutritional related 
factors, including daily dietary caloric intake and food groups, were not associated with bisphenols 
and phthalate metabolite concentrations when multiple testing corrections were applied. Adverse 
lifestyle related factors, such as pre-pregnancy obesity and the lack of folic acid supplement use, were 
associated with higher phthalate metabolite concentrations. In Chapter 2.2, we studied the associations 
of early pregnancy bisphenol and phthalate concentrations with time to pregnancy. We did not observe 
an association in the whole group, but among women without adequate preconception folic acid 
supplement use, we observed associations of higher total bisphenols and phthalic acid with reduced 
fecundability ratios (corresponding to a longer time to pregnancy). In Chapter 2.3, we evaluated the 
associations of early pregnancy bisphenol and phthalate metabolite concentrations with maternal 
hemodynamics and gestational hypertensive disorders. Bisphenols and phthalate metabolites were not 
associated with gestational hypertensive disorders or longitudinal changes in blood pressure during 
pregnancy. We observed subclinical associations of high molecular weight phthalate metabolites with 
higher early pregnancy sFlt-1/PlGF ratio and of bisphenol A with placental hemodynamics. In Chapter 
2.4, we focused on the associations of early and mid-pregnancy urinary bisphenol and phthalate 
metabolite concentrations with gestational weight gain. We showed that higher total bisphenol and 
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bisphenol S urine concentrations in early pregnancy were associated with reduced gestational weight 
gain among normal weight women. Among all women, higher total bisphenol and bisphenol A urine 
concentrations in early pregnancy were associated with a reduced gestational weight gain in the 
second half of pregnancy. Associations were independent of mid-pregnancy compounds. Bisphenols 
and phthalate metabolites were not associated with insufficient or excessive gestational weight gain. 
As a follow-up study, in Chapter 2.5, we studied the associations of early and mid-pregnancy urinary 
bisphenol and phthalate metabolite concentrations with maternal weight gain 6 years postpartum. 
Among all included women, bisphenol A and all assessed phthalate groupings were associated with 
increased maternal weight gain. Among women without subsequent pregnancies, phthalic acid, low 
molecular weight phthalate metabolites and di-n-octylphthalate metabolites remained associated 
with increased maternal weight gain. Mediation by gestational weight gain was not present and 
breastfeeding did not modify the effects. In summary, findings from Chapter 2 suggest that exposure 
to bisphenols and phthalates during pregnancy may lead to adverse maternal health outcomes in the 
short and long-term. 
In Chapter 3, we performed an individual participant data meta-analysis among 229,158 families from 
28 pregnancy or birth cohorts from Europe and North America to assess the associations of parental 
smoking with adverse birth outcomes and childhood overweight. Compared with non-smoking 
mothers, maternal first trimester smoking only was not associated with adverse birth outcomes but was 
associated with a higher risk of childhood overweight. Children from mothers who continued smoking 
during pregnancy had higher risks of preterm birth, being small size for gestational age and childhood 
overweight. Children from mothers who reduced the number of cigarettes between the first and third 
trimester, without quitting, still had a higher risk to be born small size for gestational age, but the effect 
estimate was smaller. Among non-smoking mothers, paternal smoking was associated with childhood 
overweight, but not with adverse birth outcomes. 
Finally, in Chapter 4, a general discussion of all studies included in this thesis, suggestions for future 
research and implications for clinical practice and policy are presented. 
In conclusion, findings from this thesis suggest that environmental exposures during pregnancy, such 
as bisphenols, phthalates and smoking may affect maternal and child health outcomes in the short 
and long-term. The observed associations are relatively small, but may be important for the burden of 





In Hoofdstuk 1 wordt de achtergrond van de onderzoeken in dit proefschrift besproken. Hoofdstuk 
1.1 beschrijft de achtergrond, hypothese, de doelstellingen en de opzet van dit proefschrift. Mensen 
worden gedurende het leven blootgesteld aan diverse omgevingsfactoren die van grote invloed op 
de gezondheid kunnen zijn. Een toenemend aantal studies wijst erop dat blootstelling aan bisfenolen 
en ftalaten zou kunnen leiden tot verschillende ongunstige gezondheidseffecten op de korte en lange 
termijn, inclusief het ontwikkelen van cardiometabole aandoeningen. Tot dusver hebben slechts 
enkele studies onderzoek gedaan naar associaties van bisfenolen en ftalaten met het beloop van de 
zwangerschap en de maternale gezondheid. Verder blijven veel vrouwen in de vruchtbare leeftijd roken, 
wat een risico vormt voor de kinderen van deze rokende moeders. Het roken van moeders is geassocieerd 
met verhoogde risico’s op geboorte complicaties en overgewicht op de kinderleeftijd. Het blijft 
onbekend in welke mate deze uitkomsten beïnvloed worden wanneer moeder enkel tijdens de vroege 
zwangerschap rookt, haar rookgedrag tijdens de zwangerschap verandert en welk aandeel het roken 
van vaders hierin heeft. De onderzoeken die in dit proefschrift worden besproken zijn op basis van data 
van de Generation R Study, een populatie-gebaseerd cohort dat gevolgd wordt vanaf het vroege foetale 
leven in Rotterdam, Nederland, en het LifeCycle Project, een internationaal consortium van Europese 
cohorten die gestart zijn tijdens de zwangerschap of op de kinderleeftijd. In Hoofdstuk 1.2 hebben we 
de beschikbare studies over bisfenolen en ftalaten samengevat, inclusief de blootstellingsroutes, het 
metabolisme en het potentiële werkingsmechanisme. Daarnaast hebben we een review gemaakt van 
de bestaande onderzoeken naar de associaties van bisfenolen en ftalaten met maternale en foetale 
uitkomsten en groei op de kinderleeftijd. Hoewel er maar een klein aantal onderzoeken gericht was 
op maternale uitkomsten, zoals hoe lang het duurt om zwanger te worden, zwangerschapsdiabetes en 
hypertensieve aandoeningen in de zwangerschap, zijn er al potentiële ongunstige effecten beschreven. 
Observationele studies laten voornamelijk negatieve associaties van ftalaten en negatieve ofwel geen 
associaties van bisphenol A zien met de zwangerschapsduur of lichaamsafmetingen bij geboorte. 
Onderzoeken naar effecten op groei op de kinderleeftijd laten tegenstrijdige resultaten zien, maar 
suggereren wel een potentieel modificerende rol voor geslacht, puberteitsstadium en etniciteit. 
Hoofdstuk 2 beschrijft onderzoeken naar de associaties van bisfenolen en ftalaat metabolieten met 
maternale determinanten en uitkomsten. In Hoofdstuk 2.1 vonden we dat bisfenol S en F blootstelling 
onder zwangere vrouwen in Nederland in 2004-5 al wijd verspreid was. Voedingsgerelateerde factoren, 
inclusief de dagelijkse calorie inname via voeding en groepen van voedingsmiddelen, waren niet 
geassocieerd met bisfenolen en ftalaat metabolieten wanneer een correctie voor de veelvoud aan 
testen was toegepast. Ongunstige leefstijlgerelateerde factoren, zoals obesitas voorafgaand aan de 
zwangerschap en het niet nemen van foliumzuur supplementen, waren geassocieerd met hogere 
concentraties van ftalaat metabolieten. In Hoofdstuk 2.2 hebben we de associaties bestudeerd 
van bisfenol en ftalaat metaboliet concentraties tijdens de vroege zwangerschap met hoe lang het 
geduurd heeft om zwanger te worden. We vonden geen associaties in de volledige groep, maar 
onder de vrouwen die geen preconceptionele foliumzuur supplementen hadden genomen vonden 
we dat een hoger totaal bisfenol en ftaalzuur geassocieerd was met een verminderde vruchtbaarheid 
(corresponderend met een langere tijd om zwanger te worden). In Hoofdstuk 2.3 hebben we gekeken 
of er associaties zijn van bisfenol en ftalaat metaboliet concentraties in de vroege zwangerschap met 
maternale hemodynamiek en hypertensieve aandoeningen in de zwangerschap. Bisfenolen en ftalaat 
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metabolieten waren niet geassocieerd met hypertensieve aandoeningen in de zwangerschap of 
met longitudinale veranderingen in de bloeddruk tijdens de zwangerschap. We vonden subklinische 
associaties van hoog moleculair gewicht ftalaat metabolieten met een hogere sFlt-1/PlGF ratio in de 
vroege zwangerschap en van bisfenol A met placenta hemodynamiek. In Hoofdstuk 2.4 hebben we 
ons gericht op de associaties van urine concentraties van bisfenolen en ftalaat metabolieten vroeg en 
halverwege in de zwangerschap met gewichtstoename tijdens de zwangerschap. We vonden dat hogere 
urine concentraties van totaal bisfenol en bisfenol S in de vroege zwangerschap geassocieerd waren met 
een verminderde gewichtstoename tijdens de zwangerschap onder vrouwen met een gezond gewicht. 
Hogere urine concentraties van totaal bisfenol en bisfenol A tijdens de vroege zwangerschap waren 
geassocieerd met een verminderde gewichtstoename in de tweede helft van de zwangerschap onder 
alle vrouwen. Deze associaties waren onafhankelijk van het niveau van blootstelling halverwege de 
zwangerschap. Bisfenolen en ftalaat metabolieten waren niet geassocieerd met inadequate of excessieve 
gewichtstoename tijdens de zwangerschap. Hierop volgend hebben we in Hoofdstuk 2.5 gekeken naar 
associaties van urine concentraties van bisfenolen en ftalaat metabolieten vroeg en halverwege in de 
zwangerschap met maternale gewichtstoename 6 jaar postpartum. Onder alle geïncludeerde vrouwen 
waren bisfenol A en alle ftalaat groepen geassocieerd met een toename van het maternale gewicht. 
Onder vrouwen zonder volgende zwangerschappen bleven ftaalzuur, laag moleculair gewicht ftalaat 
metabolieten en di-n-octylftalaat metabolieten geassocieerd met een toename van het maternale 
gewicht. Associaties werden niet gemedieerd door gewichtstoename tijdens de zwangerschap en het 
geven van borstvoeding modificeerde de effecten niet. Samenvattend suggereren de bevindingen 
in Hoofdstuk 2 dat blootstelling aan bisfenolen en ftalaten tijdens de zwangerschap kan leiden tot 
ongunstige maternale gezondheidsuitkomsten op de korte en lange termijn. 
In Hoofdstuk 3 hebben we een meta-analyse verricht van individuele deelnemersgegevens onder 
229.158 gezinnen van 28 zwangerschaps- of geboorte cohorten uit Europa en Noord-Amerika om de 
associaties te onderzoeken van het roken van ouders met geboortecomplicaties en overgewicht op de 
kinderleeftijd. Vergeleken met niet rokende moeders was roken enkel tijdens de vroege zwangerschap 
niet geassocieerd met geboortecomplicaties, maar wel met een hoger risico op overgewicht op de 
kinderleeftijd. Kinderen van moeders die bleven roken tijdens de zwangerschap hadden een hoger 
risico op vroeggeboorte, een te laag geboortegewicht voor de zwangerschapsduur en overgewicht op 
de kinderleeftijd. Kinderen van moeders die bleven roken maar het aantal sigaretten dat zij dagelijks 
rookten tussen het eerste en derde trimester verminderden hadden nog steeds een verhoogd risico om 
geboren te worden met een te laag geboortegewicht voor de zwangerschapsduur, maar de effectgrootte 
was afgenomen. Onder niet rokende moeders was het roken van vaders geassocieerd met overgewicht 
op de kinderleeftijd, maar niet met geboortecomplicaties. 
Tot slot wordt in Hoofdstuk 4 een algemene discussie over alle studies in dit proefschrift gepresenteerd, 
samen met suggesties voor verder onderzoek en implicaties voor de klinische praktijk en beleid. 
Concluderend suggereren de bevindingen van dit proefschrift dat blootstelling aan omgevingsfactoren 
tijdens de zwangerschap, zoals bisfenolen, ftalaten en roken, gezondheidsuitkomsten van moeder 
en kind kunnen beïnvloeden op de korte en lange termijn. De effectgrootte van de geobserveerde 
associaties is relatief klein, maar op populatieniveau zouden deze associaties van belang kunnen zijn 
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DOHaD: Developmental Origins of Health and Disease
E2: estradiol
ECHA: European Chemicals Agency
EDC: endocrine-disrupting chemical
ER: estrogen receptor
FCS: fully conditional specification
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GWG: gestational weight gain
GRP30: G-protein-coupled receptor 30
HCHs: hexachlorocyclohexanes
HDL: high-density lipoprotein
HMW: high molecular weight
HOMA-IR: homeostatic model assessment of insulin resistance
HPLC-ESI-MS/MS: high performance liquid chromatography electrospray ionization-tandem mass 
spectrometry
IGF-1: insulin-like growth factor 1
IOM: Institute of Medicine
IPD: individual participant data
IQR: inter-quartile range
IVF: in vitro fertilization
LLE: liquid-liquid extraction
LOD: limit of detection
LOQ: limit of quantification
LMW: low molecular weight































PlGF: placental growth factor
POPs: persistant organic pollutions
PPAR: peroxisome proliterator-activated receptor
PVC: polyvinyl chloride plastics
RI: resistance index
RXR: retinoid X receptor
SD: standard deviation
SDS: standard deviation scores
sFlt: soluble fms-like tyrosine kinase
SGA: small size for gestational age
SPE: solid-phase extraction
TTP: time to pregnancy
UGT: UDP-glucuronosyltransferase
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